EurekaMag PDF full texts Chapter 53,519

Mancone, C.; Steindler, C.; Santangelo, L.; Simonte, G.; Vlassi, C.; Longo, M.Antonella.; D'Offizi, G.; Di Giacomo, C.; Pucillo, L.Paolo.; Amicone, L.; Tripodi, M.; Alonzi, T. 2011: Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut 60(3): 378-386

Lee, H.-C.; Sung, S.-S.J.; Krueger, P.D.; Jo, Y.-A.; Rosen, H.R.; Ziegler, S.F.; Hahn, Y.S. 2013: Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology 57(4): 1314-1324

Wu, S.; Kanda, T.; Nakamoto, S.; Imazeki, F.; Yokosuka, O. 2013: Hepatitis C virus protease inhibitor-resistance mutations: our experience and review. World Journal of Gastroenterology 19(47): 8940-8948

Abdel-Magid, A.F. 2012: Hepatitis C virus protease inhibitors: patent highlight. ACS medicinal chemistry letters 3(9): 699-700

Chen, Z.; Zhu, Y.; Ren, Y.; Tong, Y.; Hua, X.; Zhu, F.; Huang, L.; Liu, Y.; Luo, Y.; Lu, W.; Zhao, P.; Qi, Z. 2011: Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement. Plos one 6(4): E18933

Nishina, S.; Korenaga, M.; Hidaka, I.; Shinozaki, A.; Sakai, A.; Gondo, T.; Tabuchi, M.; Kishi, F.; Hino, K. 2010: Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice. Liver International: Official Journal of the International Association for the Study of the Liver 30(5): 683-692

Piccoli, C.; Scrima, R.; Quarato, G.; D'Aprile, A.; Ripoli, M.; Lecce, L.; Boffoli, D.; Moradpour, D.; Capitanio, N. 2007: Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46(1): 58-65

Dubuisson, J. 2007: Hepatitis C virus proteins. World Journal of Gastroenterology 13(17): 2406-2415

Ivanov, A.V.; Smirnova, O.A.; Ivanova, O.N.; Masalova, O.V.; Kochetkov, S.N.; Isaguliants, M.G. 2011: Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. Plos one 6(9): E24957

Lerat, H.é; Kammoun, H.él.èn.L.; Hainault, I.; Mérour, E.; Higgs, M.R.; Callens, C.él.; Lemon, S.M.; Foufelle, F.; Pawlotsky, J.-M. 2009: Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. Journal of Biological Chemistry 284(48): 33466-33474

Braconi, C.; Valeri, N.; Gasparini, P.; Huang, N.; Taccioli, C.; Nuovo, G.; Suzuki, T.; Croce, C.M.; Patel, T. 2010: Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(3): 957-966

Moradpour, D.; Penin, F.ço. 2013: Hepatitis C virus proteins: from structure to function. Current Topics in Microbiology and Immunology 369: 113-142

Menezes, G.B.L.; Pereira, F.A.; Duarte, C.és.A.B.; Carmo, T.M.A.; Silva Filho, H.P.d.; Zarife, M.A.; Krieger, M.A.él.; Reis, E.A.G.; Reis, M.G. 2012: Hepatitis C virus quantification in serum and saliva of HCV-infected patients. Memorias do Instituto Oswaldo Cruz 107(5): 680-683

Laskus, T.; Wilkinson, J.; Karim, R.; Mack, W.; Radkowski, M.; deGiacomo, M.; Nasseri, J.; Chen, Z.; Xu, J.; Kovacs, A. 2007: Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART). Hepatology 46(2): 359-370

Figlerowicz, M.; Jackowiak, P.; Formanowicz, P.; Kędziora, P.ł; Alejska, M.; Malinowska, N.; Błażewicz, J.; Figlerowicz, M. 2010: Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Archives of Virology 155(12): 1977-1987

Vera-Otarola, J.; Barría, M.I.; León, U.; Marsac, D.; Carvallo, P.; Soza, A.; López-Lastra, M. 2009: Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naïve chronically infected patients. Journal of Viral Hepatitis 16(9): 633-643

Yazici, O.; Sendur, M.A.N.; Aksoy, S. 2014: Hepatitis C virus reactivation in cancer patients in the era of targeted therapies. World Journal of Gastroenterology 20(22): 6716-6724

Mensa, L.; Crespo, G.; Gastinger, M.J.; Kabat, J.; Pérez-del-Pulgar, S.ía.; Miquel, R.; Emerson, S.U.; Purcell, R.H.; Forns, X. 2011: Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics. Hepatology 53(5): 1436-1445

Viazov, S.; Ross, S.S.; Kyuregyan, K.K.; Timm, J.; Neumann-Haefelin, C.; Isaeva, O.V.; Popova, O.E.; Dmitriev, P.N.; El Sharkawi, F.; Thimme, R.; Michailov, M.I.; Roggendorf, M. 2010: Hepatitis C virus recombinants are rare even among intravenous drug users. Journal of Medical Virology 82(2): 232-238

Gelley, F.; Gámán, G.ör.; Gerlei, Z.; Zádori, G.; Görög, D.én.; Kóbori, L.ás.ó; Fehérvári, I.; Schuller, J.án.; Szőnyi, L.ás.ó; Nagy, P.ét.; Doros, A.; Fazakas, J.án.; Lengyel, G.; Schaff, Z.; Kiss, A.ás.; Sárváry, E.ő; Nemes, B.áz. 2013: Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years. Orvosi Hetilap 154(27): 1058-1066

Jiménez-Pérez, M.; Sáez-Gómez, A.B.; Pérez-Daga, J.A.; Lozano-Rey, J.M.; de la Cruz-Lombardo, J.; Rodrigo-López, J.M. 2010: Hepatitis C virus recurrence after liver transplantation: analysis of factors related to sustained viral response. Transplantation Proceedings 42(2): 666-668

Maluf, D.G.; Archer, K.J.; Villamil, F.; Stravitz, R.T.; Mas, V. 2010: Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. Expert Review of Gastroenterology and Hepatology 4(4): 445-458

Aguilera, V. 2014: Hepatitis C virus recurrence after liver transplantation: how to treat and when. Transplantation Proceedings 46(9): 3100-3103

Manzia, T.M.; Angelico, R.; Toti, L.; Lai, Q.; Ciano, P.; Angelico, M.; Tisone, G. 2012: Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. Expert Review of Clinical Immunology 8(7): 635-644

Lin, W.; Tsai, W.-L.; Shao, R.-X.; Wu, G.; Peng, L.F.; Barlow, L.L.; Chung, W.J.; Zhang, L.; Zhao, H.; Jang, J.-Y.; Chung, R.T. 2010: Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138(7): 2509

Dall'Agata, M.; Gramenzi, A.; Biselli, M.; Bernardi, M. 2014: Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?. World Journal of Gastroenterology 20(28): 9253-9260

Marco, A.; Esteban, J.I.; Solé, C.; da Silva, A.; Ortiz, J.; Roget, M.; Sarriera, C.; Teixidó, N.; Guerrero, R.A.; Caylà, J.A. 2013: Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. Journal of Hepatology 59(1): 45-51

Grebely, J.; Pham, S.T.; Matthews, G.V.; Petoumenos, K.; Bull, R.A.; Yeung, B.; Rawlinson, W.; Kaldor, J.; Lloyd, A.; Hellard, M.; Dore, G.J.; White, P.A. 2012: Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology 55(4): 1058-1069

Grady, B.P.; Schinkel, J.; Thomas, X.V.; Dalgard, O. 2013: Hepatitis C virus reinfection following treatment among people who use drugs. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(Suppl 2): S105-S110

Bolognesi, M.; Quaglio, C.; Bombonato, G.; Guido, M.; Cavalletto, L.; Chemello, L.; Merkel, C.; Rugge, M.; Gatta, A.; Sacerdoti, D. 2008: Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color Doppler. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 14(5): 616-624

Martin, T.C.S.; Martin, N.K.; Hickman, M.; Vickerman, P.; Page, E.E.; Everett, R.; Gazzard, B.G.; Nelson, M. 2013: Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. Aids 27(16): 2551-2557

Farhat, R.; Goueslain, L.; Wychowski, C.; Belouzard, S.; Fénéant, L.; Jackson, C.L.; Dubuisson, J.; Rouillé, Y. 2013: Hepatitis C virus replication and Golgi function in brefeldin a-resistant hepatoma-derived cells. Plos one 8(9): E74491

O'Leary, J.G.; Davis, G.L. 2010: Hepatitis C virus replication and potential targets for direct-acting agents. Therapeutic Advances in Gastroenterology 3(1): 43-53

Chukkapalli, V.; Randall, G. 2014: Hepatitis C virus replication compartment formation: mechanism and drug target. Gastroenterology 146(5): 1164-1167

Bartenschlager, R.; Cosset, F.-L.; Lohmann, V. 2010: Hepatitis C virus replication cycle. Journal of Hepatology 53(3): 583-585

Ruiz-Mateos, E.; Machmach, K.; Romero-Sanchez, M.C.; Ferrando-Martinez, S.; Viciana, P.; Del Val, M.; Muñoz-Fernandez, M.A.; Genebat, M.; Leal, M. 2011: Hepatitis C virus replication in Caucasian HIV controllers. Journal of Viral Hepatitis 18(7): E350-E357

Nandakumar, R.; Finsterbusch, K.; Lipps, C.; Neumann, B.; Grashoff, M.; Nair, S.; Hochnadel, I.; Lienenklaus, S.; Wappler, I.; Steinmann, E.; Hauser, H.ör.; Pietschmann, T.; Kröger, A. 2013: Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Gastroenterology 145(6): 1414-23.E1

Carreño, V.; Bartolomé, J.; Castillo, I.; Quiroga, J.Antonio. 2009: Hepatitis C virus replication in patients with occult hepatitis C virus infection. Hepatology 49(6): 2128-9; Author Reply 2129

Santos-López, G.; Vallejo-Ruiz, V.ón.; Reyes-Leyva, J. 2007: Hepatitis C virus replication in vitro. Gaceta Medica de Mexico 143(4): 351-352

Hiasa, Y.; Kuzuhara, H.; Tokumoto, Y.; Konishi, I.; Yamashita, N.; Matsuura, B.; Michitaka, K.; Chung, R.T.; Onji, M. 2008: Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta. Hepatology 48(1): 59-69

Lee, C.H.; Kim, J.H.; Kim, H.W.; Myung, H.; Lee, S.-W. 2012: Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme. Nucleic Acid Therapeutics 22(1): 17-29

Lohmann, V.; Bartenschlager, R. 2013: Hepatitis C virus replicons volume 3 and 4. Gastroenterology 144(1): 13-15

Park, J.; Jang, K.L. 2014: Hepatitis C virus represses E-cadherin expression via DNA methylation to induce epithelial to mesenchymal transition in human hepatocytes. Biochemical and Biophysical Research Communications 446(2): 561-567

Xiong, Y.; Zhang, C.; Yuan, J.; Zhu, Y.; Tan, Z.; Kuang, X.; Wang, X. 2015: Hepatitis C virus represses the cellular antiviral response by upregulating the expression of signal transducer and activator of transcription 3 through sponging microRNA‑122. Molecular Medicine Reports 11(3): 1733-1737

Salvatierra, K.; Fareleski, S.; Forcada, A.; López-Labrador, F.X. 2013: Hepatitis C virus resistance to new specifically-targeted antiviral therapy: a public health perspective. World Journal of Virology 2(1): 6-15

Halfon, P.; Locarnini, S. 2011: Hepatitis C virus resistance to protease inhibitors. Journal of Hepatology 55(1): 192-206

Arnaud, Nëlla.; Dabo, Séphanie.; Akazawa, D.; Fukasawa, M.; Shinkai-Ouchi, F.; Hugon, J.; Wakita, T.; Meurs, E.F. 2011: Hepatitis C virus reveals a novel early control in acute immune response. Plos Pathogens 7(10): E1002289

Hahn, J.A.; Evans, J.L.; Davidson, P.J.; Lum, P.J.; Page, K. 2010: Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction 105(7): 1254-1264

Maia, L.P.íc.V.; Martins-Filho, O.A.; Teixeira-Carvalho, A.éa.; Speziali, E.; Vermhren, R.; Lira, E.F.; Lima, T.A.; Braga, W.S.; Torres, K.át.L.; Malheiro, A. 2009: Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis. Journal of Medical Virology 81(7): 1220-1231

Backus, L.I.; Belperio, P.S.; Loomis, T.P.; Yip, G.H.; Mole, L.A. 2013: Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA internal medicine 173(16): 1549-1552

Hwang, J.P.; Suarez-Almazor, M.E.; Torres, H.A.; Palla, S.L.; Huang, D.S.; Fisch, M.J.; Lok, A.S.F. 2014: Hepatitis C virus screening in patients with cancer receiving chemotherapy. Journal of Oncology Practice 10(3): E167-E174

Cartwright, E.J.; Rentsch, C.; Rimland, D. 2014: Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965. Bmc Research Notes 7: 449

Petitjean Lecherbonnier, J.; Gouarin, S.; Dina, J.; Vabret, A.; Freymuth, F. 2007: Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV). Pathologie-Biologie 55(10): 512-520

Clark, P.J.; Thompson, A.J.; Vock, D.M.; Kratz, L.E.; Tolun, A.A.; Muir, A.J.; McHutchison, J.G.; Subramanian, M.; Millington, D.M.; Kelley, R.I.; Patel, K. 2012: Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 56(1): 49-56

Redondo, I.; Otón, E.; Bárcena, R.; Del Campo, S.; Rodriguez-Gandía, M.; Cuervas-Mons, V. 2009: Hepatitis C virus sensitivity to combined antiviral therapy in liver transplant versus immunocompetent patients. Transplantation Proceedings 41(6): 2195-2196

Deng, Z.; Yan, H.; Hu, J.; Zhang, S.; Peng, P.; Liu, Q.; Guo, D. 2012: Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathway. Plos one 7(5): E37700

Martró, E.; Valero, A.; Jordana-Lluch, E.; Saludes, V.ón.; Planas, R.ón.; González-Candelas, F.; Ausina, V.; Bracho, M.A. 2011: Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain. Journal of Medical Virology 83(5): 820-826

Latli, B.; Hrapchak, M.; Gorys, V.; Llinàs-Brunet, M.; Campbell, S.S.; Song, J.; Senanayake, C.H. 2014: Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors. Journal of Labelled Compounds and Radiopharmaceuticals 57(5): 350-357

Lee, M.-H.; Yang, H.-I.; Lu, S.-N.; Jen, C.-L.; Yeh, S.-H.; Liu, C.-J.; Chen, P.-J.; You, S.-L.; Wang, L.-Y.; Chen, W.J.; Chen, C.-J. 2010: Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(30): 4587-4593

Pawlak, K.; Mysliwiec, M.; Pawlak, D. 2010: Hepatitis C virus seropositivity and TNF superfamily receptors: sCD40, sFas--the new putative determinants of endothelial dysfunction in haemodialysis patients. Thrombosis Research 126(5): 393-398

Parboosing, R.; Paruk, I.; Lalloo, U.G. 2008: Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality. Journal of Medical Virology 80(9): 1530-1536

Heimer, R.; Eritsyan, K.; Barbour, R.; Levina, O.S. 2014: Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities. Bmc Infectious Diseases 14(Suppl 6): S12

Kim, A.Y.; Page, K. 2013: Hepatitis C virus serosorting in people who inject drugs: sorting out the details. Journal of Infectious Diseases 208(12): 1929-1931

Zhang, Y.-L.; Guo, Y.-J.; Bin Li; Sun, S.-H. 2009: Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7. Journal of Hepatology 51(1): 29-38

Naarding, M.A.; Falkowska, E.; Xiao, H.; Dragic, T. 2011: Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice. Vaccine 29(16): 2910-2917

Amini, M.; Poustchi, H. 2012: Hepatitis C virus spontaneous clearance: immunology and genetic variance. Viral Immunology 25(4): 241-248

Nasimuzzaman, M.; Waris, G.; Mikolon, D.; Stupack, D.G.; Siddiqui, A. 2007: Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. Journal of Virology 81(19): 10249-10257

Syed, G.H.; Tang, H.; Khan, M.; Hassanein, T.; Liu, J.; Siddiqui, A. 2014: Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. Journal of Virology 88(5): 2519-2529

Berger, K.L.; Kelly, S.M.; Jordan, T.X.; Tartell, M.A.; Randall, G. 2011: Hepatitis C virus stimulates the phosphatidylinositol 4-kinase IIi alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. Journal of Virology 85(17): 8870-8883

Cheng, D.; Jiang, Y.-f.; Xiao, X.-q.; Gong, G.-z. 2012: Hepatitis C virus strain JFH1 down-regulates expression of growth arrest and DNA damage-inducible gene 45a in human hepatoma Huh7.5.1 cells. Zhonghua Gan Zang Bing Za Zhi 20(11): 807-810

Calado, R.A.; Rocha, M.R.; Parreira, R.; Piedade, J.ão.; Venenno, T.; Esteves, A. 2011: Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. Journal of Medical Virology 83(4): 608-615

Sedano, C.D.; Sarnow, P. 2014: Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell Host and Microbe 16(2): 257-264

Rodrigue-Gervais, I.G.ël.; Lamarre, D. 2010: Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells. Medecine Sciences: M/S 26(10): 869-874

Ramírez, S.; Pérez-del-Pulgar, S.ía.; Carrión, J.é A.; Coto-Llerena, M.; Mensa, L.; Dragun, J.; García-Valdecasas, J.C.; Navasa, M.; Forns, X. 2010: Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains. Journal of General Virology 91(Part 5): 1183-1188

Kim, H.; Meyer, K.; Di Bisceglie, A.M.; Ray, R. 2013: Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. Journal of Virology 87(10): 5858-5867

Cao, W.; Sun, B.; Feitelson, M.A.; Wu, T.; Tur-Kaspa, R.; Fan, Q. 2009: Hepatitis C virus targets over-expression of arginase i in hepatocarcinogenesis. International Journal of Cancer 124(12): 2886-2892

Petrovic, D.; Stamataki, Z.; Dempsey, E.; Golden-Mason, L.; Freeley, M.; Doherty, D.; Prichard, D.; Keogh, C.; Conroy, J.; Mitchell, S.; Volkov, Y.; McKeating, J.A.; O'Farrelly, C.; Kelleher, D.; Long, A. 2011: Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion. Hepatology 53(6): 1846-1853

Yehia, B.R.; Herati, R.S.; Fleishman, J.A.; Gallant, J.E.; Agwu, A.L.; Berry, S.A.; Korthuis, P.T.; Moore, R.D.; Metlay, J.P.; Gebo, K.A.; Edelstein, H.; Rutstein, R.; Corales, R.; Jacobson, J.; Allen, S.; Boswell, S.; Gebo, K.; Moore, R.; Agwu, A.; Beil, R.; Chu, C.; Hanau, L.; Korthuis, P.T.; Akbar, M.; Armas-Kolostroubis, L.; Gaur, A.; Sharp, V.; Arpadi, S.; Somboonwit, C.; Mathews, W. C.; Cohn, J.; Hellinger, F.; Fleishman, J.; Fraser, I.; Mills, R.; Malitz, F.; Moore, R.; Keruly, J.; Gebo, K.; Voss, C.; Balding, N. 2014: Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. Plos one 9(7): E102766

Back, E. 2013: Hepatitis C virus testing of persons born during 1945-1965. Annals of internal medicine 158(9): 704-705

Smith, B.D.; Morgan, R.L.; Beckett, G.A.; Falck-Ytter, Y.; Holtzman, D.; Ward, J.W. 2012: Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Annals of internal medicine 157(11): 817-822

Jewett, A.; Garg, A.; Meyer, K.; Wagner, L.D.; Krauskopf, K.; Brown, K.A.; Pan, J.-J.; Massoud, O.; Smith, B.D.; Rein, D.B. 2015: Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings. Health Promotion Practice 16(2): 256-263

Schooley, R.T. 2012: Hepatitis C virus therapeutics: at the end of the beginning. Topics in Antiviral Medicine 20(1): 17-19

Alisi, A.; Tomaselli, S.; Balsano, C.; Gallo, A. 2011: Hepatitis C virus therapeutics: editing enzymes promising therapeutic targets?. Hepatology 54(2): 742; Author Reply 742-3

Roche, B.; Sebagh, M.; Canfora, M.L.; Antonini, T.; Roque-Afonso, A.-M.; Delvart, V.; Saliba, F.; Duclos-Vallee, J.-C.; Castaing, D.; Samuel, D. 2008: Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 14(12): 1766-1777

Shiffman, M.L. 2014: Hepatitis C virus therapy in the direct acting antiviral era. Current Opinion in Gastroenterology 30(3): 217-222

Gordon, S.C.; Hamzeh, F.M.; Pockros, P.J.; Hoop, R.S.; Buikema, A.R.; Korner, E.J.; Terrault, N.A. 2013: Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease. Alimentary Pharmacology and Therapeutics 38(7): 784-793

Foster, G.; Mathurin, P. 2008: Hepatitis C virus therapy to date. Antiviral Therapy 13(Suppl 1): 3-8

Casey, L.C.; Lee, W.M. 2013: Hepatitis C virus therapy update 2013. Current Opinion in Gastroenterology 29(3): 243-249

Berkhout, B. 2010: Hepatitis C virus therapy: blocking the little microRNA helper of the virus. Journal of the Formosan Medical Association 109(3): 173-176

Dibrov, S.M.; Parsons, J.; Carnevali, M.; Zhou, S.; Rynearson, K.D.; Ding, K.; Garcia Sega, E.; Brunn, N.D.; Boerneke, M.A.; Castaldi, M.P.; Hermann, T. 2014: Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site. Journal of Medicinal Chemistry 57(5): 1694-1707

Liu, H.Minyi.; Aizaki, H.; Machida, K.; Ou, J-H.James.; Lai, M.M.C. 2012: Hepatitis C virus translation preferentially depends on active RNA replication. Plos one 7(8): E43600

Fischer, B.; Powis, J.; Firestone Cruz, M.; Rudzinski, K.; Rehm, J.ür. 2008: Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. European Journal of Gastroenterology and Hepatology 20(1): 29-32

Anonymous 2009: Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008. Mmwr. Morbidity and Mortality Weekly Report 58(8): 189-194

Wang, G.P.; Sherrill-Mix, S.A.; Chang, K.-M.; Quince, C.; Bushman, F.D. 2010: Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. Journal of Virology 84(12): 6218-6228

Thompson, N.D.; Novak, R.T.; Datta, D.; Cotter, S.; Arduino, M.J.; Patel, P.R.; Williams, I.T.; Bialek, S.R. 2009: Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infection Control and Hospital Epidemiology 30(9): 900-903

Maher, L.; Wand, H. 2012: Hepatitis C virus transmission in people who inject drugs: swabs may not be the main culprit. Journal of Infectious Diseases 205(12): 1892; Author Reply 1892-3

Rathore, J.A.; Shah, M.A.; Mehraj, A. 2012: Hepatitis C virus transmission risk factors. Journal of Ayub Medical College Abbottabad: Jamc 24(3-4): 106-108

Gough, E.K.; Kempf, M.-C.; Chamot, E. 2014: Hepatitis C virus transmission risk in incarcerated or detained populations. Hepatology 59(2): 733

Saxena, V.; Terrault, N. 2012: Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies. Current Opinion in Organ Transplantation 17(3): 216-224

Borman, M.; Swain, M.G. 2011: Hepatitis C virus treatment complicated by rheumatoid arthritis. Gastroenterology and Hepatology 7(11): 774-776

Martin, N.K.; Vickerman, P.; Grebely, J.; Hellard, M.; Hutchinson, S.J.; Lima, V.D.; Foster, G.R.; Dillon, J.F.; Goldberg, D.J.; Dore, G.J.; Hickman, M. 2013: Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology 58(5): 1598-1609

Roche, B.; Samuel, D. 2012: Hepatitis C virus treatment pre- and post-liver transplantation. Liver International: Official Journal of the International Association for the Study of the Liver 32(Suppl 1): 120-128

Murray, M.C.M.; Barrios, R.; Zhang, W.; Hull, M.; Montessori, V.; Hogg, R.S.; Montaner, J.S.G. 2011: Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic. European Journal of Gastroenterology and Hepatology 23(1): 45-50

Ahmad, U.; Li, X.; Sodeman, T.; Daboul, I. 2013: Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature. American Journal of Therapeutics 20(5): 585-587

Sulkowski, M.S.; Shiffman, M.L.; Afdhal, N.H.; Reddy, K.R.; McCone, J.; Lee, W.M.; Herrine, S.K.; Harrison, S.A.; Poordad, F.F.; Koury, K.; Deng, W.; Noviello, S.; Pedicone, L.D.; Brass, C.A.; Albrecht, J.K.; McHutchison, J.G.; Al-Osaimi, A.; Bacon, B.; Balart, L.; Bennett, M.; Bernstein, D.; Bini, E.; Black, M.; Bloomer, J.; Bonilla, H.; Box, T.; Boyer, T.; Brau, N.; Brown, K.; Brown, R.; Bruno, C.; Cassidy, W.; Chung, R.; Clain, D.; Crippin, J.; Dalke, D.; Davis, C.; Davis, G.; Davis, M.; Felizarta, F.; Firpi-Morell, R.; Flamm, S.; Franco, J.; Freilich, B.; Galati, J.; Galler, G.W.; Ghalib, R.; Gibas, A.; Godofsky, E.; Gordon, F.; Gross, J.; Herrera, J.; Herring, R.; Hu, K.-Q.; Israel, J.; Jacobson, I.; Joshi, S.; Khalili, M.; Kilby, A.;, 2010: Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology 139(5): 1602

Kanwal, F.; El-Serag, H.B. 2014: Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 12(8): 1381-1383

Kim, S.-J.; Syed, G.H.; Khan, M.; Chiu, W.-W.; Sohail, M.A.; Gish, R.G.; Siddiqui, A. 2014: Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proceedings of the National Academy of Sciences of the United States of America 111(17): 6413-6418

Ogawa, K.; Hishiki, T.; Shimizu, Y.; Funami, K.; Sugiyama, K.; Miyanari, Y.; Shimotohno, K. 2009: Hepatitis C virus utilizes lipid droplet for production of infectious virus. Proceedings of the Japan Academy. Series B Physical and Biological Sciences 85(7): 217-228

Wakita, T. 2008: Hepatitis C virus vaccine. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(10): 1961-1964

Cox, A.L.; Thomas, D.L. 2013: Hepatitis C virus vaccines among people who inject drugs. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(Suppl 2): S46-S50

Shi, C.; Ploss, A. 2013: Hepatitis C virus vaccines in the era of new direct-acting antivirals. Expert Review of Gastroenterology and Hepatology 7(2): 171-185

Fauvelle, C.; Lepiller, Q.; Felmlee, D.J.; Fofana, I.; Habersetzer, F.ço.; Stoll-Keller, F.ço.; Baumert, T.F.; Fafi-Kremer, S. 2013: Hepatitis C virus vaccines--progress and perspectives. Microbial Pathogenesis 58: 66-72

Rehermann, B. 2009: Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. Journal of Clinical Investigation 119(7): 1745-1754

Vierling, J.M. 2013: Hepatitis C virus viral assays in the direct-acting antiviral era. Clinics in Liver Disease 17(1): 27-45

Dai, C.-Y.; Ho, C.-K.; Huang, J.-F.; Hsieh, M.-Y.; Hou, N.-J.; Lin, Z.-Y.; Chen, S.-C.; Hsieh, M.-Y.; Wang, L.-Y.; Chang, W.-Y.; Yu, M.-L.; Chuang, W.-L. 2010: Hepatitis C virus viremia and low platelet count: a study in a hepatitis B and C endemic area in Taiwan. Journal of Hepatology 52(2): 160-166

Peters, L.; Grint, D.; Lundgren, J.D.; Rockstroh, J.ür.K.; Soriano, V.; Reiss, P.; Grzeszczuk, A.; Sambatakou, H.; Mocroft, A.; Kirk, O.; Losso, M.; Elias, C.; Ramos, J.M.; Vetter, N.; Wien, Z.d.S.; Zangerle, R.; Karpov, I.; Vassilenko, A.; Mitsura, V.M.; Suetnov, O.; Clumeck, N.; De Wit, S.; Delforge, M.; Vandekerckhove, L.; Hadziosmanovic, V.; Kostov, K.; Begovac, J.; Machala, L.; Jilich, D.; Sedlacek, D.; Kronborg, G.; Benfield, T.; Larsen, M.; Gerstoft, J.; Katzenstein, T.; Hansen, A.-B. E.; Skinhøj, P.; Pedersen, C.; Ostergaard, L.; Zilmer, K.; Smidt, J.; Siseklinik, N.; Katlama, C.; Herriot, E.; Vanhems, P.; Bernard, C.; Pradier, C.; Dabis, F.; Neau, D.; Schmidt, R.; van Lunzen, J.; Degen, O.; Staszewski, S.; Goethe, J.W.; Bogner, J 2012: Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. Aids 26(15): 1917-1926

Meier, V.; Ramadori, G. 2009: Hepatitis C virus virology and new treatment targets. Expert Review of AntI-Infective Therapy 7(3): 329-350

Duan, H.; Struble, E.; Zhong, L.; Mihalik, K.; Major, M.; Zhang, P.; Feinstone, S.; Feigelstock, D. 2010: Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies. Vaccine 28(25): 4138-4144

Puoti, C. 2007: Hepatitis C virus with normal transaminase levels. Digestive Diseases 25(3): 277-278

Eksioglu, E.A. 2012: Hepatitis C virus' initial encounters: mechanisms of innate immunity. Frontiers in Bioscience 17(1): 281-299

Torres, J.; Aguado, J.M.ía.; San Juan, R.; Andrés, A.; Sierra, P.; López-Medrano, F.; Morales, J.M.ía. 2008: Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 21(9): 873-878

Felmlee, D.J.; Hafirassou, M.Lamine.; Lefevre, M.; Baumert, T.F.; Schuster, C. 2013: Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses 5(5): 1292-1324

Fabrizi, F. 2012: Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence. Scientifica 2012: 128382

Mihm, S. 2010: Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes. Digestive Diseases 28(1): 280-284

Golkar, Z.; Jamil, N. 2010: Hepatitis C virus, human immunodeficiency virus and Pseudomonas phage PS5 triad share epitopes of immunogenic determinants. Virology Journal 7: 346

Ruggieri, V.; Mazzoccoli, C.; Pazienza, V.; Andriulli, A.; Capitanio, N.; Piccoli, C. 2014: Hepatitis C virus, mitochondria and auto/mitophagy: exploiting a host defense mechanism. World Journal of Gastroenterology 20(10): 2624-2633

Tanaka, N.; Yokoyama, T.; Horiuchi, A. 2009: Hepatitis C virus, splenic vein thrombosis, and lymphoma. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 7(2): A24

Negro, F.; Sanyal, A.J. 2009: Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver International: Official Journal of the International Association for the Study of the Liver 29(Suppl 2): 26-37

Petrovic, D.; Dempsey, E.; Doherty, D.G.; Kelleher, D.; Long, A. 2012: Hepatitis C virus--T-cell responses and viral escape mutations. European Journal of Immunology 42(1): 17-26

Keyvani, H.; Fazlalipour, M.; Monavari, S.H.R.; Mollaie, H.R. 2012: Hepatitis C virus--proteins, diagnosis, treatment and new approaches for vaccine development. Asian Pacific Journal of Cancer Prevention: Apjcp 13(12): 5931-5949

Kowala-Piaskowska, A. 2006: Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance. Postepy Biochemii 52(4): 399-407

Lin, M.V.; King, L.Y.; Chung, R.T. 2015: Hepatitis C virus-associated cancer. Annual Review of Pathology 10: 345-370

Berenguer, M.; McCaughan, G. 2013: Hepatitis C virus-associated cholestatic hepatitis: we cannot seem to agree on diagnostic criteria. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 19(2): 115-117

Tang, S.C.W.; Lai, K.N. 2013: Hepatitis C virus-associated glomerulonephritis. Contributions to Nephrology 181: 194-206

Hung, C.-H.; Lee, C.-M.; Lu, S.-N. 2011: Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications. Expert Review of AntI-Infective Therapy 9(5): 525-533

Yuki, N.; Yoshioka, A.; Yasuda, R.; Ohmichi, T.; Oka, N. 2014: Hepatitis C virus-associated neuropathy accompanied by eosinophilic vasculitis and granuloma formation. Internal Medicine 53(11): 1187-1190

Saadoun, D.; Terrier, B.; Semoun, O.; Sene, D.; Maisonobe, T.; Musset, L.; Amoura, Z.; Rigon, M.R.; Cacoub, P. 2011: Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care and Research 63(3): 427-435

Monteith, C.; Ní Áinle, F.; Cooley, S.; Lambert, J.S.; Kelleher, B.; Jackson, V.; Eogan, M. 2014: Hepatitis C virus-associated thrombocytopenia in pregnancy: impact upon multidisciplinary care provision. Journal of Perinatal Medicine 42(1): 135-138

Afifi, O.A.; Sewify, E.M.; El-Attar, M.M.; Taie, A.O.; Mostafa, A.K. 2007: Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 13(2): 76-80

Lo, K-Yik.; Chen, C-Yin.; Lee, C-Shiung. 2009: Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis. Renal Failure 31(2): 149-152

Saitou, K.; Mizumoto, K.; Nishimura, T.; Kai, C.; Tsukiyama-Kohara, K. 2009: Hepatitis C virus-core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in hepatocytes. Virus Research 144(1-2): 266-271

Hassan, M.; Selimovic, D.; El-Khattouti, A.; Ghozlan, H.; Haikel, Y.; Abdelkader, O. 2012: Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2(2): 7-25

Sulkowski, M.S. 2012: Hepatitis C virus-human immunodeficiency virus coinfection. Liver International: Official Journal of the International Association for the Study of the Liver 32(Suppl 1): 129-134

Mohl, B-Patrick.; Tedbury, P.R.; Griffin, S.; Harris, M. 2012: Hepatitis C virus-induced autophagy is independent of the unfolded protein response. Journal of Virology 86(19): 10724-10732

Ali, N.; Allam, H.; May, R.; Sureban, S.M.; Bronze, M.S.; Bader, T.; Umar, S.; Anant, S.; Houchen, C.W. 2011: Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. Journal of Virology 85(23): 12292-12303

Sarma, N.J.; Tiriveedhi, V.; Crippin, J.S.; Chapman, W.C.; Mohanakumar, T. 2014: Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. Journal of Virology 88(7): 3733-3743

Neufeldt, C.J.; Joyce, M.A.; Levin, A.; Steenbergen, R.H.; Pang, D.; Shields, J.; Tyrrell, D.L.J.; Wozniak, R.W. 2013: Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication. Plos Pathogens 9(10): E1003744

Presser, L.D.; Haskett, A.; Waris, G. 2011: Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication. Virology 412(2): 284-296

Bartosch, B.; Thimme, R.; Blum, H.E.; Zoulim, F. 2009: Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 51(4): 810-820

Lim, E.J.; El Khobar, K.; Chin, R.; Earnest-Silveira, L.; Angus, P.W.; Bock, C.-T.; Nachbur, U.; Silke, J.; Torresi, J. 2014: Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis. Journal of General Virology 95(Part 10): 2204-2215

Neuschwander-Tetri, B.A. 2008: Hepatitis C virus-induced insulin resistance: not all genotypes are the same. Gastroenterology 134(2): 619-622

Simula, M.P.; De Re, V. 2010: Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. PROTEOMICS. Clinical Applications 4(10-11): 782-793

Miura, K.; Taura, K.; Kodama, Y.; Schnabl, B.; Brenner, D.A. 2008: Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48(5): 1420-1429

Nattermann, J.; Sherzada, R.; Iwan, A.; Bogen, D.; Niederle, I.M.; Schulte, D.; Mertens, E.; Nischalke, H.D.; Krämer, B.; Sauerbruch, T.; Leifeld, L.; Spengler, U. 2008: Hepatitis C virus-induced secretion of inflammatory chemokines preferentially recruits NKG2A+CD8+ T cells. Journal of Infectious Diseases 198(2): 213-217

Negro, F. 2010: Hepatitis C virus-induced steatosis: an overview. Digestive Diseases 28(1): 294-299

Zhang, Y.; Wei, W.; Cheng, N.; Wang, K.; Li, B.; Jiang, X.; Sun, S. 2012: Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56(5): 1631-1640

Duong, F.H.T.; Christen, V.; Lin, S.; Heim, M.H. 2010: Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology 51(3): 741-751

Cacoub, P.; Terrier, B.; Saadoun, D. 2014: Hepatitis C virus-induced vasculitis: therapeutic options. Annals of the Rheumatic Diseases 73(1): 24-30

Holder, K.A.; Stapleton, S.N.; Gallant, M.E.; Russell, R.S.; Grant, M.D. 2013: Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. Journal of Immunology 191(6): 3308-3318

Peek, R.; Reddy, K.R. 2007: Hepatitis C virus-infected donors in liver transplantation. Gastroenterology 133(2): 381-382

Lonardo, A.; Ballestri, S.; Adinolfi, L.E.; Violi, E.; Carulli, L.; Lombardini, S.; Scaglioni, F.; Ricchi, M.; Ruggiero, G.; Loria, P. 2009: Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. a comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. Canadian Journal of Gastroenterology 23(4): 273-278

González-Mendez, Y.; Hernández-Guerra, M.; Turnes, J.; Abreu, I.; García, D.; Quintero, E. 2013: Hepatitis C virus-infected patients with a history of epileptic fits can and should be treated with standard therapy. Gastroenterologia y Hepatologia 36(7): 494-495

Lawson, A.; Austin, A.; Freeman, J.G.; Semeraro, D.; Aldersley, M.; Davies, M.; Jones, R.; Milson, C.; Wyatt, J.; Harvey, J.; Aravamuthan, S.; Jones, D.A.; Harrison, G.; Irving, W.L.; Neal, K.R.; Ryder, S.D.; Thomson, B.J.; Zaitoun, A.; Dube, A.; Gleeson, D.; Green, S.; Kudesia, G.; McKendrick, M.W.; Poll, R.; Vedio, A.; Delahooke, T.; Grant, A.; McGregor, A.; Wiselka, M. 2010: Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?. Journal of Viral Hepatitis 17(1): 51-58

Dresler, C.M.; Kent, M.S.; Whyte, R.I.; Sade, R.M. 2013: Hepatitis C virus-infected resident: end of residency, end of career?. Annals of thoracic surgery 95(3): 779-786

Lai, J.C.; Verna, E.C.; Brown, R.S.; O'Leary, J.G.; Trotter, J.F.; Forman, L.M.; Duman, J.D.; Foster, R.G.; Stravitz, R.T.; Terrault, N.A. 2011: Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology 54(2): 418-424

Ripoli, M.; D'Aprile, A.; Quarato, G.; Sarasin-Filipowicz, M.; Gouttenoire, J.ér.ôm.; Scrima, R.; Cela, O.; Boffoli, D.; Heim, M.H.; Moradpour, D.; Capitanio, N.; Piccoli, C. 2010: Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. Journal of Virology 84(1): 647-660

Hassan, M.; Selimovic, D.; El-Khattouti, A.; Soell, M.; Ghozlan, H.; Haikel, Y.; Abdelkader, O.; Megahed, M. 2014: Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies. World Journal of Gastroenterology 20(42): 15467-15475

Nicolau, A.; Tănăsescu, R.; Bălănescu, E.; Bălănescu, P.; Pătraşcu, R.; Tănăsescu, C. 2011: Hepatitis C virus-mixed cryoglobulinemia-lymphoma relationship. Romanian Journal of Internal Medicine 49(1): 3-10

Abdelwahab, S.F.; Zakaria, Z.; Sobhy, M.; Rewisha, E.; Mahmoud, M.A.; Amer, M.A.; Del Sorbo, M.; Capone, S.; Nicosia, A.; Folgori, A.; Hashem, M.; El-Kamary, S.S. 2012: Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection. Clinical and Vaccine Immunology: Cvi 19(5): 780-786

Pellicelli, A.M.; Marignani, M.; Zoli, V.; Romano, M.; Morrone, A.; Nosotti, L.; Barbaro, G.; Picardi, A.; Gentilucci, U.V.; Remotti, D.; D'Ambrosio, C.; Furlan, C.; Mecenate, F.; Mazzoni, E.; Majolino, I.; Villani, R.; Andreoli, A.; Barbarini, G. 2011: Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World Journal of Hepatology 3(11): 278-284

Riccio, A.; Tarantino, G. 2012: Hepatitis C virus-related arthritis and rheumatoid arthritis: could they be different aspects of the same disease?. International Journal of Immunopathology and Pharmacology 25(1): 293-296

Ogasawara, K.; Terada, T.; Katsura, T.; Hatano, E.; Ikai, I.; Yamaoka, Y.; Inui, K.-i. 2010: Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters. Drug Metabolism and Pharmacokinetics 25(2): 190-199

Gordovskaia, N.B.; Kozlovskaia, L.V.; Milovanova, S.I.; Ignatova, T.M.; Korotchaeva, I.V. 2013: Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment. Terapevticheskii Arkhiv 85(6): 78-84

St Clair, E.William. 2012: Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. Arthritis and Rheumatism 64(3): 604-608

Wu, H.; Zou, H.-B.; Xu, Y.; Zhang, L.; Du, Y.-J.; Yu, J.-Y.; Lu, R.-H.; Li, X. 2013: Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy. American Journal of the Medical Sciences 346(4): 345-348

Pecic, V.; Stankovic-Djordjevic, D.; Nestorovic, M.; Radojkovic, M.; Marjanovic, H.; Ilic, B.; Milojkovic, M. 2011: Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis. Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 277-281

Selimovic, D.; El-Khattouti, A.; Ghozlan, H.; Haikel, Y.; Abdelkader, O.; Hassan, M. 2012: Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World Journal of Hepatology 4(12): 342-355

Kamar, N.; Izopet, J.; Alric, L.; Guilbeaud-Frugier, C.; Rostaing, L. 2008: Hepatitis C virus-related kidney disease: an overview. Clinical Nephrology 69(3): 149-160

Sumida, K.; Ubara, Y.; Hoshino, J.; Suwabe, T.; Nakanishi, S.; Hiramatsu, R.; Hasegawa, E.; Hayami, N.; Yamanouchi, M.; Sawa, N.; Takemoto, F.; Takaichi, K.; Oohashi, K. 2010: Hepatitis C virus-related kidney disease: various histological patterns. Clinical Nephrology 74(6): 446-456

Zeremski, M.; Dimova, R.B.; Zavala, R.; Kritz, S.; Lin, M.; Smith, B.D.; Zibbell, J.E.; Talal, A.H. 2014: Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. Journal of Addiction Medicine 8(4): 249-257

Tsukiyama-Kohara, K.; Sekiguchi, S.; Kasama, Y.; Salem, N.E.; Machida, K.; Kohara, M. 2011: Hepatitis C virus-related lymphomagenesis in a mouse model. Isrn Hematology 2011: 167501

Zignego, A.-L.; Giannini, C.; Ferri, C. 2007: Hepatitis C virus-related lymphoproliferative disorders: an overview. World Journal of Gastroenterology 13(17): 2467-2478

Gragnani, L.; Fognani, E.; Piluso, A.; Zignego, A.L. 2013: Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?. World Journal of Gastroenterology 19(47): 8910-8915

Tatsumi, T.; Takehara, T.; Miyagi, T.; Nakazuru, S.; Mita, E.; Kanto, T.; Hiramatsu, N.; Hayashi, N. 2011: Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-α and ribavirin combination therapy in patients with chronic hepatitis C virus infection. Hepatology Research: the Official Journal of the Japan Society of Hepatology 41(1): 30-38

Moonka, D.; Milkovich, K.A.; Rodriguez, B.; Abouljoud, M.; Lederman, M.M.; Anthony, D.D. 2008: Hepatitis C virus-specific T-cell gamma interferon and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver. Journal of Virology 82(23): 11742-11748

Tsuzaki, R.; Takaki, A.; Yagi, T.; Ikeda, F.; Koike, K.; Iwasaki, Y.; Shiraha, H.; Miyake, Y.; Sadamori, H.; Shinoura, S.; Umeda, Y.; Yoshida, R.; Nobuoka, D.; Utsumi, M.; Nakayama, E.; Fujiwara, T.; Yamamoto, K. 2014: Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation. Acta Medica Okayama 68(5): 291-302

Li, S.; Vriend, L.E.M.; Nasser, I.A.; Popov, Y.; Afdhal, N.H.; Koziel, M.J.; Schuppan, D.; Exley, M.A.; Alatrakchi, N. 2012: Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 56(6): 2094-2105

Rowan, A.G.; Fletcher, J.M.; Ryan, E.J.; Moran, B.; Hegarty, J.E.; O'Farrelly, C.; Mills, K.H.G. 2008: Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. Journal of Immunology 181(7): 4485-4494

El-Kamary, S.S.; Hashem, M.; Saleh, D.A.; Abdelwahab, S.F.; Sobhy, M.; Shebl, F.M.; Shardell, M.D.; Strickland, G.T.; Shata, M.T. 2013: Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus. Journal of Pediatrics 162(1): 148-154

Qiu, F.; Bi, S.; Wang, Y.; Guo, M.; Yi, Y.; Chen, S.; Guo, Y.; Shen, L.; Jia, Z. 2012: Hepatitis C virus-specific cellular and humoral immune responses following immunization with a multi-epitope fusion protein. International Journal of Molecular Medicine 29(1): 12-17

Rivière, Y.; Montange, T.; Janvier, G.èv.; Marnata, C.; Durrieu, L.; Chaix, M.-L.; Isaguliants, M.; Launay, O.; Bresson, J.-L.; Pol, S. 2012: Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection. Virology Journal 9: 76

Roque-Cuéllar, M.ía.C.; Sánchez, B.; García-Lozano, J.é R.; Praena-Fernández, J.M.; Márquez-Galán, J.é L.; Núñez-Roldán, A.; Aguilar-Reina, J.é 2014: Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells. Liver International: Official Journal of the International Association for the Study of the Liver 34(6): E80-E88

Delang, L.; Neyts, J.; Vliegen, I.; Abrignani, S.; Neddermann, P.; De Francesco, R. 2013: Hepatitis C virus-specific directly acting antiviral drugs. Current Topics in Microbiology and Immunology 369: 289-320

Zeremski, M.; Makeyeva, J.; Arasteh, K.; Des Jarlais, D.C.; Talal, A.H. 2012: Hepatitis C virus-specific immune responses in noninjecting drug users. Journal of Viral Hepatitis 19(8): 554-559

Parker, R.; Weston, C.J.; Miao, Z.; Corbett, C.; Armstrong, M.J.; Ertl, L.; Ebsworth, K.; Walters, M.J.; Baumart, T.; Newland, D.; McMahon, J.; Zhang, P.; Singh, R.; Campbell, J.; Newsome, P.N.; Charo, I.; Schall, T.J.; Adams, D.H. 2018: CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 314(4): G483-G493

Hua, L.; Andersen, J.W.; Daar, E.S.; Glesby, M.J.; Hollabaugh, K.; Tierney, C. 2013: Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. Aids 27(17): 2725-2734

Mancuso, M.E.; Rumi, M.G.; Aghemo, A.; Santagostino, E.; Puoti, M.; Coppola, A.; Colombo, M.; Mannucci, P.M. 2009: Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy. Journal of Thrombosis and Haemostasis: Jth 7(12): 1997-2005

Verga-Gérard, A.; Porcherot, M.; Meyniel-Schicklin, Lène.; André, P.; Lotteau, V.; Perrin-Cocon, L. 2013: Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF-β signaling. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(10): 4027-4040

Pol, S. 2013: Hepatitis C virus: 25 years-old, the end?. Medecine Sciences: M/S 29(11): 998-1003

Ali, M.A. 1995: Hepatitis C virus: Current studies in Hematology. Annals of Saudi Medicine 15(1): 84

Chayama, K.; Hayes, C.N. 2011: Hepatitis C virus: how genetic variability affects pathobiology of disease. Journal of Gastroenterology and Hepatology 26(Suppl 1): 83-95

Albeldawi, M.; Ruiz-Rodriguez, E.; Carey, W.D. 2010: Hepatitis C virus: Prevention, screening, and interpretation of assays. Cleveland Clinic Journal of Medicine 77(9): 616-626

Gupta, E.; Bajpai, M.; Choudhary, A. 2014: Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian Journal of Transfusion Science 8(1): 19-25

Nelson, D.R.; Davis, G.L.; Jacobson, I.; Everson, G.T.; Fried, M.W.; Harrison, S.A.; Hassanein, T.; Jensen, D.M.; Lindsay, K.L.; Terrault, N.; Zein, N. 2009: Hepatitis C virus: a critical appraisal of approaches to therapy. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 7(4): 397-414; Quiz 366

Nelson, D.R.; Jensen, D.M.; Sulkowski, M.S.; Everson, G.; Fried, M.W.; Gordon, S.C.; Jacobson, I.; Reau, N.S.; Sherman, K.; Terrault, N.; Thomas, D. 2012: Hepatitis C virus: a critical appraisal of new approaches to therapy. Hepatitis Research and Treatment 2012: 138302

Bezerra, M.L.E.; Harumi, J.A.; Shinosaki, J.S.M.; Pedroso, J.L.; Henriques de Aquino, C.C.; de Souza, L.T.; Baiense, R.F.; Bulle de Oliveira, A.S. 2011: Hepatitis C virus: a rare manifestation--remitting relapsing central and peripheral demyelination. Neurology India 59(1): 114-116

Carrozzo, M. 2014: Hepatitis C virus: a silent killer relevant to dentistry. Oral Diseases 20(5): 425-429

Klevens, R.M.; Moorman, A.C. 2013: Hepatitis C virus: an overview for dental health care providers. Journal of the American Dental Association 144(12): 1340-1347

Jones, D.M.; McLauchlan, J. 2010: Hepatitis C virus: assembly and release of virus particles. Journal of Biological Chemistry 285(30): 22733-22739

Klenerman, P.; Gupta, P.K. 2012: Hepatitis C virus: current concepts and future challenges. Qjm: Monthly Journal of the Association of Physicians 105(1): 29-32

Urquijo, J.J.; Diago, M. 2011: Hepatitis C virus: five-year follow-up of patients with sustained virological response. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 103(2): 53-55

Barsoum, R.S. 2007: Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(7): 1840-1848

Farinati, F.; Cardin, R.; Bortolami, M.; Burra, P.; Russo, F.P.; Rugge, M.; Guido, M.; Sergio, A.; Naccarato, R. 2007: Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. Journal of Viral Hepatitis 14(12): 821-829

Dugum, M.; O'Shea, R. 2014: Hepatitis C virus: here comes all-oral treatment. Cleveland Clinic Journal of Medicine 81(3): 159-172

Cavalheiro, N.d.P.; La Rosa, A.d.; Elagin, S.; Tengan, F.M.; Barone, A.A. 2010: Hepatitis C virus: molecular and epidemiological evidence of male-to-female transmission. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 14(5): 427-432

Sharma, S.D. 2010: Hepatitis C virus: molecular biology and current therapeutic options. Indian Journal of Medical Research 131: 17-34

Ramia, S. 1995: Hepatitis C virus: molecular virology and its implications for serologic diagnosis. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 6(2): 190-196

Yi, M. 2010: Hepatitis C virus: propagation, quantification, and storage. Current Protocols in Microbiology Chapter 15: Unit 15d.1

Pawlotsky, J.-M. 2013: Hepatitis C virus: standard-of-care treatment. Advances in Pharmacology 67: 169-215

Ward, J.W. 2014: Hepatitis C virus: the 25-year journey from discovery to cure. Hepatology 60(5): 1479-1482

Thomson, B.J. 2009: Hepatitis C virus: the growing challenge. British Medical Bulletin 89: 153-167

Uzicanin, S.; Hu, Y.-W.; Alsousi, H.; Pelchat, M.; Rocheleau, L.; Nair, R.C.; Brown, E.G. 2012: Hepatitis C virus: the role of molecular mimicry in response to interferon treatment. Journal of Medical Virology 84(10): 1571-1585

Clément, S.; Negro, F. 2007: Hepatitis C virus: the viral way to fatty liver. Journal of Hepatology 46(6): 985-987

Nikolaeva, L.I.; Sapronov, G.V. 2012: Hepatitis C virus: therapeutic targets and new drugs. Voprosy Virusologii 57(5): 10-15

McLauchlan, J. 2009: Hepatitis C virus: viral proteins on the move. Biochemical Society Transactions 37(Pt 5): 986-990

Kim, C.W.; Chang, K.-M. 2013: Hepatitis C virus: virology and life cycle. Clinical and Molecular Hepatology 19(1): 17-25

Chevaliez, S.ép.; Pawlotsky, J.-M. 2007: Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World Journal of Gastroenterology 13(17): 2461-2466

Mahboobi, N.; Mahboobi, N.; Oliaei, P.; Alavian, S.M. 2014: Hepatitis C virus; its implication for endodontists. Iranian Endodontic Journal 9(3): 169-173

Lu, J.; Jiang, Y.-q.; Zhao, H.-l.; Jiang, Y.-q.; Jiang, Y.-z.; Tian, R.-g.; Zhang, Y.; Wang, X.-y.; Bi, S.-l. 2011: Hepatitis C viruses infection situation in the human population of six provinces in China. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 25(6): 448-449

Thimme, R. 2010: Hepatitis C with fatigue and polyneuropathy. Deutsche Medizinische Wochenschrift 135(48): 2428

Kretzer, I.Fabricia.; do Livramento, A.; da Cunha, J.; Gonçalves, S.; Tosin, I.; Spada, C.; Treitinger, A. 2014: Hepatitis C worldwide and in Brazil: silent epidemic--data on disease including incidence, transmission, prevention, and treatment. Thescientificworldjournal 2014: 827849

Künzler-Heule, P.; Panfil, E-Maria. 2012: Hepatitis C! Experience in diagnosis and medical treatment. A literature review. Pflege 25(3): 185-195

Loebstein, R.; Mahagna, R.; Maor, Y.; Kurnik, D.; Elbaz, E.; Halkin, H.; Olchovsky, D.; Ezra, D.; Almog, S. 2008: Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Israel Medical Association Journal: Imaj 10(11): 775-778

Verma, R.; Behera, B.K.; Jain, R.B.; Arora, V.; Chayal, V.; Gill, P.S. 2014: Hepatitis C, a silent threat to the community of Haryana, India: a community-based study. Australasian Medical Journal 7(1): 11-16

Myers, R.P.; Shaheen, A.A.M. 2009: Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity. Hepatology 49(4): 1399-1400

Zarski, J.-P.; Doffoel, M.; Filoche, B.; Marcellin, P.; Samuel, D.; Bedossa, P. 2008: Hepatitis C, cirrhosis and hepatocellular carcinoma. Gastroenterologie Clinique et Biologique 32(3 Part 2): S117-S120

Lacombe, K. 2014: Hepatitis C, from screening to treatment, a revolution. Journal of the International Aids Society 17(4 Suppl 3: 19499

Kotler, D.P. 2009: Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions. Liver International: Official Journal of the International Association for the Study of the Liver 29(Suppl 2): 38-46

Serfaty, L.; Capeau, J. 2009: Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver International: Official Journal of the International Association for the Study of the Liver 29(Suppl 2): 13-25

Abdo, A.A.; Lee, S.S. 2012: Hepatitis C, insulin resistance and fatty liver: bad things come in threes. Canadian Journal of Gastroenterology 26(6): 323

Hepworth, J.; Bain, T.; van Driel, M. 2013: Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review. International Journal for Equity in Health 12: 92

Ryan Caballes, F.; Sendi, H.; Bonkovsky, H.L. 2012: Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver International: Official Journal of the International Association for the Study of the Liver 32(6): 880-893

Marinho, R.T.; Barreira, D.P. 2013: Hepatitis C, stigma and cure. World Journal of Gastroenterology 19(40): 6703-6709

Quansah, R.; Cooper, C.J.; Said, S.; Bizet, J.; Paez, D.; Hernandez, G.T. 2014: Hepatitis C- and HIV-induced porphyria cutanea tarda. American Journal of Case Reports 15: 35-40

Christensen, P.B. 2011: Hepatitis C--a disease coming out in the cold. Ugeskrift for Laeger 173(19): 1345

Vik, I.S.S.; Skaug, K.; Dalgard, O.; Steen, T.W.; Hoddevik, G. 2008: Hepatitis C--a health problem also in Norway. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(5): 563-566

Shah, S.I.; Shah, S.; Hannan, A. 2014: Hepatitis C--a risk factor for gallstone disease. Journal of Ayub Medical College Abbottabad: Jamc 26(1): 84-87

Holmes, J.; Thompson, A.; Bell, S. 2013: Hepatitis C--an update. Australian Family Physician 42(7): 452-456

Bhandari, B.; Pal, A. 2007: Hepatitis C--clinical profile. Journal of the Indian Medical Association 105(8): 453

Dufour, D.R. 2011: Hepatitis C--removing barriers to diagnosing the "silent epidemic". Clinical Chemistry 57(7): 939-940

Meyer, R.üd. 2006: Hepatitis C--the forgotten epidemic. Deutsche Medizinische Wochenschrift Suppl 1: 68

Fischler, Börn.; Einberg, A.Psaros. 2007: Hepatitis C--where should we look back?. Acta Paediatrica 96(10): 1551; Author Reply 1551-2

Gragnani, L.; Fognani, E.; Piluso, A.; Zignego, A.L. 2013: Hepatitis C-associated B-cell non-Hodgkin lymphomas: the emerging role of miRNA-26b. Journal of Hepatology 59(6): 1362-1363

Khalighi, M.A.; Lassman, C.R. 2013: Hepatitis C-associated cryoglobulinemic glomerulonephritis with crystalline deposits. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 62(2): 384-389

Daniels, A.H.; Wilson, C.L.; Harrison, R.A. 2008: Hepatitis C-associated leukocytoclastic vasculitis with anticardiolipin antibodies causing penile necrosis and deep venous thrombosis in the absence of cryoglobulinemia. Journal of Hospital Medicine 3(2): 170-172

Herzer, K.; Gerken, G.; Hofmann, T.G. 2014: Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies. World Journal of Gastroenterology 20(35): 12367-12371

Sidharthan, S.; Kim, C.-W.; Murphy, A.A.; Zhang, X.; Yang, J.; Lempicki, R.A.; Sneller, M.C.; Kottilil, S. 2014: Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells. Frontiers in Immunology 5: 248

Schwartz, K.M.; Skinner, J.A. 2008: Hepatitis C-associated osteosclerosis: a case report. Skeletal Radiology 37(7): 679-681

Buskila, D. 2009: Hepatitis C-associated rheumatic disorders. Rheumatic Diseases Clinics of North America 35(1): 111-123

Praga, M.; Gutiérrez Solís, E.; Morales, E. 2012: Hepatitis C-induced renal disease in patients with AIDS: an emergent problem. Contributions to Nephrology 176: 24-34

Kemmer, N.M.; Sherman, K.E. 2010: Hepatitis C-related arthropathy: Diagnostic and treatment considerations. Journal of Musculoskeletal Medicine 27(9): 351-354

Mamori, S.; Mamori, H. 2011: Hepatitis C-related cirrhosis with sustained prevention of hepatocellular carcinoma recurrence by long-term administration of super-low-dose peginterferon-alpha 2b. Case Reports in Gastroenterology 5(1): 56-62

Toshikuni, N.; Arisawa, T.; Tsutsumi, M. 2014: Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality. World Journal of Gastroenterology 20(11): 2876-2887

Fabrizi, F.; Dixit, V.; Messa, P.; Martin, P. 2012: Hepatitis C-related liver disease in dialysis patients. Contributions to Nephrology 176: 42-53

Hashimoto, N.; Tanemura, A.; Yamada, M.; Itoi, S.; Katayama, I. 2014: Hepatitis C-related mixed type vitiligo in a patient with Ivemark syndrome. Journal of Dermatology 41(2): 185-186

Makis, W.; Stern, J. 2010: Hepatitis C-related primary effusion lymphoma of the pleura and peritoneum, imaged with F-18 FDG PET/CT. Clinical Nuclear Medicine 35(10): 797-799

Pelgrom, J.M.; Vogelaers, D.; Colle, I. 2008: Hepatitis C-seroconversion within three to six months after having contracted clinical syphilis and/or lymphogranuloma venereum rectitis in five homosexually active, HIV seropositive men. Acta Clinica Belgica 63(5): 335-338

Warpakowski, A. 2014: Hepatitis C. An increase in interferon-free therapy. MMW Fortschritte der Medizin 156 Suppl. 1: 8

Magdzik, Wław. 2006: Hepatitis C. The most important epidemiological aspects. Przeglad Epidemiologiczny 60(4): 751-757

Ananthakrishnan, A.N.; McGinley, E.L.; Fangman, J.; Saeian, K. 2010: Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV. Journal of Viral Hepatitis 17(10): 720-729

Perez, Víctor. 2005: Hepatitis C: 15 years of life. Acta Gastroenterologica Latinoamericana 35 Suppl. 1: S9-10

Hepworth, J.; Krug, G.J. 1999: Hepatitis C: a Socio-cultural Perspective on the Effects of a new Virus on a Community's Health. Journal of Health Psychology 4(2): 237-246

Shafran, S.D.; Conly, J.M. 1993: Hepatitis C: Recent advances. Canadian Journal of Infectious Diseases 4(4): 195-197

Pálsson, P.S.; Jónasson, J.ón.G.; Olafsson, S. 2008: Hepatitis C: a clinical-histopathological study. Laeknabladid 94(1): 13-17

Richmond, J.; Dunning, P.; Desmond, P. 2004: Hepatitis C: a medical and social diagnosis. Australian Nursing Journal 12(1): 23-25

Gluud, C.; Koretz, R.; Gurusamy, K. 2014: Hepatitis C: a new direction, but an old story?. Lancet 383(9935): 2122-2123

Perreault, D. 2014: Hepatitis C: a study predicts a costly future if nothing is done now. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(4): 14

Nau, J.-y. 2014: Hepatitis C: cost of eradication. Revue Medicale Suisse 10(415): 306-307

Romero-Gómez, M.; García-Romero, D. 2008: Hepatitis C: cryoglobulinemia and non-Hodgkin lymphoma. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 100(3): 164-170

Mishra, P.; Jensen, D.M. 2008: Hepatitis C: current and future therapies. Mount Sinai Journal of Medicine new York 75(4): 405-414

Thomas, E.; Fried, M.W. 2008: Hepatitis C: current options for nonresponders to peginterferon and ribavirin. Current Gastroenterology Reports 10(1): 53-59

Pol, S.; Vallet-Pichard, A.ïs.; Corouge, M.; Mallet, V.O. 2012: Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contributions to Nephrology 176: 1-9

Moore, G.A.; Hawley, D.A.; Bradley, P. 2009: Hepatitis C: experiencing stigma. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 32(2): 94-104

Shaikh, F.H.; Ali Abro, H.; Ali Chhutto, M.; Abbasi, P.A.; Shaikh, A.W.; Ali Buriro, S. 2009: Hepatitis C: frequency and risk factors associated with sero-positivity among adults in Larkana City. Journal of Ayub Medical College Abbottabad: Jamc 21(2): 107-109

Mehta, B.; Kumar, V.; Chawla, S.; Jindal, H.; Bhatt, B. 2014: Hepatitis C: is a vaccine the solution?. Human Vaccines and Immunotherapeutics 10(2): 417-419

Martyn, F.; Phelan, O.; O'Connell, M. 2011: Hepatitis C: is there a case for universal screening in pregnancy?. Irish Medical Journal 104(5): 144-146

Zaaijer, H.L. 2011: Hepatitis C: many small steps. Netherlands Journal of Medicine 69(5): 209-210

Campos-Outcalt, D. 2012: Hepatitis C: new CDC screening recommendations. Journal of Family Practice 61(12): 744-746

Schwarz, K.B. 2010: Hepatitis C: not so indolent in survivors of pediatric cancer?. Pediatric Blood and Cancer 55(1): 7

Shimakami, T.; Lanford, R.E.; Lemon, S.M. 2009: Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities. Current Opinion in Pharmacology 9(5): 537-544

Ferreira, M.R.M.N.; Lonardoni, M.V.C.; Bertolini, D.A. 2008: Hepatitis C: serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringá, Maringá PR Brazil. Haemophilia: the Official Journal of the World Federation of Hemophilia 2008

Cavalheiro, N.d.P.; De La Rosa, A.; Elagin, S.; Tengan, F.át.M.; Araújo, E.S.A.d.; Barone, A.A. 2009: Hepatitis C: sexual or intrafamilial transmission? Epidemiological and phylogenetic analysis of hepatitis C virus in 24 infected couples. Revista da Sociedade Brasileira de Medicina Tropical 42(3): 239-244

Moore, G.A.; Hawley, D.A.; Bradley, P. 2008: Hepatitis C: studying stigma. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 31(5): 346-352

Poll, R. 2013: Hepatitis C: the case against routine partner notification. International Journal of Std and Aids 24(3): 165-168

King, E.; Trabue, C.; Yin, D.; Yao, Z.Q.; Moorman, J.P. 2007: Hepatitis C: the complications of immune dysfunction. Expert Review of Clinical Immunology 3(2): 145-157

Alter, H.J.; Liang, T.J. 2012: Hepatitis C: the end of the beginning and possibly the beginning of the end. Annals of Internal Medicine 156(4): 317-318

Sherman, M. 2008: Hepatitis C: the juggernaut rolls on unchecked. Canadian Journal of Gastroenterology 22(4): 355-356

Houghton, M. 2014: Hepatitis C: the next 25years. Antiviral Research 110: 77-78

Marcellin, P. 2009: Hepatitis C: the recovery. Gastroenterologie Clinique et Biologique 33(8-9): 819-829

Asselah, T.; Estrabaud, E.; Bieche, I.; Lapalus, M.; De Muynck, S.; Vidaud, M.; Saadoun, D.; Soumelis, V.; Marcellin, P. 2010: Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver International: Official Journal of the International Association for the Study of the Liver 30(9): 1259-1269

Lee, L.-W.; Chang, T.-Y.; Lo, H.-W.; Lo, S.J. 2011: Hepatitis D antigens cause growth retardation and brood-size reduction in C. elegans. Frontiers in Bioscience 3(1): 380-390

Onyekwere, C.A.; Audu, R.A.; Duro-Emmanuel, F.; Ige, F.A. 2012: Hepatitis D infection in Nigeria. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 31(1): 34-35

Davies, J.; Tong, S.Y.C.; Davis, J.S. 2013: Hepatitis D is rare or non-existent in hepatitis B virus-infected Indigenous Australians in the Northern Territory. Australian and New Zealand Journal of Public Health 37(2): 188-189

Børresen, M.L.; Olsen, O.R.; Ladefoged, K.; McMahon, B.J.; Hjuler, T.; Panum, I.; Simonetti, J.; Jones, C.; Krarup, H.; Koch, A. 2010: Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. Journal of Viral Hepatitis 17(3): 162-170

Wedemeyer, H. 2011: Hepatitis D revival. Liver International: Official Journal of the International Association for the Study of the Liver 31 Suppl. 1: 140-144

Negro, F. 2014: Hepatitis D virus coinfection and superinfection. Cold Spring Harbor Perspectives in Medicine 4(11): A021550

Shadur, B.; MacLachlan, J.; Cowie, B. 2013: Hepatitis D virus in Victoria 2000-2009. Internal medicine journal 43(10): 1081-1087

Ataei, B.; Yazdani, M.R.; Kalantari, H.; Yaran, M.; Nokhodian, Z.; Javadi, A.A.; Babak, A.; Adibi, P. 2011: Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepatitis Monthly 11(4): 269-272

Braga, W.S.M.; Castilho, M.ár.d.C.; Borges, F.G.; Leão, J.R.D.T.; Martinho, A.C.d.S.; Rodrigues, I.S.; Azevedo, E.P.d.; Barros Júnior, G.M.d.; Paraná, R. 2012: Hepatitis D virus infection in the Western Brazilian Amazon - far from a vanishing disease. Revista da Sociedade Brasileira de Medicina Tropical 45(6): 691-695

Huang, C.-R.; Lo, S.J. 2014: Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus. World Journal of Gastroenterology 20(40): 14589-14597

Wedemeyer, H.; Heidrich, B.; Manns, M.P. 2007: Hepatitis D virus infection--not a vanishing disease in Europe!. Hepatology 45(5): 1331-2; Author Reply 1332-3

Grabowski, J.; Yurdaydìn, C.; Zachou, K.; Buggisch, P.; Hofmann, W.P.; Jaroszewicz, J.; Schlaphoff, V.; Manns, M.P.; Cornberg, M.; Wedemeyer, H. 2011: Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Liver International: Official Journal of the International Association for the Study of the Liver 31(9): 1395-1405

Pascarella, Séphanie.; Negro, F. 2011: Hepatitis D virus: an update. Liver International: Official Journal of the International Association for the Study of the Liver 31(1): 7-21

Yatsuhashi, H. 2011: Hepatitis D--overview. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 595-599

Abbas, Z.; Jafri, W.; Raza, S. 2010: Hepatitis D: Scenario in the Asia-Pacific region. World Journal of Gastroenterology 16(5): 554-562

Rizzetto, M. 2010: Hepatitis D: clinical features and therapy. Digestive Diseases 28(1): 139-143

Moradpour, D.; Negro, F. 2010: Hepatitis D: forgotten but not gone. Revue Medicale Suisse 6(261): 1656-1659

Rizzetto, M. 2009: Hepatitis D: the comeback?. Liver International: Official Journal of the International Association for the Study of the Liver 29(Suppl 1): 140-142

Rizzetto, M. 2009: Hepatitis D: thirty years after. Journal of Hepatology 50(5): 1043-1050

Wu, J.; Li, L.; Liu, J.; Wang, Y.; Wang, Z.; Wang, Y.; Liu, W.; Zhou, Z.; Chen, C.; Liu, R.; Yang, R. 2018: CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis. Acta Biochimica et Biophysica Sinica 50(9): 835-842

Emerson, S.U.; Purcell, R.H. 2007: Hepatitis e. Pediatric Infectious Disease Journal 26(12): 1147-1148

Kamar, N.; Bendall, R.; Legrand-Abravanel, F.; Xia, N.-S.; Ijaz, S.; Izopet, J.; Dalton, H.R. 2012: Hepatitis e. Lancet 379(9835): 2477-2488

Hoofnagle, J.H.; Nelson, K.E.; Purcell, R.H. 2012: Hepatitis E. New England Journal of Medicine 367(13): 1237-1244

Dalton, H.R.; Hunter, J.G.; Bendall, R.P. 2013: Hepatitis e. Current Opinion in Infectious Diseases 26(5): 471-478

Pauli, G.; Blümel, J.; Burger, R.; Drosten, C.; Gröner, A.; Gürtler, L.; Heiden, M.; Hildebrandt, M.; Jansen, B.; Klamm, H.; Montag-Lessing, T.; Offergeld, R.; Seitz, R.; Schlenkrich, U.; Schottstedt, V.; Willkommen, H.; Wirsing von König, C-Heinz. 2008: Hepatitis E Virus. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 35(1): 50-57

Anonymous 2009: Hepatitis E Virus. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 36(1): 40-47

Yoon, Y.; Jeong, H.Sook.; Yun, H.; Lee, H.; Hwang, Y-Sung.; Park, B.; Lee, C.Jin.; Lee, S.; Hyeon, J-Yeon. 2014: Hepatitis E Virus (HEV) seroprevalence in the general population of the Republic of Korea in 2007-2009: a nationwide cross-sectional study. BMC infectious diseases 14: 517

Takahashi, M.; Tanaka, T.; Takahashi, H.; Hoshino, Y.; Nagashima, S.; Jirintai; Mizuo, H.; Yazaki, Y.; Takagi, T.; Azuma, M.; Kusano, E.; Isoda, N.; Sugano, K.; Okamoto, H. 2010: Hepatitis e Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. Journal of Clinical Microbiology 48(4): 1112-1125

Mesquita, J.R.; Oliveira, R.M.S.; Coelho, C.; Vieira-Pinto, M.; Nascimento, M.S.J. 2016: Hepatitis e Virus in Sylvatic and Captive Wild Boar from Portugal. Transboundary and Emerging Diseases 63(5): 574-578

Kenfak-Foguena, A.; Schöni-Affolter, F.; Bürgisser, P.; Witteck, A.; Darling, K.E.A.; Kovari, H.; Kaiser, L.; Evison, J.-M.; Elzi, L.; Gurter-De La Fuente, V.; Jost, J.; Moradpour, D.; Abravanel, F.; Izpopet, J.; Cavassini, M. 2011: Hepatitis e Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging Infectious Diseases 17(6): 1074-1078

Geurtsvankessel, C.H.; Islam, Z.; Mohammad, Q.D.; Jacobs, B.C.; Endtz, H.P.; Osterhaus, A.D.M.E. 2013: Hepatitis e and Guillain-Barre syndrome. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(9): 1369-1370

Giordani, M.T.; Fabris, P.; Brunetti, E.; Goblirsch, S.; Romanò, L. 2013: Hepatitis e and lymphocytic leukemia in Man, Italy. Emerging Infectious Diseases 19(12): 2054-2056

Aggarwal, R. 2007: Hepatitis e and pregnancy. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 26(1): 3-5

Navaneethan, U.; Al Mohajer, M.; Shata, M.T. 2008: Hepatitis e and pregnancy: understanding the pathogenesis. Liver International: Official Journal of the International Association for the Study of the Liver 28(9): 1190-1199

Birke, L.; Cormier, S.A.; You, D.; Stout, R.W.; Clement, C.; Johnson, M.; Thompson, H. 2014: Hepatitis e antibodies in laboratory rabbits from 2 US vendors. Emerging Infectious Diseases 20(4): 693-696

Baumann-Popczyk, A. 2011: Hepatitis e as zoonosis. Przeglad Epidemiologiczny 65(1): 9-13

Lockwood, G.L.; Fernandez-Barredo, S.; Bendall, R.; Banks, M.; Ijaz, S.; Dalton, H.R. 2008: Hepatitis e autochthonous infection in chronic liver disease. European Journal of Gastroenterology and Hepatology 20(8): 800-803

Bali, S.; Kar, S.S.; Kumar, S.; Ratho, R.K.; Dhiman, R.K.; Kumar, R. 2008: Hepatitis e epidemic with bimodal peak in a town of north India. Indian Journal of Public Health 52(4): 189-193; 199

Teshale, E.H.; Howard, C.M.; Grytdal, S.P.; Handzel, T.R.; Barry, V.; Kamili, S.; Drobeniuc, J.; Okware, S.; Downing, R.; Tappero, J.W.; Bakamutumaho, B.; Teo, C.G.; Ward, J.W.; Holmberg, S.D.; Hu, D.J. 2010: Hepatitis e epidemic, Uganda. Emerging Infectious Diseases 16(1): 126-129

Zhang, F.; Qi, Y.; Harrison, T.J.; Luo, B.; Zhou, Y.; Li, X.; Song, A.; Huang, W.; Wang, Y. 2014: Hepatitis e genotype 4 virus from feces of monkeys infected experimentally can be cultured in PLC/PRF/5 cells and upregulate host interferon-inducible genes. Journal of Medical Virology 86(10): 1736-1744

Yong, M.K.; Paige, E.K.; Anderson, D.; Hoy, J.F. 2014: Hepatitis e in Australian HIV-infected patients: an under-recognised pathogen?. Sexual Health 11(4): 375-378

Pedersen, A.; Christensen, E. 2007: Hepatitis e in Denmark. Ugeskrift for Laeger 169(10): 925-927

Pischke, S.; Behrendt, P.; Bock, C-Thomas.; Jilg, W.; Manns, M.P.; Wedemeyer, H. 2014: Hepatitis E in Germany--an under-reported infectious disease. Deutsches Arzteblatt International 111(35-36): 577-583

Pischke, S.; Ho, H.; Urbanek, F.; Meyer-Olsen, D.; Suneetha, P.V.; Manns, M.P.; Stoll, M.; Wedemeyer, H. 2010: Hepatitis e in HIV-positive patients in a low-endemic country. Journal of Viral Hepatitis 17(8): 598-599

Romanò, L.; Paladini, S.; Tagliacarne, C.; Canuti, M.; Bianchi, S.; Zanetti, A.R. 2011: Hepatitis e in Italy: a long-term prospective study. Journal of Hepatology 54(1): 34-40

Cummings, M.J.; Wamala, J.F.; Komakech, I.; Lukwago, L.; Malimbo, M.; Omeke, M.E.; Mayer, D.; Bakamutumaho, B. 2014: Hepatitis E in Karamoja, Uganda, 2009-2012: epidemiology and challenges to control in a setting of semi-nomadic pastoralism. Transactions of the Royal Society of Tropical Medicine and Hygiene 108(10): 648-655

Shrestha, S.M. 2006: Hepatitis e in Nepal. Kathmandu University Medical Journal 4(4): 530-544

Ibrahim, A.S.; Alkhal, A.; Jacob, J.; Ghadban, W.; Almarri, A. 2009: Hepatitis e in Qatar imported by expatriate workers from Nepal: epidemiological characteristics and clinical manifestations. Journal of Medical Virology 81(6): 1047-1051

Akai, P.S.; Fonseca, K.; Horne, D.; Ho, M. 1995: Hepatitis e in a Canadian traveller. Canadian Journal of Infectious Diseases 6(1): 39-41

Colson, P.; Kaba, M.; Moreau, J.; Brouqui, P. 2009: Hepatitis e in an HIV-infected patient. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 45(4): 269-271

Pavio, N.; Mansuy, J.-M. 2010: Hepatitis e in high-income countries. Current Opinion in Infectious Diseases 23(5): 521-527

Drebber, U.; Odenthal, M.; Aberle, S.W.; Winkel, N.; Wedemeyer, I.; Hemberger, J.; Holzmann, H.; Dienes, H.-P. 2013: Hepatitis e in liver biopsies from patients with acute hepatitis of clinically unexplained origin. Frontiers in Physiology 4: 351

Buffaz, C.; Scholtes, C.; Dron, A.-G.; Chevallier-Queyron, P.; Ritter, J.; André, P.; Ramière, C. 2014: Hepatitis e in liver transplant recipients in the Rhône-Alpes region in France. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 33(6): 1037-1043

Ðaković Rode, O.; Jemeršić, L.; Brnić, D.; Pandak, N.; Mikulić, R.; Begovac, J.; Vince, A. 2014: Hepatitis e in patients with hepatic disorders and HIV-infected patients in Croatia: is one diagnostic method enough for hepatitis e diagnosis?. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 33(12): 2231-2236

Kuo, V.C. 2012: Hepatitis E infection. Proceedings 25(2): 119-120

Sherman, K.E.; Terrault, N.; Barin, B.; Rouster, S.D.; Shata, M.T. 2014: Hepatitis e infection in HIV-infected liver and kidney transplant candidates. Journal of Viral Hepatitis 21(8): E74-E77

Sayani, F.; Goldberg, D.; Slaven, L.; Russell, J.E. 2015: Hepatitis e infection in a patient with transfusion-dependent β thalassemia. American Journal of Hematology 90(3): E50

Kamar, N.; Abravanel, F.; Mansuy, J.-M.; Peron, J.-M.; Izopet, J.; Rostaing, L. 2010: Hepatitis e infection in dialysis and after transplantation. Nephrologie and Therapeutique 6(2): 83-87

Unzueta, A.; Rakela, J. 2014: Hepatitis e infection in liver transplant recipients. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(1): 15-24

Haim-Boukobza, Séphanie.; Coilly, A.; Sebagh, Mène.; Bouamoud, M.; Antonini, T.; Roche, B.; Yordanova, O.; Savary, J.; Saliba, F.; Duclos-Vallee, J-Charles.; Samuel, D.; Ichai, P.; Roque-Afonso, A-Marie. 2015: Hepatitis E infection in patients with severe acute alcoholic hepatitis. Liver International: Official Journal of the International Association for the Study of the Liver 35(3): 870-875

De Silva, S.; Hassan-Ibrahim, M.O.; Austin, M.; Newport, M.; Verma, S. 2012: Hepatitis e infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 44(11): 930-934

Rootjes, P.A.; Wagtmans, M.J.; Verheij, J. 2013: Hepatitis e infections in the Western world. Nederlands Tijdschrift Voor Geneeskunde 157(3): A5461

Ollier, L.; Bigaillon, C.; Tieulie, N.; Tesse, S.; Heudier, P.; Sanderson, F.éd.ér.; Giordanengo, V.ér.; Nicand, E.; Fuzibet, J.-G. 2009: Hepatitis e initially serologically silent with prolonged evolution in a patient treated for a lymphoma. Presse Medicale 38(11): 1700-1704

Said, B.ü; Ijaz, S.; Kafatos, G.; Booth, L.; Thomas, H.L.; Walsh, A.; Ramsay, M.; Morgan, D.; Harris, H.; Zambra, R.; Tedder, R.; Halm, A.; Woodhouse, J.; Wood, A.; Newton, A.; Wilson, D.; Duffell, E.; Nixon, G.; Neal, K.; Bennett, S.; Salimee, S.; Sundkvist, T.; Johnson, S.; Harmer, D.; Modi, A.; Decraene, V.; Smith Palmer, A.; Cowden, J.; Smith, R.; Evans, M.; Mitten, C.; Montsho-Hammond, F.; Sheridan, P.; Irish, C. 2009: Hepatitis e outbreak on cruise ship. Emerging Infectious Diseases 15(11): 1738-1744

Ahmed, J.A.; Moturi, E.; Spiegel, P.; Schilperoord, M.; Burton, W.; Kassim, N.H.; Mohamed, A.; Ochieng, M.; Nderitu, L.; Navarro-Colorado, C.; Burke, H.; Cookson, S.; Handzel, T.; Waiboci, L.W.; Montgomery, J.M.; Teshale, E.; Marano, N. 2013: Hepatitis e outbreak, Dadaab refugee camp, Kenya, 2012. Emerging Infectious Diseases 19(6): 1010-1012

Masood, I.; Rafiq, A.; Majid, Z. 2014: Hepatitis e presenting with thrombocytopaenia. Tropical Doctor 44(4): 219-220

Hassing, R.J.; van der Eijk, A.A.; Lopes, V.B.; Snijdewind, I.J.; de Man, R.A.; Pas, S.D.; van der Ende, M.E. 2014: Hepatitis e prevalence among HIV infected patients with elevated liver enzymes in the Netherlands. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 408-410

Rathod, S.B.; Tripathy, A.S. 2014: Hepatitis e rORF2p stimulated and unstimulated peripheral expression profiling in patients with self-limiting hepatitis e infection. Journal of Immunology Research 2014: 565284

Pawlotsky, J.-M. 2014: Hepatitis e screening for blood donations: an urgent need?. Lancet 384(9956): 1729-1730

Gajjar, M.D.; Bhatnagar, N.M.; Sonani, R.V.; Gupta, S.; Patel, T. 2014: Hepatitis e seroprevalence among blood donors: a pilot study from Western India. Asian Journal of Transfusion Science 8(1): 29-31

Eick, A.; Ticehurst, J.; Tobler, S.; Nevin, R.; Lindler, L.; Hu, Z.; MacIntosh, V.; Jarman, R.; Gibbons, R.; Myint, K.; Gaydos, J. 2010: Hepatitis E seroprevalence and seroconversion among US military service members deployed to Afghanistan. Journal of Infectious Diseases 202(9): 1302-1308

Van Hoecke, F.; Van Maerken, T.; De Boulle, M.; Geerts, A.; Vlierberghe, V.; Colle, I.; Padalko, H.E. 2012: Hepatitis e seroprevalence in east and west Flanders, Belgium. Acta Gastro-Enterologica Belgica 75(3): 322-324

Hauser, L.; Roque-Afonso, A.-M.; Beylouné, A.; Simonet, M.; Deau Fischer, B.én.éd.; Burin des Roziers, N.; Mallet, V.; Tiberghien, P.; Bierling, P. 2014: Hepatitis e transmission by transfusion of Intercept blood system-treated plasma. Blood 123(5): 796-797

Lindberg, J.; Böttiger, B.; Norder, H.én.; Christensen, P.B. 2009: Hepatitis e transmission in Denmark. Ugeskrift for Laeger 171(26): 2199-2200

Basu, S.; Lurie, P. 2007: Hepatitis E vaccine. New England Journal of Medicine 356(23): 2421-2422; Author Reply 2421-2422

Aggarwal, R.; Jameel, S. 2008: Hepatitis E vaccine. Hepatology International 2(3): 308-315

Wu, T.; Li, S.-W.; Zhang, J.; Ng, M.-H.; Xia, N.-S.; Zhao, Q. 2012: Hepatitis e vaccine development: a 14 year odyssey. Human Vaccines and Immunotherapeutics 8(6): 823-827

Holmberg, S.D. 2010: Hepatitis e vaccine: not a moment too soon. Lancet 376(9744): 849-851

Selvi, B.R.; Cassel, J.-C.; Kundu, T.K.; Boutillier, A.-L. 2010: Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochimica et Biophysica Acta 1799(10-12): 840-853

Tanaka, E. 2010: Hepatitis e viral markers. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 458-461

Abravanel, F.; Lhomme, S.; Dubois, M.; Peron, J-M.; Alric, L.; Kamar, N.; Izopet, J. 2013: Hepatitis E virus. Medecine et Maladies Infectieuses 43(7): 263-270

Geng, J.-b.; Fu, H.-w.; Wang, L.; Wang, X.-j.; Guan, J.-m.; Chang, Y.-b.; Li, L.-j.; Zhu, Y.-h.; Zhuang, H.; Liu, Q.-h.; Peng, X.-c. 2010: Hepatitis e virus (HEV) genotype and the prevalence of anti-HEV in 8 species of animals in the suburbs of Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 31(1): 47-50

La Fauci, V.; Sindoni, D.; Grillo, O.C.; Calimeri, S.; Lo Giudice, D.; Squeri, R. 2010: Hepatitis E virus (HEV) in sewage from treatment plants of Messina University Hospital and of Messina City Council. Journal of preventive medicine and hygiene 51(1): 28-30

Paliwal, D.; Panda, S.K.; Kapur, N.; Varma, S.P.K.; Durgapal, H. 2014: Hepatitis e virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. Journal of General Virology 95(Part 8): 1689-1700

Suneetha, P.V.; Pischke, S.; Schlaphoff, V.; Grabowski, J.; Fytili, P.; Gronert, A.; Bremer, B.; Markova, A.; Jaroszewicz, J.; Bara, C.; Manns, M.P.; Cornberg, M.; Wedemeyer, H. 2012: Hepatitis e virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 55(3): 695-708

John, L.; Thomas, S.; Herchenröder, O.; Pützer, B.M.; Schaefer, S. 2011: Hepatitis e virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins. Plos one 6(9): E25378

Parvez, M.K.; Purcell, R.H.; Emerson, S.U. 2011: Hepatitis e virus ORF2 protein over-expressed by baculovirus in hepatoma cells, efficiently encapsidates and transmits the viral RNA to naïve cells. Virology Journal 8: 159

Ma, H.; Song, X.; Harrison, T.J.; Zhang, H.; Huang, W.; Wang, Y. 2011: Hepatitis e virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay. Journal of Medical Virology 83(5): 827-832

Mahajan, R.; Collier, M.G.; Kamili, S.; Drobeniuc, J.; Cuevas-Mota, J.; Garfein, R.S.; Teshale, E. 2013: Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010. Emerging infectious diseases 19(10): 1664-1666

Baylis, S.A.; Nick, S.; Blümel, J.; Micha Nübling, C. 2010: Hepatitis e virus and blood donors in Germany. Vox Sanguinis 98(3 Part 2): 479

Smith, D.B.; Simmonds, P. 2015: Hepatitis e virus and fulminant hepatitis--a virus or host-specific pathology?. Liver International: Official Journal of the International Association for the Study of the Liver 35(4): 1334-1340

Rapicetta, M.; Monarca, R.; Kondili, L.A.; Chionne, P.; Madonna, E.; Madeddu, G.; Soddu, A.; Candido, A.; Carbonara, S.; Mura, M.S.; Starnini, G.; Babudieri, S. 2013: Hepatitis e virus and hepatitis a virus exposures in an apparently healthy high-risk population in Italy. Infection 41(1): 69-76

Shrestha, A.C.; Seed, C.R.; Flower, R.L.P.; Rooks, K.M.; Keller, A.J.; Harley, R.J.; Chan, H.-T.; Holmberg, J.A.; Faddy, H.M. 2014: Hepatitis e virus and implications for blood supply safety, Australia. Emerging Infectious Diseases 20(11): 1940-1942

Kamar, N.; Bendall, R.P.; Peron, J.M.; Cintas, P.; Prudhomme, L.; Mansuy, J.M.; Rostaing, L.; Keane, F.; Ijaz, S.; Izopet, J.; Dalton, H.R. 2011: Hepatitis e virus and neurologic disorders. Emerging Infectious Diseases 17(2): 173-179

Aggarwal, R. 2010: Hepatitis E virus and person-to-person transmission. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 51(4): 477-8; author reply 478-9

Casas, M.; Martín, M. 2010: Hepatitis e virus and pigs: a zoonotic risk in Europe?. Veterinary Journal 186(2): 135-136

Crossan, C.; Scobie, L.; Godwin, J.; Hunter, J.G.; Hawkes, T.; Dalton, H.R. 2013: Hepatitis e virus and porcine-derived heparin. Emerging Infectious Diseases 19(4): 686-688

Hosseini Moghaddam, S.M. 2011: Hepatitis e virus and renal transplantation. Hepatitis Monthly 11(8): 599-600

Kamar, N.; Weclawiak, H.; Guilbeau-Frugier, C.él.; Legrand-Abravanel, F.; Cointault, O.; Ribes, D.; Esposito, L.; Cardeau-Desangles, I.; Guitard, J.; Sallusto, F.; Muscari, F.; Peron, J.M.; Alric, L.; Izopet, J.; Rostaing, L. 2012: Hepatitis e virus and the kidney in solid-organ transplant patients. Transplantation 93(6): 617-623

Mansuy, J.-M.; Bendall, R.; Legrand-Abravanel, F.; Sauné, K.; Miédouge, M.; Ellis, V.; Rech, H.; Destruel, F.ço.; Kamar, N.; Dalton, H.R.; Izopet, J. 2011: Hepatitis e virus antibodies in blood donors, France. Emerging Infectious Diseases 17(12): 2309-2312

Atiq, M.; Shire, N.J.; Barrett, A.; Rouster, S.D.; Sherman, K.E.; Shata, M.T. 2009: Hepatitis e virus antibodies in patients with chronic liver disease. Emerging Infectious Diseases 15(3): 479-481

Larska, M.; Krzysiak, M.K.; Jabłoński, A.; Kęsik, J.; Bednarski, M.; Rola, J. 2015: Hepatitis e virus antibody prevalence in wildlife in Poland. Zoonoses and Public Health 62(2): 105-110

Van Welzen, B.J.; Verduyn Lunel, F.M.; Meindertsma, F.; Hoepelman, A.I.M.; Arends, J.E. 2012: Hepatitis e virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 60(2): E65-E67

Gérolami, R.é; Moal, V.ér.; Picard, C.; Colson, P. 2009: Hepatitis e virus as an emerging cause of chronic liver disease in organ transplant recipients. Journal of Hepatology 50(3): 622-624

Yang, C.; Pan, H.; Wei, M.; Zhang, X.; Wang, N.; Gu, Y.; Du, H.; Zhang, J.; Li, S.; Xia, N. 2013: Hepatitis e virus capsid protein assembles in 4M urea in the presence of salts. Protein Science: a Publication of the Protein Society 22(3): 314-326

Okamoto, H. 2011: Hepatitis e virus cell culture models. Virus Research 161(1): 65-77

Zaki, M.E.S.; Salama, O.S.; Mansour, F.A.; Hossein, S. 2008: Hepatitis e virus coinfection with hepatotropic viruses in Egyptian children. Journal of Microbiology Immunology and Infection 41(3): 254-258

Nagashima, S.; Jirintai, S.; Takahashi, M.; Kobayashi, T.; Tanggis; Nishizawa, T.; Kouki, T.; Yashiro, T.; Okamoto, H. 2014: Hepatitis e virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. Journal of General Virology 95(Part 10): 2166-2175

Eker, A.; Tansel, O.; Kunduracilar, H.; Tokuç, B.; Yuluğkural, Z.; Yüksel, P. 2009: Hepatitis e virus epidemiology in adult population in Edirne province, Turkey. Mikrobiyoloji Bulteni 43(2): 251-258

Tavitian, S.; Péron, J.-M.; Huynh, A.; Mansuy, J.-M.; Ysebaert, L.; Huguet, F.ço.; Vinel, J.-P.; Attal, M.; Izopet, J.; Récher, C. 2010: Hepatitis e virus excretion can be prolonged in patients with hematological malignancies. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 49(2): 141-144

Alvarado-Esquivel, C.; Sánchez-Anguiano, L.F.; Hernández-Tinoco, J.ús. 2014: Hepatitis e virus exposure in pregnant women in rural Durango, Mexico. Annals of Hepatology 13(5): 510-517

Nguyen, H.T.; Shukla, P.; Torian, U.; Faulk, K.; Emerson, S.U. 2014: Hepatitis e virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels. Journal of Virology 88(2): 868-877

Villalba, M.ía.d.l.C.M.; Lay, L.d.L.A.R.íg.; Chandra, V.; Corredor, M.é B.; Frometa, S.S.; Moreno, A.G.; Jameel, S. 2008: Hepatitis e virus genotype 1, Cuba. Emerging Infectious Diseases 14(8): 1320-1322

Clemente-Casares, P.; Rodriguez-Manzano, J.; Girones, R. 2009: Hepatitis e virus genotype 3 and sporadically also genotype 1 circulate in the population of Catalonia, Spain. Journal of Water and Health 7(4): 664-673

Legrand-Abravanel, F.; Mansuy, J.-M.; Dubois, M.; Kamar, N.; Peron, J.-M.; Rostaing, L.; Izopet, J. 2009: Hepatitis e virus genotype 3 diversity, France. Emerging Infectious Diseases 15(1): 110-114

Dell'Amico, M.C.; Cavallo, A.; Gonzales, J.é L.; Bonelli, S.I.; Valda, Y.; Pieri, A.; Segund, H.; Ibañez, R.ón.; Mantella, A.; Bartalesi, F.; Tolari, F.; Bartoloni, A. 2011: Hepatitis e virus genotype 3 in humans and Swine, Bolivia. Emerging Infectious Diseases 17(8): 1488-1490

Crossan, C.; Baker, P.J.; Craft, J.; Takeuchi, Y.; Dalton, H.R.; Scobie, L. 2012: Hepatitis e virus genotype 3 in shellfish, United Kingdom. Emerging Infectious Diseases 18(12): 2085-2087

Lack, J.B.; Volk, K.; Van Den Bussche, R.A. 2012: Hepatitis e virus genotype 3 in wild rats, United States. Emerging Infectious Diseases 18(8): 1268-1273

S de Paula, V.; Wiele, M.; Mbunkah, A.H.; Daniel, A.M.; Kingsley, M.T.; Schmidt-Chanasit, J. 2013: Hepatitis e virus genotype 3 strains in domestic pigs, Cameroon. Emerging Infectious Diseases 19(4): 666-668

Monne, I.; Ceglie, L.; DI Martino, G.; Natale, A.; Zamprogna, S.; Morreale, A.; Rampazzo, E.; Cattoli, G.; Bonfanti, L. 2015: Hepatitis e virus genotype 4 in a pig farm, Italy, 2013. Epidemiology and Infection 143(3): 529-533

Xu, F.; Pan, Y.; Baloch, A.R.; Tian, L.; Wang, M.; Na, W.; Ding, L.; Zeng, Q. 2014: Hepatitis e virus genotype 4 in yak, northwestern China. Emerging Infectious Diseases 20(12): 2182-2184

Garbuglia, A.R.; Scognamiglio, P.; Petrosillo, N.; Mastroianni, C.Maria.; Sordillo, P.; Gentile, D.; La Scala, P.; Girardi, E.; Capobianchi, M.R. 2013: Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerging Infectious Diseases 19(1): 110-114

Midgley, S.; Vestergaard, H.T.; Dalgaard, C.; Enggaard, L.; Fischer, T.K.øl. 2014: Hepatitis e virus genotype 4, Denmark, 2012. Emerging Infectious Diseases 20(1): 156-157

Dai, X.; Dong, C.; Zhou, Z.; Liang, J.; Dong, M.; Yang, Y.; Fu, J.; Tian, H.; Wang, S.; Fan, J.; Meng, J.; Purdy, M.A. 2013: Hepatitis E virus genotype 4, Nanjing, China, 2001-2011. Emerging infectious diseases 19(9): 1528-1530

Zhang, W.; He, Y.; Wang, H.; Shen, Q.; Cui, L.; Wang, X.; Shao, S.; Hua, X. 2010: Hepatitis e virus genotype diversity in eastern China. Emerging Infectious Diseases 16(10): 1630-1632

Béji-Hamza, A.; Hassine-Zaafrane, M.; Khélifi-Gharbi, H.; Della Libera, S.; Iaconelli, M.; Muscillo, M.; Petricca, S.; Ciccaglione, A.R.; Bruni, R.; Taffon, S.; Aouni, M.; La Rosa, G. 2015: Hepatitis e virus genotypes 1 and 3 in wastewater samples in Tunisia. Archives of Virology 160(1): 183-189

Said, B.; Ijaz, S.; Chand, M.A.; Kafatos, G.; Tedder, R.; Morgan, D. 2014: Hepatitis e virus in England and Wales: indigenous infection is associated with the consumption of processed pork products. Epidemiology and Infection 142(7): 1467-1475

Renou, C.; Lafeuillade, A.; Cadranel, J.-F.ço.; Pavio, N.; Pariente, A.; Allègre, T.; Poggi, C.éc.; Pénaranda, G.; Cordier, F.ço.; Nicand, E. 2010: Hepatitis e virus in HIV-infected patients. Aids 24(10): 1493-1499

Kanai, Y.; Miyasaka, S.; Uyama, S.; Kawami, S.; Kato-Mori, Y.; Tsujikawa, M.; Yunoki, M.; Nishiyama, S.; Ikuta, K.; Hagiwara, K. 2012: Hepatitis e virus in Norway rats (Rattus norvegicus) captured around a pig farm. Bmc Research Notes 5: 4

Cleland, A.; Smith, L.; Crossan, C.; Blatchford, O.; Dalton, H.R.; Scobie, L.; Petrik, J. 2013: Hepatitis e virus in Scottish blood donors. Vox Sanguinis 105(4): 283-289

Hewitt, P.E.; Ijaz, S.; Brailsford, S.R.; Brett, R.; Dicks, S.; Haywood, B.; Kennedy, I.T.R.; Kitchen, A.; Patel, P.; Poh, J.; Russell, K.; Tettmar, K.I.; Tossell, J.; Ushiro-Lumb, I.; Tedder, R.S. 2014: Hepatitis e virus in blood components: a prevalence and transmission study in southeast England. Lancet 384(9956): 1766-1773

Gardinali, N.R.; Barry, A.F.; Otonel, R.A.A.; Alfieri, A.F.; Alfieri, A.A. 2012: Hepatitis e virus in liver and bile samples from slaughtered pigs of Brazil. Memorias do Instituto Oswaldo Cruz 107(7): 935-939

Crossan, C.L.; Simpson, K.J.; Craig, D.G.; Bellamy, C.; Davidson, J.; Dalton, H.R.; Scobie, L. 2014: Hepatitis e virus in patients with acute severe liver injury. World Journal of Hepatology 6(6): 426-434

Berto, A.; Martelli, F.; Grierson, S.; Banks, M. 2012: Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerging infectious diseases 18(8): 1358-1360

Berto, A.; Grierson, S.; Hakze-van der Honing, R.; Martelli, F.; Johne, R.; Reetz, J.; Ulrich, R.G.; Pavio, N.; Van der Poel, W.H.M.; Banks, M. 2013: Hepatitis e virus in pork liver sausage, France. Emerging Infectious Diseases 19(2): 264-266

Di Bartolo, I.; Diez-Valcarce, M.; Vasickova, P.; Kralik, P.; Hernandez, M.; Angeloni, G.; Ostanello, F.; Bouwknegt, M.; Rodríguez-Lázaro, D.; Pavlik, I.; Ruggeri, F.M. 2012: Hepatitis e virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerging Infectious Diseases 18(8): 1282-1289

Cossaboom, C.M.; Córdoba, L.; Dryman, B.A.; Meng, X.-J. 2011: Hepatitis e virus in rabbits, Virginia, USA. Emerging Infectious Diseases 17(11): 2047-2049

Purcell, R.H.; Engle, R.E.; Rood, M.P.; Kabrane-Lazizi, Y.; Nguyen, H.T.; Govindarajan, S.; St Claire, M.; Emerson, S.U. 2011: Hepatitis e virus in rats, Los Angeles, California, USA. Emerging Infectious Diseases 17(12): 2216-2222

Dos Santos, D.R.L.; de Paula, V.S.; de Oliveira, J.M.; Marchevsky, R.S.ér.; Pinto, M.A. 2011: Hepatitis e virus in swine and effluent samples from slaughterhouses in Brazil. Veterinary Microbiology 149(1-2): 236-241

Kamar, N.; Izopet, J.; Rostaing, L. 2013: Hepatitis e virus infection. Current Opinion in Gastroenterology 29(3): 271-278

Kamar, N.; Dalton, H.R.; Abravanel, F.; Izopet, J. 2014: Hepatitis e virus infection. Clinical Microbiology Reviews 27(1): 116-138

Fu, H.; Li, L.; Zhu, Y.; Wang, L.; Geng, J.; Chang, Y.; Xue, C.; Du, G.; Li, Y.; Zhuang, H. 2010: Hepatitis e virus infection among animals and humans in Xinjiang, China: possibility of swine to human transmission of sporadic hepatitis e in an endemic area. American Journal of Tropical Medicine and Hygiene 82(5): 961-966

Adjei, A.A.; Aviyase, J.T.; Tettey, Y.; Adu-Gyamfi, C.; Mingle, J.A.A.; Ayeh-Kumi, P.F.; Adiku, T.K.; Gyasi, R.K. 2009: Hepatitis e virus infection among pig handlers in Accra, Ghana. East African Medical Journal 86(8): 359-363

Pas, S.D.; de Man, R.A.; Mulders, C.; Balk, A.H.M.M.; van Hal, P.T.W.; Weimar, W.; Koopmans, M.P.G.; Osterhaus, A.D.M.E.; van der Eijk, A.A. 2012: Hepatitis e virus infection among solid organ transplant recipients, the Netherlands. Emerging Infectious Diseases 18(5): 869-872

Pischke, S.; Suneetha, P.V.; Baechlein, C.; Barg-Hock, H.; Heim, A.; Kamar, N.; Schlue, J.; Strassburg, C.P.; Lehner, F.; Raupach, R.; Bremer, B.; Magerstedt, P.; Cornberg, M.; Seehusen, F.; Baumgaertner, W.; Klempnauer, J.; Izopet, J.; Manns, M.P.; Grummer, B.; Wedemeyer, H. 2010: Hepatitis e virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 16(1): 74-82

Taton, B.; Moreau, K.; Lepreux, S.; Bachelet, T.; Trimoulet, P.; De Ledinghen, V.; Pommereau, A.; Ronco, P.; Kamar, N.; Merville, P.; Couzi, L. 2013: Hepatitis e virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transplant Infectious Disease: An Official Journal of the Transplantation Society 15(6): E211-E215

Pradhan, M.; Anand, B.; Singh, A. 2012: Hepatitis E virus infection causing isolated fetal ascites: a case report. Fetal Diagnosis and Therapy 32(4): 292-294

Meldal, B.H.M.; Sarkodie, F.; Owusu-Ofori, S.; Allain, J-P. 2013: Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. Vox Sanguinis 104(1): 30-36

Crum-Cianflone, N.F.; Curry, J.; Drobeniuc, J.; Weintrob, A.; Landrum, M.; Ganesan, A.; Bradley, W.; Agan, B.K.; Kamili, S. 2012: Hepatitis e virus infection in HIV-infected persons. Emerging Infectious Diseases 18(3): 502-506

Myint, K.S.A.; Duripunt, P.; Mammen, M.P.; Sirisopana, N.; Rodkvamtook, W.; Gibbons, R.V. 2007: Hepatitis e virus infection in Thai troops deployed with U.N. peacekeeping forces. Military Medicine 172(11): 1217-1219

Thapa, R.; Pramanik, S.; Biswas, B.; Mallick, D. 2009: Hepatitis e virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase deficiency. Journal of Pediatric Hematology/Oncology 31(3): 223-224

Te, H.S.; Drobeniuc, J.; Kamili, S.; Dong, C.; Hart, J.; Sharapov, U.M. 2013: Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplantation Proceedings 45(2): 810-813

Yoo, N.; Bernstein, J.; Caldwell, C.; Dong, C.; Drobeniuc, J.; Kamili, S.; Landry, M.L. 2013: Hepatitis e virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays. Transplant Infectious Disease: An Official Journal of the Transplantation Society 15(4): E166-E168

Zhang, W.; Yang, S.; Ren, L.; Shen, Q.; Cui, L.; Fan, K.; Huang, F.; Kang, Y.; Shan, T.; Wei, J.; Xiu, H.; Lou, Y.; Liu, J.; Yang, Z.; Zhu, J.; Hua, X. 2009: Hepatitis e virus infection in central China reveals no evidence of cross-species transmission between human and swine in this area. Plos one 4(12): E8156

Miyamura, T. 2011: Hepatitis e virus infection in developed countries. Virus Research 161(1): 40-46

Han, J.; Zeng, H.; Wang, L.; Liu, P.; Liu, L.; Xia, J.; Zhang, Y.; Wang, L.; Zhuang, H. 2014: Hepatitis e virus infection in farmed rabbits and swine in the Eastern Chinese city Lianyungang: showing no potential interspecies transmission. Journal of Medical Virology 86(11): 1898-1904

Van der Eijk, A.A.; Pas, S.D.; Cornelissen, J.J.; de Man, R.A. 2014: Hepatitis e virus infection in hematopoietic stem cell transplant recipients. Current Opinion in Infectious Diseases 27(4): 309-315

Dastgerdi, E.S.; Amini-Bavil-Olyaee, S. 2011: Hepatitis e virus infection in macaca mulatta. Hepatitis Monthly 11(10): 852-853

Ramezani, A.; Velayati, A.A.; Khorami-Sarvestani, S.; Eslamifar, A.; Mohraz, M.; Banifazl, M.; Bidari-Zerehpoosh, F.; Yaghmaei, F.; McFarland, W.; Foroughi, M.; Keyvani, H.; Mostafavi, E.; Aghakhani, A. 2013: Hepatitis e virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran. International Journal of Std and Aids 24(10): 769-774

Kaba, M.; Richet, H.é; Ravaux, I.; Moreau, J.; Poizot-Martin, I.; Motte, A.; Nicolino-Brunet, C.; Dignat-George, F.ço.; Ménard, A.él.; Dhiver, C.; Brouqui, P.; Colson, P. 2011: Hepatitis e virus infection in patients infected with the human immunodeficiency virus. Journal of Medical Virology 83(10): 1704-1716

Sang, L.-y.; Zhuang, P.-f.; Fu, L.-q.; Liu, Y.; Ge, S.-x.; Zhang, J. 2007: Hepatitis e virus infection in population of non-remunerate blood donors in Shaoxing. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(1): 29-31

Widasari, D.I.; Yano, Y.; Utsumi, T.; Heriyanto, D.S.; Anggorowati, N.; Rinonce, H.T.; Utoro, T.; Lusida, M.I.; Soetjipto; Asmara, W. 2013: Hepatitis e virus infection in two different regions of Indonesia with identification of swine HEV genotype 3. Microbiology and Immunology 57(10): 692-703

Adjei, A.A.; Tettey, Y.; Aviyase, J.T.; Adu-Gyamfi, C.; Obed, S.; Mingle, J.A.A.; Ayeh-Kumi, P.F.; Adiku, T.K. 2009: Hepatitis e virus infection is highly prevalent among pregnant women in Accra, Ghana. Virology Journal 6: 108

Liu, X.; Shen, T.; Wang, Z.; Zhuang, L.; Zhang, W.; Yu, J.; Wu, J.; Zheng, S. 2014: Hepatitis E virus infection results in acute graft failure after liver transplantation: a case report. Journal of Infection in Developing Countries 8(2): 245-248

Legrand-Abravanel, F.; Kamar, N.; Sandres-Saune, K.; Lhomme, S.; Mansuy, J.-M.; Muscari, F.; Sallusto, F.; Rostaing, L.; Izopet, J. 2011: Hepatitis e virus infection without reactivation in solid-organ transplant recipients, France. Emerging Infectious Diseases 17(1): 30-37

Halliday, J.S.; Harrison, G.L.Abby.; Brown, A.; Hunter, J.G.; Bendall, R.; Penny, D.; Toatu, T.; Abdad, M.Y.; Klenerman, P.; Barnes, E.; Dalton, H.R. 2014: Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003-2005. Emerging infectious diseases 20(6): 1057-1058

Hosseini-Moghaddam, S.M.; Zarei, A.; Alavian, S.M.; Mansouri, M. 2010: Hepatitis e virus infection: a general review with a focus on hemodialysis and kidney transplant patients. American Journal of Nephrology 31(5): 398-407

Pischke, S.; Wedemeyer, H. 2013: Hepatitis e virus infection: multiple faces of an underestimated problem. Journal of Hepatology 58(5): 1045-1046

Labrique, A.; Nelson, K. 2010: Hepatitis E virus infections among US military personnel deployed to Afghanistan. Journal of Infectious Diseases 202(9): 1297-1299

Gallian, P.; Lhomme, S.éb.; Piquet, Y.; Sauné, K.; Abravanel, F.; Assal, A.; Tiberghien, P.; Izopet, J. 2014: Hepatitis e virus infections in blood donors, France. Emerging Infectious Diseases 20(11): 1914-1917

Song, Y.-J.; Park, W.-J.; Park, B.-J.; Lee, J.-B.; Park, S.-Y.; Song, C.-S.; Lee, N.-H.; Seo, K.-H.; Kang, Y.-S.; Choi, I.-S. 2014: Hepatitis e virus infections in humans and animals. Clinical and Experimental Vaccine Research 3(1): 29-36

Vivek, R.; Kang, G. 2011: Hepatitis e virus infections in swine and swine handlers in Vellore, Southern India. American Journal of Tropical Medicine and Hygiene 84(4): 647-649

Nan, Y.; Yu, Y.; Ma, Z.; Khattar, S.K.; Fredericksen, B.; Zhang, Y.-J. 2014: Hepatitis e virus inhibits type i interferon induction by ORF1 products. Journal of Virology 88(20): 11924-11932

Mahtab, M.-A.; Rahman, S.; Khan, M.; Karim, M.F. 2009: Hepatitis e virus is a leading cause of acute-on-chronic liver disease: experience from a tertiary centre in Bangladesh. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(1): 50-52

Breum, S.Ø; Hjulsager, C.K.; de Deus, N.; Segalés, J.; Larsen, L.E. 2010: Hepatitis e virus is highly prevalent in the Danish pig population. Veterinary Microbiology 146(1-2): 144-149

Leblanc, D.; Poitras, E.; Gagné, M.-J.ée.; Ward, P.; Houde, A. 2010: Hepatitis e virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR. International Journal of Food Microbiology 139(3): 206-209

Smith, D.B.; Vanek, J.; Wellington, L.; Johannessen, I.; Ramalingam, S.; Simmonds, P. 2013: Hepatitis e virus mixed infection in immunocompetent patient. Emerging Infectious Diseases 19(3): 468-470

Moal, V.ér.; Gérolami, R.é; Ferretti, A.; Purgus, R.; Devichi, P.; Burtey, S.ép.; Colson, P. 2014: Hepatitis e virus of subtype 3i in chronically infected kidney transplant recipients in southeastern France. Journal of Clinical Microbiology 52(11): 3967-3972

Zhou, Y.; Geng, Y.; Yang, J.; Zhao, C.; Harrison, T.J.; Wang, Y. 2014: Hepatitis e virus open reading frame 3 protein interacts with porcine liver-specific plasminogen and α2-antiplasmin. Journal of Medical Virology 86(3): 487-495

Yamamoto, H.; Suzuki, J.; Matsuda, A.; Ishida, T.; Ami, Y.; Suzaki, Y.; Adachi, I.; Wakita, T.; Takeda, N.; Li, T.-C. 2012: Hepatitis e virus outbreak in monkey facility, Japan. Emerging Infectious Diseases 18(12): 2032-2034

Abravanel, F.; Lhomme, S.; Chapuy-Regaud, S.; Mansuy, J.-M.; Muscari, F.; Sallusto, F.; Rostaing, L.; Kamar, N.; Izopet, J. 2014: Hepatitis e virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. Journal of Infectious Diseases 209(12): 1900-1906

Varma, S.P.K.; Kumar, A.; Kapur, N.; Durgapal, H.; Acharya, S.K.; Panda, S.K. 2011: Hepatitis e virus replication involves alternating negative- and positive-sense RNA synthesis. Journal of General Virology 92(Part 3): 572-581

Maral, I.; Budakoglu, I.I.; Ceyhan, M.N.; Atak, A.; Bumin, M.A. 2010: Hepatitis e virus seroepidemiology and its change during 1 year in primary school students in Ankara, Turkey. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 16(7): 831-835

Uçar, E.; Cetin, M.; Kuvandik, C.; Helvaci, M.R.; Güllü, M.; Hüzmeli, C. 2009: Hepatitis e virus seropositivity in hemodialysis patients in Hatay province, Turkey. Mikrobiyoloji Bulteni 43(2): 299-302

Faber, M.S.; Wenzel, J.ür.J.; Jilg, W.; Thamm, M.; Höhle, M.; Stark, K. 2012: Hepatitis e virus seroprevalence among adults, Germany. Emerging Infectious Diseases 18(10): 1654-1657

Zhuang, W.; Ding, X.; Lyu, C.; Xiang, L.; Teng, H.; Li, J. 2014: Hepatitis e virus seroprevalence among blood donors in Jiangsu Province, East China. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 26: 9-11

Kaufmann, A.; Kenfak-Foguena, A.; André, C.; Canellini, G.; Bürgisser, P.; Moradpour, D.; Darling, K.E.A.; Cavassini, M. 2011: Hepatitis e virus seroprevalence among blood donors in southwest Switzerland. Plos one 6(6): E21150

Ben-Ayed, Y.; Hannachi, H.; Ben-Alaya-Bouafif, N.; Gouider, E.; Triki, H.; Bahri, O. 2015: Hepatitis e virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa). Journal of Medical Virology 87(3): 441-445

Payne, B.A.I.; Medhi, M.; Ijaz, S.; Valappil, M.; Savage, E.J.; Gill, O.N.; Tedder, R.; Schwab, U. 2013: Hepatitis e virus seroprevalence among men who have sex with men, United Kingdom. Emerging Infectious Diseases 19(2): 333-335

Ren, F.; Zhao, C.; Wang, L.; Wang, Z.; Gong, X.; Song, M.; Zhuang, H.; Huang, Y.; Shan, H.; Wang, J.; Liu, Q.; Ness, P.; Nelson, K.E.; Wang, Y. 2014: Hepatitis e virus seroprevalence and molecular study among blood donors in China. Transfusion 54(3 Part 2): 910-917

Chaussade, H.él.èn.; Rigaud, E.; Allix, A.; Carpentier, A.; Touzé, A.; Delzescaux, D.; Choutet, P.; Garcia-Bonnet, N.; Coursaget, P. 2013: Hepatitis e virus seroprevalence and risk factors for individuals in working contact with animals. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 58(3): 504-508

Lagler, H.; Poeppl, W.; Winkler, H.; Herkner, H.; Faas, A.; Mooseder, G.; Burgmann, H. 2014: Hepatitis E virus seroprevalence in Austrian adults: a nationwide cross-sectional study among civilians and military professionals. Plos one 9(2): E87669

Mobaien, A.R.; Mohammadi, R.; Sorouri, R.; Sadeghi, K. 2013: Hepatitis e virus seroprevalence in haemodialysis patients in Zanjan Province, Islamic Republic of Iran. Eastern Mediterranean Health Journal 19(7): 608-612

Engle, R.E.; Kuniholm, M.H.; Nelson, K.E.; Purcell, R.H. 2015: Hepatitis E virus seroprevalence in the National Health and Nutrition Examination Survey: facts trump opinion. Hepatology 61(4): 1442

Kuniholm, M.H.; Engle, R.E.; Purcell, R.H.; Nelson, K.E. 2015: Hepatitis e virus seroprevalence in the United States: no easy answers. Hepatology 61(4): 1441-1442

Dremsek, P.; Joel, S.; Baechlein, C.; Pavio, N.; Schielke, A.; Ziller, M.; Dürrwald, R.; Renner, C.; Groschup, M.H.; Johne, R.; Krumbholz, A.; Ulrich, R.G. 2013: Hepatitis E virus seroprevalence of domestic pigs in Germany determined by a novel in-house and two reference ELISAs. Journal of Virological Methods 190(1-2): 11-16

Liang, H.; Chen, J.; Xie, J.; Sun, L.; Ji, F.; He, S.; Zheng, Y.; Liang, C.; Zhang, G.; Su, S.; Li, S. 2014: Hepatitis e virus serosurvey among pet dogs and cats in several developed cities in China. Plos one 9(6): E98068

Izopet, J.; Dubois, M.; Bertagnoli, S.ép.; Lhomme, S.éb.; Marchandeau, S.ép.; Boucher, S.; Kamar, N.; Abravanel, F.; Guérin, J.-L. 2012: Hepatitis e virus strains in rabbits and evidence of a closely related strain in humans, France. Emerging Infectious Diseases 18(8): 1274-1281

Krog, J.S.; Breum, S.Ø; Jensen, T.H.; Larsen, L.E. 2013: Hepatitis e virus variant in farmed mink, Denmark. Emerging Infectious Diseases 19(12): 2028-2030

Shah, S.A.R.; Lal, A.; Idrees, M.; Hussain, A.; Jeet, C.; Malik, F.A.; Iqbal, Z.; Rehman, H.u. 2012: Hepatitis e virus-associated aplastic anaemia: the first case of its kind. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(1): 96-97

Verma, V.; Arankalle, V.A. 2010: Hepatitis e virus-based evaluation of a virion concentration method and detection of enteric viruses in environmental samples by multiplex nested RT-PCR. Journal of Applied Microbiology 108(5): 1630-1641

Kamar, N.; Izopet, J.; Cintas, P.; Garrouste, C.; Uro-Coste, E.; Cointault, O.; Rostaing, L. 2010: Hepatitis e virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(5): 1321-1324

Del Bello, A.; Arné-Bes, M.C.; Lavayssière, L.; Kamar, N. 2012: Hepatitis e virus-induced severe myositis. Journal of Hepatology 57(5): 1152-1153

Li, C.; Wang, H.-F. 2011: Hepatitis e virus-related acute liver failure associated with pure red cell aplasia. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 10(5): 557-558

Kamar, N.; Mansuy, J.-M.; Cointault, O.; Selves, J.; Abravanel, F.; Danjoux, M.; Otal, P.; Esposito, L.; Durand, D.; Izopet, J.; Rostaing, L. 2008: Hepatitis e virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(8): 1744-1748

Kamar, N.; Legrand-Abravanel, F.; Dalton, H.R.; Izopet, J. 2012: Hepatitis E virus-specific T-cell response after transplantation. Hepatology 55(5): 1643; Author Reply 1644

Anonymous 2008: Hepatitis E virus. Position of the Blood Study Circle of the Federal Ministry of Health. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(1): 90-97

Selves, J.; Kamar, N.; Mansuy, J.-M.; Péron, J.-M. 2010: Hepatitis e virus: a new entity. Annales de Pathologie 30(6): 432-438

Gallian, P.; Piquet, Y.; Assal, A.; Djoudi, R.; Chiaroni, J.; Izopet, J.; Tiberghien, P. 2014: Hepatitis e virus: Blood transfusion implications. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 21(4-5): 173-177

Bihl, F.; Negro, F. 2010: Hepatitis e virus: a zoonosis adapting to humans. Journal of Antimicrobial ChemoTherapy 65(5): 817-821

Péron, J.-M.; Mansuy, J.-M.; Izopet, J.; Vinel, J.-P. 2006: Hepatitis e virus: an emerging disease. Sante 16(4): 239-243

Kamar, N.; Abravanel, F.; Lhomme, S.; Rostaing, L.; Izopet, J. 2015: Hepatitis e virus: chronic infection, extra-hepatic manifestations, and treatment. Clinics and Research in Hepatology and Gastroenterology 39(1): 20-27

Yugo, D.M.; Meng, X.-J. 2013: Hepatitis e virus: foodborne, waterborne and zoonotic transmission. International Journal of Environmental Research and Public Health 10(10): 4507-4533

Riveiro-Barciela, M.; Rodríguez-Frías, F.; Buti, M.ía. 2013: Hepatitis e virus: new faces of an old infection. Annals of Hepatology 12(6): 861-870

Jiménez de Oya, N.; Escribano-Romero, E.; Blázquez, A.B.én.; Saiz, J.C. 2007: Hepatitis e virus: zoonotic implications. Gastroenterologia y Hepatologia 30(7): 408-418

Zhu, Y.; Gao, X.-M.; Yang, J.; Xu, D.; Zhang, Y.; Lu, M.; Zhang, Z.; Sheng, Y.-Y.; Li, J.-H.; Yu, X.-X.; Zheng, Y.; Dong, Q.-Z.; Qin, L.-X. 2018: C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma. Cancer Science 109(3): 710-723

Sharma, B.; Nagpal, K.; Bakki Sannegowda, R.; Prakash, S. 2013: Hepatitis E with Gullain-Barré syndrome: still a rare association. Journal of Neurovirology 19(2): 186-187

Escribà, J.M.; Nakoune, E.; Recio, C.; Massamba, P.ég.-M.; Matsika-Claquin, M.D.; Goumba, C.; Rose, A.M.C.; Nicand, E.; García, E.; Leklegban, C.; Koffi, B. 2008: Hepatitis E, Central African Republic. Emerging Infectious Diseases 14(4): 681-683

Tschopp, A.; Joller, H.; Jeggli, S.; Widmeier, S.; Steffen, R.; Hilfiker, S.; Hotz, P. 2009: Hepatitis E, Helicobacter pylori and peptic ulcers in workers exposed to sewage: a prospective cohort study. Occupational and Environmental Medicine 66(1): 45-50

Labrique, A.B.; Sikder, S.S.; Krain, L.J.; West, K.P.; Christian, P.; Rashid, M.; Nelson, K.E. 2012: Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerging Infectious Diseases 18(9): 1401-1404

King, J.-H. 2011: Hepatitis E, diagnosis and treatment. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 588-592

Kumar, N.; Sarin, S.K. 2013: Hepatitis E- Is it a risk to transfusion safety?. Asian Journal of Transfusion Science 7(1): 1-3

Bächlein, C.; Grummer, B. 2010: Hepatitis E--a new zoonotic disease in Germany?. Berliner und Munchener Tierarztliche Wochenschrift 123(5-6): 198-204

Cheung, M.C.M.; Maguire, J.; Carey, I.; Wendon, J.; Agarwal, K. 2012: Hepatitis E--an unexpected problem at home. Scandinavian Journal of Gastroenterology 47(2): 253

Motte, A.; Franques, J.ér.ôm.; Weitten, T.; Colson, P. 2014: Hepatitis E-associated Parsonage-Turner syndrome, France. Clinics and Research in Hepatology and Gastroenterology 38(1): E11-E14

Bernuau, J.; Nicand, E.; Durand, Fçois. 2008: Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology 48(5): 1380-1382

De Vries, M.A.; Samijn, J.P.A.; de Man, R.; Boots, J.M.M. 2014: Hepatitis E-associated encephalopathy in a renal transplant recipient. BMJ Case Reports

Pérez-Gracia, Mía.Teresa.; Mateos-Lindemann, Mía.Luisa. 2012: Hepatitis E. Current perspectives. Medicina Clinica 139(9): 404-411

Weiss, K.; Poirier, L.; Varin, S.; Beliveau, C.; Laverdière, M. 1995: Hepatitis E: A newcomer to the hepatitis alphabet - Case report and review of the literature. Canadian Journal of Infectious Diseases 6(1): 34-37

Chau, T-Nin. 2008: Hepatitis E: A potential vaccine-preventable disease needs global concern. Journal of Gastroenterology and Hepatology 23(6): 827-828

Arends, J.E.; Ghisetti, V.; Irving, W.; Dalton, H.R.; Izopet, J.; Hoepelman, A.I.M.; Salmon, D. 2014: Hepatitis E: An emerging infection in high income countries. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 59(2): 81-88

Rosser, B.G. 1995: Hepatitis E: Canada welcomes the world. Canadian Journal of Infectious Diseases 6(1): 19-20

Teshale, E.H.; Hu, D.J. 2011: Hepatitis E: Epidemiology and prevention. World Journal of Hepatology 3(12): 285-291

Aggarwal, R. 2011: Hepatitis E: Historical, contemporary and future perspectives. Journal of Gastroenterology and Hepatology 26(Suppl 1): 72-82

Seivert, M.; Belaiche, J.; Delwaide, J. 2008: Hepatitis E: a Third World's hepatitis found in Belgium. Revue Medicale de Liege 63(9): 549-553

Abro, A.H.; Abdou, A.M.S.; Saleh, A.A.; Ustadi, A.M.; Hussaini, H.S. 2009: Hepatitis E: a common cause of acute viral hepatitis. JPMA. Journal of the Pakistan Medical Association 59(2): 92-94

Pelosi, E.; Clarke, I. 2008: Hepatitis E: a complex and global disease. Emerging Health Threats Journal 1: E8

Pavio, N.; Renou, C.; Di Liberto, G.; Boutrouille, A.; Eloit, M. 2008: Hepatitis E: a curious zoonosis. Frontiers in Bioscience: a Journal and Virtual Library 13: 7172-7183

Myint, K.S.A.; Gibbons, R.V. 2008: Hepatitis E: a neglected threat. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(3): 211-212

Romanò, L.; Paladini, S.; Zanetti, A.R. 2013: Hepatitis E: a puzzling double-faced disease. Annali di Igiene: Medicina Preventiva e di Comunita 25(3): 169-180

Pérez-Gracia, M.ía.T.; Suay, B.; Mateos-Lindemann, M.ía.L. 2014: Hepatitis E: an emerging disease. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 22: 40-59

Nicand, E.; Bigaillon, C.; Tessé, S. 2009: Hepatitis E: an emerging disease?. Pathologie-Biologie 57(2): 203-211

Soriano, V.; Barreiro, P. 2014: Hepatitis E: an emerging viral disease. Medicina Clinica 143(1): 22-24

Gruz, F.; Cleres, M.; Loredo, D.; Fernández, M.ía.G.; Raffa, S.án.; Yantorno, S.; Romero, G.A.; Munné, M.ía.S.; González, J.E.; Descalzi, V. 2013: Hepatitis E: an infrequent virus or an unfrecuently investigated agent?. Acta Gastroenterologica Latinoamericana 43(2): 143-145

Marano, G.; Vaglio, S.; Pupella, S.; Facco, G.; Bianchi, M.; Calizzani, G.; Candura, F.; Catalano, L.; Farina, B.; Lanzoni, M.; Piccinini, V.; Liumbruno, G.M.; Grazzini, G. 2015: Hepatitis E: an old infection with new implications. Blood Transfusion 13(1): 6-17

Goel, A.; Aggarwal, R. 2011: Hepatitis E: another effective vaccine, but will it make a difference?. National Medical Journal of India 24(1): 30-32

Roux, C.H.; Anty, R.; Patouraux, S.; Euller-Ziegler, L. 2013: Hepatitis E: are rheumatic patients at risk?. Journal of Rheumatology 40(1): 99

Zubkin, M.L.; Semenenko, T.A.; Kokoeva, F.K.; Borisova, V.N.; Sel'kova, E.P.; Aleshkin, V.A. 2012: Hepatitis E: current concepts. Klinicheskaia Meditsina 90(6): 4-11

Pérez-Gracia, M.ía.T.; Mateos Lindemann, M.ía.L.ís.; Caridad Montalvo Villalba, M.ía. 2013: Hepatitis E: current status. Reviews in Medical Virology 23(6): 384-398

Aggarwal, R. 2008: Hepatitis E: does it cause chronic hepatitis?. Hepatology 48(4): 1328-1330

Nau, J.-Y. 2010: Hepatitis E: first steps towards a treatment. Revue Medicale Suisse 6(255): 1382

Izopet, J.; Kamar, N. 2008: Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients. Medecine Sciences: M/S 24(12): 1023-1025

Rodríguez-Frias, F.; Jardi, R.; Buti, M.ía. 2012: Hepatitis E: molecular virology, epidemiology and pathogenesis. Enfermedades Infecciosas y Microbiologia Clinica 30(10): 624-634

Riveiro-Barciela, M.; Rodríguez-Frías, F.; Buti, M.ía. 2012: Hepatitis E: scale of the problem in Spain. Gastroenterologia y Hepatologia 35(10): 719-724

Nau, J.-Y. 2014: Hepatitis E: should we screen all blood from now on?. Revue Medicale Suisse 10(438): 1522-1523

Deshpande, A.; Gunson, R.; Bradley, A.; Cameron, S. 2013: Hepatitis E: the West of Scotland experience. Scottish Medical Journal 58(3): 178-181

Freshwater, D.A. 2013: Hepatitis E: the forgotten virus. Journal of the Royal Army Medical Corps 159(3): 167-168

Moucari, R.; Asselah, T. 2008: Hepatitis E: vaccine in a near future?. La Revue de Medecine Interne 29(8): 615-617

Acharya, S.K.; Panda, S.K. 2011: Hepatitis E: water, water everywhere - now a global disease. Journal of Hepatology 54(1): 9-11

Abbas, Z.; Afzal, R. 2014: Hepatitis E: when to treat and how to treat. Antiviral Therapy 19(2): 125-131

A D B; Stehle, R.L. 1930: Hepatitis Followed by Atrophy Due to Cinchophen Derivatives. Canadian Medical Association Journal 23(6): 830-831

Ramia, S.; Al Faleh, F.Z. 1999: Hepatitis G virus (HGV) and liver diseases. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 5(2): 50-55

Mitwalli, A.H.; Al Wakeel, J.S.; Alam, A.A.; Nauman, T.; Al Rashed, R.S.; Ramia, S. 2000: Hepatitis G virus (HGV) infection in Saudi dialysis patients and healthy controls. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 6(2): 79-83

Riaz Shah, S.A.; Idrees, M.; Hussain, A. 2011: Hepatitis G virus associated aplastic anemia: a recent case from Pakistan. Virology Journal 8: 30

Eslamifar, A.; Hamkar, R.; Ramezani, A.; Ahmadi, F.; Gachkar, L.; Jalilvand, S.; Adibi, L.; Khameneh, A.; Atabak, S.; Ghadimi, R.; Aghakhani, A. 2007: Hepatitis G virus exposure in dialysis staff. Therapeutic Apheresis and Dialysis: Official Peer-Reviewed Journal of the International Society for Apheresis the Japanese Society for Apheresis the Japanese Society for Dialysis Therapy 11(5): 370-374

Alhetheel, A.; El-Hazmi, M.M. 2014: Hepatitis G virus in Saudi blood donors and chronic hepatitis B and C patients. Journal of Infection in Developing Countries 8(1): 110-115

Hammad, A.M.; Zaghloul, M.H.E.D. 2009: Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study). Annals of Clinical Microbiology and Antimicrobials 8: 36

Salama, K.Mohamed.; Selim, O.El-Sayed. 2009: Hepatitis G virus infection in multitransfused Egyptian children. Pediatric Hematology and Oncology 26(4): 232-239

Lefrère, J.-J.; Laperche, S.; Roudot-Thoraval, F. 2008: Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation. Vox Sanguinis 95(1): 76-78

Garen, A. 2008: Hepatitis RNA viruses and hepatocellular carcinoma. Journal of Viral Hepatitis 15(8): 622

Strouse, S.; Strouse, C.D. 1948: Hepatitis Without Jaundice. California Medicine 68(5): 381-383

Torresi, J.; Johnson, D. 2011: Hepatitis a and e infection in international travellers. Current Infectious Disease Reports 13(3): 248-255

Holmberg, S.D. 2012: Hepatitis a epidemiology goes global. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(6): 782-783

Lee, D.; Cho, Y.-A.; Park, Y.; Hwang, J.-H.; Kim, J.W.; Kim, N.Y.; Lee, D.H.; Lee, W.; Jeong, S.-H. 2008: Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology 51(2): 70-74

Alavian, S.-M. 2011: Hepatitis a in developed country, the result should interpret carefully. Gut and Liver 5(3): 395-396

Abdolvahab, M.; Behnaz, K.; Sima, B.; M, T. 2010: Hepatitis a in young adults in the golestan province, northeast of iran. Journal of Global Infectious Diseases 2(2): 198-199

Rowe, S.L.; Tanner, K.; Gregory, J.E. 2009: Hepatitis a outbreak epidemiologically linked to a food handler in Melbourne, Victoria. Communicable Diseases Intelligence Quarterly Report 33(1): 46-48

Raabe, V.N.; Sautter, C.; Chesney, M.; Eckerle, J.K.; Howard, C.R.; John, C.C. 2014: Hepatitis a screening for internationally adopted children from hepatitis A endemic countries. Clinical Pediatrics 53(1): 31-37

Anonymous 2009: Hepatitis a vaccination coverage among children aged 24-35 months - United States, 2006 and 2007. MMWR. Morbidity and mortality weekly report 58(25): 689-694

Faro, S. 1995: Hepatitis a vaccine. Infectious Diseases in Obstetrics and Gynecology 3(1): 1-2

Navamani, K.; Natarajan, M.M.; Lionel, A.P.; Kumar, S. 2014: Hepatitis a virus infection-associated hemophagocytic lymphohistiocytosis in two children. Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 30(Suppl 1): 239-242

Bayani, M.; Sadeghi, M.; Kalantari, N.; Sayadmanesh, A. 2013: Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran. Iranian Red Crescent Medical Journal 15(5): 409-413

Pérez-Sautu, U.; Costafreda, M.I.; Caylà, J.; Tortajada, C.; Lite, J.; Bosch, A.; Pintó, R.M. 2011: Hepatitis a virus vaccine escape variants and potential new serotype emergence. Emerging Infectious Diseases 17(4): 734-737

Saberifiroozi, M. 2013: Hepatitis a virus: is vaccination necessary in middle East?. Middle East Journal of Digestive Diseases 5(3): 125-128

Erdem, E.; Urgancı, N.; Ceylan, Y.; Kara, N.; Ozcelik, G.; Gulec, S.G. 2010: Hepatitis a with pleural effusion, ascites and acalculous cholecystitis. Iranian Journal of Pediatrics 20(4): 479-482

Li, H.; Li, H.; Li, X.-P.; Zou, H.; Liu, L.; Liu, W.; Duan, T. 2018: C‑C chemokine receptor type 2 promotes epithelial‑to‑mesenchymal transition by upregulating matrix metalloproteinase‑2 in human liver cancer. Oncology Reports 40(5): 2734-2741

Ichikawa, S.; Motosugi, U.; Nakazawa, T.; Morisaka, H.; Sano, K.; Ichikawa, T.; Enomoto, N.; Matsuda, M.; Fujii, H.; Onishi, H. 2015: Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. Journal of Magnetic Resonance Imaging: Jmri 41(5): 1203-1208

Roberts, F. 1944: Observation in the Student's Training. British Medical Journal 2(4364): 284-286

Peyrière, Hélène.; Tatem, L.; Bories, C.; Pageaux, G-Philippe.; Blayac, J-Pierre.; Larrey, D. 2009: Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis. Annals of PharmacoTherapy 43(5): 973-977

Howells, L.; Kerr, J.D.O. 1946: Hepatitis after penicillin injections. Lancet 1(6385): 51

Lérisson, M.; Ripault, M.-P.; Pageaux, G.-P.; Guillot, B.; Larrey, D. 2014: Hepatitis after retinoid percutaneous administration. Clinics and Research in Hepatology and Gastroenterology 38(5): E99

Gardner, H.T.; Rovelstad, R.A. 1949: Hepatitis among American occupation troops in Germany; a follow-up study with particular reference to interim alcohol and physical activity. Annals of Internal Medicine 30(5): 1009-1019

Kimhi, R.; Barak, Y.; Achiron, A.; Elizur, A. 1997: Hepatitis among psychiatric inpatients: a high-risk group?. International Journal of Risk and Safety in Medicine 10(3): 207-210

Anonymous 1963: Hepatitis and Cirrhosis. British Medical Journal 1(5322): 5-6

Moreau, B.; Bastedo, C.; Michel, R.P.; Ghali, P. 2011: Hepatitis and Encephalitis due to Coxsackie Virus A9 in an Adult. Case Reports in Gastroenterology 5(3): 617-622

Hedlund, J.; Sylvan, S.; Lundell, E.; Bondesson, Kåre.; Augustini, S.; Bodin, K.; Olsson, K.; Carlsson, A.E.; Lhådö, M.; Nytell, B. 2009: Hepatitis and HIV prevention program reached every third addict. Evaluation of a cooperative project in the county of Uppsala. Lakartidningen 106(14): 1008-1011

Findlay, G.M.; Maccallum, F.O. 1938: Hepatitis and Jaundice Associated with Immunization against Certain Virus Diseases: (Section of Comparative Medicine). Proceedings of the Royal Society of Medicine 31(7): 799-806

Riad, H.; Shaikha, S.A.; Ansari, H.A.; Naama, K.A.; Sada, H.A.; Mansoori, M.A. 2013: Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis. Case Reports in Dermatology 5(2): 219-224

Shah, V.; Saini, A. 2011: Hepatitis and a rash in an immunocompromised patient. British Journal of Radiology 84(998): 194-195

Sepulveda, B.; Jinich, H. 1950: Hepatitis and amebic liver abscess; diagnosis and medical treatment. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 2(3): 283-306

Pérez, A.C.; Soler Vigil, V.; Giannivelli, S.; López Guinea, A.; Pérez-Piaya Moreno, R. 2009: Hepatitis and coagulopathy secondary to neonatal enteroviral infection. Archivos Argentinos de Pediatria 107(6): 550-553

Hughes-Hanks, J.M.; Schommer, S.K.; Mitchell, W.J.; Shaw, D.P. 2010: Hepatitis and enteritis caused by a novel herpesvirus in two monitor lizards (Varanus spp.). Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 22(2): 295-299

Kainulainen, L.; Waris, M.; Söderlund-Venermo, M.; Allander, T.; Hedman, K.; Ruuskanen, O. 2008: Hepatitis and human bocavirus primary infection in a child with T-cell deficiency. Journal of Clinical Microbiology 46(12): 4104-4105

Islam, N.; Flores, Y.N.; Ramirez, P.; Bastani, R.; Salmerón, J. 2014: Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study. International Journal of Public Health 59(2): 381-394

Pinheiro, B.d.V.; Delgado, A.d.A.; Chebli, J.M.F. 2014: Hepatitis and pneumonitis during adalimumab therapy in Crohn disease: mind the histoplasmosis!. Arquivos de Gastroenterologia 51(1): 73-76

Anonymous 2008: Hepatitis and reproduction. Fertility and sterility 90(5 Suppl): S226-S235

Białkowska, J.; Zygmunt, A.; Lewiński, A.; Stankiewicz, W.; Knopik-Dąbrowicz, A.; Szubert, W.; Jabłkowski, M. 2011: Hepatitis and the polyglandular autoimmune syndrome, type 1. Archives of Medical Science: Ams 7(3): 536-539

Pilakasiri, C.; Gibbons, R.V.; Jarman, R.G.; Supyapoung, S.; Myint, K.Saw.Aye. 2009: Hepatitis antibody profile of Royal Thai Army nursing students. Tropical Medicine and International Health: Tm and Ih 14(6): 609-611

Rosner, I.; Rozenbaum, M.; Zuckerman, E.; Naschitz, Y. 1996: Hepatitis arthritis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 2(5): 301

Bank, J.; Cheskin, L.J. 1946: Hepatitis as observed in an Army general hospital. Gastroenterology 6: 357-375

Rauff, B.; Idrees, M.; Shah, S.A.R.; Butt, S.; Butt, A.M.; Ali, L.; Hussain, A.; Irshad-Ur-Rehman; Ali, M. 2011: Hepatitis associated aplastic anemia: a review. Virology Journal 8: 87

Khurana, A.; Dasanu, C.A. 2014: Hepatitis associated aplastic anemia: case report and discussion. Connecticut Medicine 78(8): 493-495

Pischke, S.; Cornberg, M.; Manns, M.P. 2008: Hepatitis associated cryoglobulinemia. Der Internist 49(3): 297-304

Amariles, P.; Angulo, N.; Agudelo-Agudelo, J.; Gaviria, G. 2009: Hepatitis associated with aqueous green tea infusions: a case study. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 33(5): 289-291

Nagamura, N.; Ueno, S.; Fujishiro, H.; Oonuma, H. 2014: Hepatitis associated with hypereosinophilia suspected to be caused by HES that also presented with the pathological features of IgG4-related disease. Internal Medicine 53(2): 145-149

Hsu, H.-L.; Bai, K.-J.; Chiang, Y.-C.; Lin, S.-J.; Yu, M.-C. 2010: Hepatitis associated with prothionamide for treatment of multidrug-resistant tuberculosis. Journal of the Formosan Medical Association 109(12): 923-927

Rossmiller, H.R.; Ensign, W.G. 1948: Hepatitis associated with undulant fever; report of a case. Cleveland Clinic Quarterly 15(4): 184

Guglielmi, V.; Tutino, M.; Guerra, V. 2007: Hepatitis c virus and type 2 diabetes mellitus. Minerva Medica 98(1): 1-4

Ecker-Schlipf, B. 2007: Hepatitis c virus infections. New therapeutic treatments. Medizinische Monatsschrift für Pharmazeuten 30(11): 422-423

Bergman, J.; Schjøtt, J. 2009: Hepatitis caused by Lotus-f3?. Basic and Clinical Pharmacology and Toxicology 104(5): 414-416

Koytak, E.S.; Yurdaydin, C.; Glenn, J.S. 2007: Hepatitis d. Current Treatment Options in Gastroenterology 10(6): 456-463

Anonymous 2007: Hepatitis declining. Aids Patient Care and Stds 21(4): 289

Griffin, B.L.; Chasovskikh, S.; Dritschilo, A.; Casey, J.L. 2014: Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex. Journal of Virology 88(13): 7402-7411

Defenbaugh, D.A.; Johnson, M.; Chen, R.; Zheng, Y.Y.; Casey, J.L. 2009: Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding. Journal of Virology 83(9): 4548-4556

Gaeta, G.B.; Stroffolini, T.; Smedile, A.; Niro, G.; Mele, A. 2007: Hepatitis delta in Europe: vanishing or refreshing?. Hepatology 46(4): 1312-1313

Soriano, V.; Grint, D.; d'Arminio Monforte, A.; Horban, A.; Leen, C.; Poveda, E.; Antunes, F.; de Wit, S.; Lundgren, J.; Rockstroh, J.; Peters, L. 2011: Hepatitis delta in HIV-infected individuals in Europe. Aids 25(16): 1987-1992

Genné, D.; Rossi, I. 2011: Hepatitis delta in Switzerland: a silent epidemic. Swiss Medical Weekly 141: W13176

Fernández-Montero, Jé.Vicente.; Vispo, E.; Barreiro, P.; Sierra-Enguita, Río.; de Mendoza, C.; Labarga, P.; Soriano, V. 2014: Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58(11): 1549-1553

Hughes, S.A.; Wedemeyer, H.; Harrison, P.M. 2011: Hepatitis delta virus. Lancet 378(9785): 73-85

Inoue, O.; Kubota, Y.; Senoo, T. 2010: Hepatitis delta virus (HDV) marker. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 454-457

Tseng, C.-H.; Lai, M.M.C. 2009: Hepatitis delta virus RNA replication. Viruses 1(3): 818-831

Chang, C.-J.; Chiang, J.-C.; Lu, S.-N.; Wang, J.-H. 2010: Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan. Chang Gung Medical Journal 33(2): 137-144

Liao, F.-T.; Lee, Y.-J.; Ko, J.-L.; Tsai, C.-C.; Tseng, C.-J.; Sheu, G.-T. 2009: Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells. Journal of General Virology 90(Part 5): 1124-1134

Butt, F.A.; Amin, I.; Idrees, M.; Iqbal, M. 2014: Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes a and D in Pakistan. European Journal of Gastroenterology and Hepatology 26(3): 319-324

Niro, G.A.; Gioffreda, D.; Fontana, R. 2011: Hepatitis delta virus infection: open issues. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43(Suppl 1): S19-S24

Pugnale, P.; Pazienza, V.; Guilloux, K.év.; Negro, F. 2009: Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 49(2): 398-406

Park, C.-Y.; Oh, S.-H.; Kang, S.M.; Lim, Y.-S.; Hwang, S.B. 2009: Hepatitis delta virus large antigen sensitizes to TNF-alpha-induced NF-kappaB signaling. Molecules and Cells 28(1): 49-55

Williams, V.; Brichler, S.ég.èn.; Radjef, N.; Lebon, P.; Goffard, A.; Hober, D.; Fagard, R.; Kremsdorf, D.; Dény, P.; Gordien, E. 2009: Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. Journal of General Virology 90(Part 11): 2759-2767

Alves, C.; Branco, C.; Cunha, C. 2013: Hepatitis delta virus: a peculiar virus. Advances in Virology 2013: 560105

Noureddin, M.; Gish, R. 2014: Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery. Current Gastroenterology Reports 16(1): 365

Grabowski, J.; Wedemeyer, H. 2010: Hepatitis delta: immunopathogenesis and clinical challenges. Digestive Diseases 28(1): 133-138

Holmberg, S.D.; Ward, J.W. 2010: Hepatitis delta: seek and ye shall find. Journal of Infectious Diseases 202(6): 822-824

Rizzetto, M.; Alavian, S.Moayed. 2013: Hepatitis delta: the rediscovery. Clinics in Liver Disease 17(3): 475-487

Sartakhti, J.S.; Zangooei, M.H.; Mozafari, K. 2012: Hepatitis disease diagnosis using a novel hybrid method based on support vector machine and simulated annealing (SVM-SA). Computer Methods and Programs in Biomedicine 108(2): 570-579

Kuehn, B.M. 2012: Hepatitis drug reduces effects of HIV medications. JAMA 307(20): 2138

Benjamin, Z.H. 1948: Hepatitis due to cincophen, with recovery. New York State Journal of Medicine 48(20): 2282-2284

Huddam, B.ül.; Azak, A. 2012: Hepatitis due to herbal medicine in a peritoneal dialysis patient. Therapeutic Apheresis and Dialysis: Official Peer-Reviewed Journal of the International Society for Apheresis the Japanese Society for Apheresis the Japanese Society for Dialysis Therapy 16(6): 606-608

Hill, J.A.; Myerson, D.; Sedlak, R.H.; Jerome, K.R.; Zerr, D.M. 2014: Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. Transplant Infectious Disease: An Official Journal of the Transplantation Society 16(3): 477-483

Nguyen, R.H.; Cruz, P.D. 2014: Hepatitis due to mycophenolate mofetil used to treat atopic dermatitis and allergic contact dermatitis. Dermatitis: Contact Atopic Occupational Drug 25(5): 284-285

Prieto-de-Paula, J.é M.ía.; Cepedello-Pérez, S.; Martín-Luquero Ibáñez, M.; Franco-Hidalgo, S.; Uzcátegui-Urdaneta, M.ía.G. 2014: Hepatitis due to secondary syphilis. Gastroenterologia y Hepatologia 37(9): 546-549

Wu, L.-W.; Kao, J.-H. 2011: Hepatitis during antituberculosis treatment. Journal of the Formosan Medical Association 110(12): 801

Kirin, B.Kristić.; Topić, R.Zrinski.; Dodig, S. 2013: Hepatitis during respiratory syncytial virus infection--a case report. Biochemia Medica 23(1): 112-116

Vassallo, D.; Husain, M.M.; Greer, S.; McGrath, S.; Ijaz, S.; Kanigicherla, D. 2014: Hepatitis e infection in a renal transplant recipient. Case Reports in Nephrology 2014: 865471

Kamar, N. 2011: Hepatitis e virus infection in Iranian kidney-transplant patients. Hepatitis Monthly 11(11): 927-928

Larrat, S.; Gaillard, Séphanie.; Baccard, M.; Piroth, L.; Cacoub, P.; Pol, S.; Perronne, C.; Carrat, F.; Morand, P. 2012: Hepatitis e virus infection in sheltered homeless persons, france. Emerging Infectious Diseases 18(6): 1031; Author Reply 1032

Sherman, K.E. 2011: Hepatitis e virus infection: more common than previously realized?. Gastroenterology and Hepatology 7(11): 759-761

Dalton, H.R.; Pas, S.D.; Madden, R.G.; van der Eijk, A.A. 2014: Hepatitis e virus: current concepts and future perspectives. Current Infectious Disease Reports 16(4): 399

Turner, J.; Green, J. 2008: Hepatitis e: a UK perspective. British Journal of Hospital Medicine 69(9): 517-519

Dalton, H.R. 2014: Hepatitis e: the 'new kid on the block' or an old friend?. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 41(1): 6-9

Gupta, N.; Patel, C.; Panda, M. 2009: Hepatitis following famotidine: a case report. Cases Journal 2(1): 89

Moro, P.A.; Cassetti, F.; Giugliano, G.; Falce, M.T.; Mazzanti, G.; Menniti-Ippolito, F.; Raschetti, R.; Santuccio, C. 2009: Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. Journal of Ethnopharmacology 124(2): 328-332

Harris, H.; Crawford, A. 2013: Hepatitis goes viral. Nursing 43(11): 38-43; Quiz 43-4

Highleyman, L. 2010: Hepatitis highlights from CROI. Positively aware: the monthly journal of the Test Positive Aware Network 21(3): 22-23

Nicolle, L. 1994: Hepatitis in Canadian correctional institutions. Canadian Journal of Infectious Diseases 5(4): 151

Porteous, W.M. 1948: Hepatitis in New Zealand. New Zealand Medical Journal 47(259): 201-213

Foster, A.P.; Otter, A.; Naylor, R.; Wessels, M.E.; Veenstra, B. 2009: Hepatitis in a six-month-old lamb with Fusobacterium varium infection. Veterinary Record 164(3): 98

Koren, I.; Riskin, A.; Barthlen, W.; Gillis, D. 2013: Hepatitis in an infant treated with octreotide for congenital hyperinsulinism. Journal of Pediatric Endocrinology and Metabolism: Jpem 26(1-2): 183-185

Daniels, J.A.; Torbenson, M.; Vivekanandan, P.; Anders, R.A.; Boitnott, J.K. 2009: Hepatitis in common variable immunodeficiency. Human Pathology 40(4): 484-488

Zhang, X.; Sun, Z.; Wang, B.; Tang, Y.; Nguyen, L.; Li, Y.; Tao, F.F. 2018: C-C Coupling on Single-Atom-Based Heterogeneous Catalyst. Journal of the American Chemical Society 140(3): 954-962

Amon, J.J. 2011: Hepatitis in drug users: time for attention, time for action. Lancet 378(9791): 543-544

Lucas, Z.J. 1971: Hepatitis in patients undergoing hemodialysis or transplantation. California Medicine 114(3): 72-73

Benson, J.; Donohue, W. 2007: Hepatitis in refugees who settle in Australia. Australian Family Physician 36(9): 719-727

Wick, J.Y. 2012: Hepatitis in the elderly: still a scourge. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 27(7): 472-481

Fernández Fernández, N.; Joao Matias, D.; Pisabarros Blanco, C.; Rodríguez Martín, L.; Aparicio Cabezudo, M.; Linares Torres, P.; Hernando Martín, M.; Olcoz Goñi, J.L. 2015: Hepatitis induced by glatiramer acetate. Gastroenterologia y Hepatologia 38(4): 280-281

Yüksel, M.; Laukens, D.; Heindryckx, F.; Van Vlierberghe, H.; Geerts, A.; Wong, F.S.; Wen, L.; Colle, I. 2014: Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis. International Journal of Experimental Pathology 95(5): 309-320

Hassan, Z.M.; Wahsheh, M.A.; Shishani, K.R.; Pryor, E.R. 2008: Hepatitis needs assessment among Jordanian healthcare workers. International Nursing Review 55(2): 142-147

O'neill, J.F.; Harrell, G.T. 1947: Hepatitis of unknown etiology. North Carolina Medical Journal 8(9): 599-604

Kay, M. 2012: Hepatitis outbreak is traced to contaminated needles and barber shop razors, study shows. Bmj 345: E8700

Guardia, J. 2008: Hepatitis over hepatitis. Its time for prevention. Medicina Clinica 131(14): 536-537

Sundus, A.; Siddique, O.; Ibrahim, M.Faisal.; Abbasi, Z.; Aziz, S. 2013: Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan--a cross-sectional descriptive study. Jpma. Journal of the Pakistan Medical Association 63(12): 1566-1570

Xuan, D.; Yu, Y.; Shao, L.; Wang, J.; Zhang, W.; Zou, H. 2014: Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review. Clinical Rheumatology 33(4): 577-586

Purcell, R.H. 1974: Hepatitis research. Science 184(4132): 9

Sasaki, N.; Wada, K.; Smith, D.R.; Wang, G.; Ohta, H.; Shibuya, A. 2014: Hepatitis screening in Japanese individuals of working age and prejudice against infected persons in the workplace. Journal of Occupational Health 55(5): 392-397

Santoro, D.; Mazzaglia, G.; Savica, V.; Li Vecchi, M.; Bellinghieri, G. 2009: Hepatitis status and mortality in hemodialysis population. Renal Failure 31(1): 6-12

Reiter, F.P.; Denk, G.U.; Grüner, N.H.; Kleiss, P.; Rust, C. 2012: Hepatitis surface antigen clearance in a woman with liver cirrhosis and concomitant autoimmune hepatitis under immunosuppressive therapy. Hepatology Research: the Official Journal of the Japan Society of Hepatology 42(12): 1252-1254

Anonymous 2009: Hepatitis temporally associated with an herbal supplement containing artemisinin - Washington, 2008. Mmwr. Morbidity and Mortality Weekly Report 58(31): 854-856

Fuoti, M.; Pinotti, M.; Villa, M.C.; Miceli, V.; Celano, M.R.; Amoruso, C.; Carnelli, V.; Nebbia, G. 2008: Hepatitis type a with atypical course. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 30(1): 48-50

Siconolfi, D.E.; Halkitis, P.N.; Rogers, M.E. 2009: Hepatitis vaccination and infection among gay, bisexual, and other men who have sex with men who attend gyms in new York City. American Journal of Men's Health 3(2): 141-149

Nguyen, C.T.; Tran, T.T. 2009: Hepatitis vaccination and prophylaxis. Clinics in Liver Disease 13(2): 317-329

Hachem, C.Y.; Kramer, J.R.; Kanwal, F.; El-Serag, H.B. 2008: Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre. Alimentary Pharmacology and Therapeutics 28(9): 1078-1087

Storholm, E.David.; Fisher, D.G.; Reynolds, G.L.; Napper, L.E.; Morrisse, T.A.; Kochems, L.M. 2010: Hepatitis vaccination of men who have sex with men at gay pride events. Prevention Science: the Official Journal of the Society for Prevention Research 11(2): 219-227

Ness, J.M.; Bale, J.F. 2009: Hepatitis vaccines and pediatric multiple sclerosis: does timing or type matter?. Neurology 72(10): 870-871

Ciurtin, C.; Stoica, V. 2008: Hepatitis virus C infection, adipokines and hepatic steato-fibrosis. Journal of Medicine and Life 1(1): 49-54

Milazzo, L.; Antinori, S. 2014: Hepatitis virus and HIV interactions. LANCET. Infectious Diseases 14(11): 1025-1027

He, L.; Porterfield, Z.; van der Schoot, P.; Zlotnick, A.; Dragnea, B. 2013: Hepatitis virus capsid polymorph stability depends on encapsulated cargo size. Acs Nano 7(10): 8447-8454

Wyles, D.L. 2008: Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(11): 1476-1478

Kuzin, S.N.; Samokhvalov, E.I.; Zabotina, E.E.; Kudriavtseva, E.N.; Krel', P.E.; Korabel'nikova, M.I.; Bogomolov, P.O.; Kupriianova, N.V.; Kovalenko, E.S.; Mamonova, N.A.; Ignatova, T.M.; Lopatkina, T.N.; Burnevi, E.Z.; Lisitsyna, E.V.; Kuzina, L.E.; Lavrov, V.F. 2011: Hepatitis virus genotype structure in patients with chronic hepatitis C. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 33-38

Ramakrishnaiah, V.; van der Laan, L.J.W. 2014: Hepatitis virus hijacks shuttle: exosome-like vesicles provide protection against neutralizing antibodies. Hepatology 59(6): 2416-2418

Crane, M.; Matthews, G.; Lewin, S.R. 2008: Hepatitis virus immune restoration disease of the liver. Current Opinion in HIV and Aids 3(4): 446-452

He, B.; Fan, Q.; Yang, F.; Hu, T.; Qiu, W.; Feng, Y.; Li, Z.; Li, Y.; Zhang, F.; Guo, H.; Zou, X.; Tu, C. 2013: Hepatitis virus in long-fingered bats, Myanmar. Emerging Infectious Diseases 19(4): 638-640

Okamoto, Y.; Shinjo, K.; Shimizu, Y.; Sano, T.; Yamao, K.; Gao, W.; Fujii, M.; Osada, H.; Sekido, Y.; Murakami, S.; Tanaka, Y.; Joh, T.; Sato, S.; Takahashi, S.; Wakita, T.; Zhu, J.; Issa, J.-P.J.; Kondo, Y. 2014: Hepatitis virus infection affects DNA methylation in mice with humanized livers. Gastroenterology 146(2): 562-572

Roccatello, D.; Solfietti, L.; Salussolia, I.; Sorasio, D.; Manna, E.; Binello, G.; Strani, G.; Quaglino, F.; Giancaspero, K. 2012: Hepatitis virus-related nephropathies. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(Suppl 56): S62-S69

Kew, M.C. 2013: Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. Journal of Viral Hepatitis 20(3): 149-157

Verna, E.C. 2014: Hepatitis viruses and liver transplantation: evolving trends in antiviral management. Clinics in Liver Disease 18(3): 575-601

Marcucci, F.; Mele, A. 2011: Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117(6): 1792-1798

Datta, S.; Chatterjee, S.; Policegoudra, R.S.; Gogoi, H.K.; Singh, L. 2012: Hepatitis viruses and non-Hodgkin's lymphoma: a review. World Journal of Virology 1(6): 162-173

Srivatanakul, P.; Honjo, S.; Kittiwatanachot, P.; Jedpiyawongse, A.; Khuhaprema, T.; Miwa, M. 2010: Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pacific Journal of Cancer Prevention: Apjcp 11(4): 985-988

Zhang, L.-p.; Yang, P.; Li, F.-h.; Yan, Y.; Wen, M.; Zhang, Y.-r.; Jiang, Y.-z. 2008: Hepatitis viruses infection situation in Mianyang of the Sichuan province. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(6): 449-451

Lu, J.; Li, H.-y.; Tian, R.-g.; Jiang, Y.-z.; Xu, Y.-n.; Yu, D.-s.; Jiang, J.-x.; Bi, S.-l. 2009: Hepatitis viruses infection situation in human population of the Gansu province. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(5): 349-351

Gallegos-Orozco, J.F.; Rakela-Brödner, J. 2010: Hepatitis viruses: not always what it seems to be. Revista Medica de Chile 138(10): 1302-1311

Bird, R.G. 1946: Hepatitis with Abscess Infected by Staph. pyogenes and B. coli. Proceedings of the Royal Society of Medicine 39(6): 298-299

Bird, R.G. 1946: Hepatitis with abscess secondarily infected by Staphylococcus pyogenes and B. coli. Proceedings of the Royal Society of Medicine 39: 298

Van Malenstein, H.; Libbrecht, L.; Cassiman, D. 2014: Hepatitis with brown pigment in the liver. Gastroenterology 147(4): E5-E6

Diniz, J.B.; Badra, P. 1948: Hepatitis with jaundice in a patient with total visceral inversion and patent ductus arteriosus. Revista Paulista de Medicina 33(3): 134-138

DeMARSH, Q.B.; Alt, H.L. 1947: Hepatitis without jaundice in infections mononucleosis. Journal of Laboratory and Clinical Medicine 32(3): 320

Angle, R.M. 1949: Hepatitis without jaundice in infectious mononucleosis. Gastroenterology 12(4): 617-622

Caravati, C.M. 1948: Hepatitis, acute, fulminant. Gastroenterology 11(2): 240-245

Leard, S.E.; Greer, W.E.R.; Kaufman, I.C. 1949: Hepatitis, exfoliative dermatitis and abnormal bone marrow occurring during tridione therapy; report of a case with recovery. New England Journal of Medicine 240(24): 962-966

Wang, L.Y.; Young, T.-H. 2012: Hepatitis, gallbladder hydrops, splenomegaly, and ascites in a child with scarlet fever. Pediatric Emergency Care 28(11): 1215-1217

Mirick, G.S. 1948: Hepatitis, modern concepts. Southern Medical Journal 41(8): 743-746

Rajaram, M. 2009: Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use. BMJ Case Reports

Tan, C.Kiat. 2014: Hepatitis--cure and prevention. Annals of the Academy of Medicine Singapore 43(7): 341-342

Yadav, Y.K.; Aggarwal, R.; Gupta, O.; Ranga, S. 2011: Hepatitis-B associated cryoglobulinemia presenting as pseudoleucocytosis. Journal of Laboratory Physicians 3(2): 133-135

Thompson, P.A.; Tam, C.S.; Thursky, K.; Seymour, J.F. 2010: Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge. Leukemia and Lymphoma 51(9): 1592-1595

Azodo, C.; Ehizele, A.; Uche, I.; Erhabor, P. 2012: Hepatitis-B vaccination status among dental surgeons in benin city, Nigeria. Annals of Medical and Health Sciences Research 2(1): 24-28

Teira, R.ón.; Suarez-Lozano, I.; Lozano, F.; Viciana, P.; Domingo, P.; Galindo, P.; Geijo, P.; Terron, A.; Cosın, J.; Ribera, E.; Roca, B.; Garcia-Alcalde, M.L.; Sanchez, T.; Munoz-Sanz, A.; Romero, A.; Lopez-Aldeguer, J.; Pedrol, E.; Vidal, F.; Garrido, M.; Munoz, P.; Puig, T.; Deig, E.; Estrada, V.; Castano, M. 2013: Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients. Aids 27(5): 845-848

Feitelson, M. 1995: Hepatitis-B x-antigen in the pathogenesis of hepatocellular-carcinoma (review). Oncology Reports 2(2): 193-202

Aledavood, S.A.; Ghavam-Nasiri, M.R.; Ghaffarzadegan, K.; Raziee, H.R.; Saboori, G.; Anvari, K.; Mohtashami, S.; Ahadi, M.; Memar, B. 2014: Hepatitis-C Infection Incidence Among the non-Hodgkin's B-cell Lymphoma Patients in the Northeast of Iran. Iranian Journal of Cancer Prevention 7(3): 147-151

SeyedAlinaghi, S.; Jam, S.; Mehrkhani, F.; Fattahi, F.; Sabzvari, D.; Kourorian, Z.; Jabbari, H.; Mohraz, M. 2011: Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Medica Iranica 49(4): 252-257

Mayor, A.M.; Fernández, D.M.; Colón, Héctor..M.; Thomas, J.C.; Miranda, C.; Hunter-Mellado, R.F. 2013: Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention. Journal of Health Care for the Poor and Underserved 24(4 Suppl): 29-37

Locasciulli, A.; Bacigalupo, A.; Bruno, B.; Montante, B.; Marsh, J.; Tichelli, Aé.; Socié, G.; Passweg, J. 2010: Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party. British Journal of Haematology 149(6): 890-895

Ishimura, M.; Ohga, S.; Ichiyama, M.; Kusuhara, K.; Takada, H.; Hara, T.; Takahashi, M.; Okamoto, H. 2010: Hepatitis-associated aplastic anemia during a primary infection of genotype 1a torque teno virus. European Journal of Pediatrics 169(7): 899-902

Breakey, V.R.; Meyn, S.; Ng, V.; Allen, C.; Dokal, I.; Lansdorp, P.M.; Abla, O.; Dror, Y. 2009: Hepatitis-associated aplastic anemia presenting as a familial bone marrow failure syndrome. Journal of Pediatric Hematology/Oncology 31(11): 884-887

Ray, K. 2011: Hepatitis: Cryoblobulinemia—a useful predictor of treatment response in patients with chronic HCV infection?. Nature Reviews. Gastroenterology and Hepatology 8(1): 6

Goksu, E.; Kilic, T.; Yilmaz, D. 2012: Hepatitis: a herbal remedy Germander. Clinical Toxicology 50(2): 158

Craxi, L. 2012: Hepatitis: a longstanding companion in human history. Le Infezioni in Medicina 20(1): 52-57

Maugh, T.H. 1972: Hepatitis: a new understanding emerges. Science 176(4040): 1225-1226

Clemente, M.G.; Schwarz, K. 2011: Hepatitis: general principles. Pediatrics in Review 32(8): 333-340

Boylston, G.A. 1948: Hepatitis; a clinical consideration. Bulletin. Portland Or. Clinic 2(2): 27-38

Duncan, G.G. 1948: Hepatitis; a clinical evaluation. American Practitioner and Digest of Treatment 3(4): 214-220

Schiff, L. 1946: Hepatitis; newer developments. Cincinnati Journal of Medicine 27: 97-107

François, M.; Alla, F.; Rabaud, C.; Raphaël, F. 2011: Hepatitis B virus vaccination by French family physicians. Medecine et Maladies Infectieuses 41(10): 518-525

Zou, Q.-L.; Wei, G.-N.; Chen, J.-X.; Ye, Q.; Shan, P.-F. 2014: Hepatitis B virus-associated nephropathy in a patient with diabetes mellitus. Journal of Diabetes Investigation 5(1): 87-89

Riva, E.; Scagnolari, C.; Turriziani, O.; Antonelli, G. 2014: Hepatitis C virus and interferon type IIi (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(12): 1237-1245

Ippolito, G.; Antonelli, G.; Capobianchi, M.R.; Lanini, S. 2014: Hepatitis C virus treatment revolution: need for close monitoring. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(11): O790-O791

Pawlotsky, J-M. 2011: Hepatitis C virus: from discovery to eradication in 40 years?. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 17(2): 105-106

Yağci, M.ün.; Ozkurt, Z.üb.N.; Yeğin, Z.A.; Aki, Z.; Sucak, G.ül.T.ür.öz.; Haznedar, R. 2010: Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies. Hematology 15(4): 240-244

Preethi, K.C.; Kuttan, R. 2009: Hepato and reno protective action of Calendula officinalis L. flower extract. Indian Journal of Experimental Biology 47(3): 163-168

Sukhanov, D.S.; Artyushkova, E.B.; Dudka, V.T. 2013: Hepato- and endothelioprotective action of runihol and ademetionine in experimental liver injury induced by TB drugs in combination with alcohol. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 45-49

Nworu, C.S.; Ihim, S.A.; Ugwu, L.E.; Laiyemo, K.A.; Akah, P.A. 2014: Hepato- and nephroprotective activities of a Nigerian local king tuber oyster mushroom, Pleurotus tuberregium (higher Basidiomycetes), in chemically induced organ toxicities in rats. International Journal of Medicinal Mushrooms 16(4): 305-318

Hay, E.C. 1947: Hepato- and nephrotoxic effect of glycine. Federation Proceedings 6(1 Part 2): 125

Vyas, S.; Markar, S.; Ezzat, T.; Rodriguez-Justo, M.; Webster, G.; Imber, C.; Malago, M. 2012: Hepato-biliary Cystadenoma with Intraductal Extension: Unusual Cause of Obstructive Jaundice. Journal of Gastrointestinal Cancer 43(Suppl 1): S32-S37

Yamamoto, M. 2009: Hepato-biliary and pancreatic surgery of high technical difficulty and its technological evaluation. Nihon Geka Gakkai Zasshi 110(Suppl 3): 23-24

Klingenberg, S.L.; Nikolova, D.; Alexakis, N.; Als-Nielsen, B.; Colli, A.; Conte, D.; D'Amico, G.; Davidson, B.; Fingerhut, A.; Fraquelli, M.; Gluud, L.L.; Gurusamy, K.; Keus, F.; Khan, S.; Koretz, R.; van Laarhoven, C.; Liu, J.; Myers, R.; Pagliaro, L.; Simonetti, R.; Sutton, R.; Thorlund, K.; Gluud, C. 2011: Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews. Journal of Gastroenterology and Hepatology 26(4): 649-656

Marche, J. 1950: Hepato-biliary functions and vitamin metabolism. II. Hydrosoluble vitamins. La Revue du Foie 9(5-6): 177-203

Pitegoff, C.H. 1947: Hepato-biliary infection following administration of priodax. Connecticut State Medical Journal 11(9): 739

Castellino, S.; Muir, A.; Shah, A.; Shope, S.; McMullen, K.; Ruble, K.; Barber, A.; Davidoff, A.; Hudson, M.M. 2010: Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. Pediatric Blood and Cancer 54(5): 663-669

Maerckx, C.éd.; Scheers, I.; Tondreau, T.; Campard, D.; Nyabi, O.; Najimi, M.; Sokal, E. 2012: Hepato-biliary profile of potential candidate liver progenitor cells from healthy rat liver. World Journal of Gastroenterology 18(27): 3511-3519

Pan, H.; Liang, Z.; Yin, T.-s.; Xie, Y.; Li, D.-w. 2014: Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice. Medical Oncology 31(3): 853

Fouad, Y.M.; Yehia, R. 2014: Hepato-cardiac disorders. World Journal of Hepatology 6(1): 41-54

Konovalov, N.V. 1947: Hepato-cerebral affections. Klinicheskaia Meditsina 25(3): 3-20

Mariani, G.A.; Maroni, L.; Bianchi, L.; Broccoli, A.; Lazzarini, E.; Marchegiani, G.; Mazzotti, A.; Mazzotti, M.Carla.; Billi, A.Maria.; Piccari, G.Giuliani.; Cocco, L.; Manzoli, L. 2013: Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature. Italian Journal of Anatomy and Embryology 118(2): 217-222

Hemanth, K.; Garg, S.; Yadav, T.D.; Sahni, D.; Singh, R. 2011: Hepato-gastro-phrenic trunk and hepato-spleno-mesenteric trunk: a rare anatomic variation. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 32(1): 56-59

Rougier, P.; Legoux, J-Louis.; Lepage, Côme.; Michel, P. 2011: Hepato-gastroenterologists and oncologists are complementary in the management of digestive cancers. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43(8): 583-584

Boutillon, G. 1951: Hepato-ovarian syndromes and the Vichy cure. Revue Generale de Medecine and de Chirurgie de l'Union Francaise 31(582): 943-945

De, U.; Mukherjee, M.; Das, S.; Kumar, R. 2010: Hepato-pancreatic ascariasis. Tropical Doctor 40(4): 227-229

Ben-Haim, M.; Nakache, R.; Klausner, J.M. 2009: Hepato-pancreato-biliary (HPB) surgery and abdominal organ transplantation, a defined subspecialty, integrated within the surgical division: professional, operative and educational aspects. Harefuah 148(4): 215-8 278

Pitt, H.A. 2007: Hepato-pancreato-biliary fat: the good, the bad and the ugly. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 9(2): 92-97

Lee, J.S.; Raja, P.; Pan, D.; Pesola, J.M.; Coen, D.M.; Knipe, D.M. 2018: CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection. Mbio 9(1)

Chang, Y.-J.; Mittal, V.K. 2009: Hepato-pancreato-biliary training in general surgery residency: is it enough for the real world?. American Journal of Surgery 197(3): 291-295

Thiemann, M.; Benhidjeb, T.; Anders, S.; Gebauer, B.; Strik, M.W. 2008: Hepato-pericardial fistula following radiofrequency ablation (RFA) for liver metastasis: a case report and review of the literature. Langenbeck's Archives of Surgery 393(6): 1013-1016

Alnuaimi, O.; Lazăr, M.; Apostolescu, C.ăt.ăl.; Scheau, C.; Adriana Ion, D. 2011: Hepato-porto-biliary changes following a high energy electrical shock. Germs 1(1): 22-26

Kapoor, S. 2013: Hepato-protective effects of alpha lipoic acid besides its role in preventing fatty liver disease. Liver International: Official Journal of the International Association for the Study of the Liver 33(1): 162-163

Firdous, A.P.; Sindhu, E.R.; Kuttan, R. 2011: Hepato-protective potential of carotenoid meso-zeaxanthin against paracetamol, CCl4 and ethanol induced toxicity. Indian Journal of Experimental Biology 49(1): 44-49

Kwape, T.E.; Chaturvedi, P.; Kamau, J.M.; George, S. 2013: Hepato-protective potential of methanol extract of leaf of Ziziphus mucronata (ZMLM) against dimethoate toxicity: biochemical and histological approach. Ghana Medical Journal 47(3): 112-120

Shenoy, V.Prasad.; Vishwanath, S.; Indira, B.; Rodrigues, G. 2010: Hepato-pulmonary amebiasis: a case report. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 14(4): 372-373

Bozomitu, L.; Moraru, E.; Stana, B.; Burlea, M.; Aprodu, G.; Moraru, D. 2010: Hepato-pulmonary syndrome. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 114(3): 625-632

Shorr, E.; Zweifach, B.W.; Furchgott, R.F. 1948: Hepato-renal factors in circulatory hemeostasis; the influence of humoral factors of hepato-renal origin on the vascular reactions to hemorrhage. Annals of the new York Academy of Sciences 49(Art 4: 571-592

Shorr, E.; Zweifach, B.W. 1948: Hepato-renal factors in circulatory homeostasis; VEM and VDM mechanisms in nutritional cirrhosis in rats. Federation Proceedings 7(1 Pt): 115

Zweifch, B.W.; Shorr, E.; Baez, S. 1947: Hepato-renal factors in circulatory homeostasis; a vaso-excitor principle in the blood of hypertensive dogs. Federation Proceedings 6(1 Part 2): 232

Baez, S.; Mazur, A.; Shorr, E. 1948: Hepato-renal factors in circulatory homeostasis; antidiuretic action of liver VDM concentrates. Federation Proceedings 7(1 Part 1): 5

Zweifach, B.W.; Baez, S.; Shorr, E. 1947: Hepato-renal factors in circulatory homeostasis; effects of acute renal ischemia on the renal vaso-excitor mechanisms. Federation Proceedings 6(1 Part 2): 232

Mazur, A.; Shorr, E. 1947: Hepato-renal factors in circulatory homeostasis; properties of a partially purified hepatic vaso-depressor principle. Federation Proceedings 6(1 Part 2): 275

Zweifach, B.W.; Baez, S. 1948: Hepato-renal factors in circulatory homeostasis; relation of renal VEM to vascular compensation in shock. Federation Proceedings 7(1 Part 1): 139

Zweifach, B.W.; Rosenfeld, S.; Shorr, E. 1948: Hepato-renal factors in circulatory homeostasis; vascular changes in mesentery in renal hypertension in rats. Federation Proceedings 7(1 Part 1): 139

Baez, S.; Zweifach, B.W.; Shorr, E. 1947: Hepato-renal factors in circulatory homeostasis; vascular effects of acute renal occlusion in dogs. Federation Proceedings 6(1 Part 2): 71

Stroope, A.; Radtke, B.; Huang, B.; Masyuk, T.; Torres, V.; Ritman, E.; LaRusso, N. 2010: Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease. American Journal of Pathology 176(3): 1282-1291

Dibirov, M.D.; Briskin, B.S.; Kostiuchenko, M.V.; Dobriakova, E.A.; Mkhitarova, L.A. 2009: Hepato-renal syndrome and problem of protein-energy metabolism correction during urgent surgery of the abdominal organs. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2009(2): 83-87

Vikrant, S. 2015: Hepato-renal toxicity-associated with methyl parathion exposure. Renal Failure 37(2): 355-356

Shorr, E.; Zweifach, B.W. 1947: Hepato-renal vasotropic factors in experimental shock and renal hypertension. Transactions of the Association of American Physicians 60(1 Vol): 28-51

Pietrzak, A.; Bartosińska, J.; Dybiec, E.; Chodorowska, G.ży.; Krasowska, D.; Hercogova, J.; Lotti, T. 2014: Hepato-splenic and lipid profile abnormalities--do they exist in children affected with vitiligo?. Acta Dermatovenerologica Croatica: Adc 22(1): 19-25

Jira, M.; Sekkach, Y.; Abouzahir, A.; Amezyane, T.; Ghafir, D. 2015: Hepato-splenic tuberculosis. Presse Medicale 44(2): 258-259

Sridhar Varma, K.; Pamidi, N.; Vollala, V.Ramana.; Bolla, S.R. 2010: Hepato-spleno-mesenteric trunk: a case report. Romanian Journal of Morphology and Embryology 51(2): 401-402

Shaw, H.B. 1908: Hepato-splenomegaly with Ascites. Proceedings of the Royal Society of Medicine 1(Clin Sect): 56-57

Potter, C.T. 1937: Hepato-splenomegaly: ? Idiopathic Cirrhosis. Proceedings of the Royal Society of Medicine 30(4): 409-410

Tarquini, R.; Masini, E.; La Villa, G.; Mazzoccoli, G.; Mastroianni, R.; Romanelli, R.G.; Vizzutti, F.; Arena, U.; Santosuosso, U.; Laffi, G. 2012: Hepato-systemic gradient of carbon monoxide in cirrhosis. European Journal of Internal Medicine 23(1): E14-E18

Wu, J.; Li, P.-C.; Pang, J.-Y.; Liu, G.-Y.; Xie, X.-M.; Li, J.-Y.; Yin, Y.-C.; Han, J.-H.; Guo, X.-Z.; Qiu, L. 2017: CCCTC-binding factor inhibits breast cancer cell proliferation and metastasis via inactivation of the nuclear factor-kappaB pathway. Oncotarget 8(55): 93516-93529

Soltys, K.A.; Mazariegos, G.V. 2012: Hepatoadrenal syndrome in critically ill children with liver failure: is it true, true, and unrelated?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 13(3): 366-367

Hauser, G.J.; Brotzman, H.M.; Kaufman, S.S. 2012: Hepatoadrenal syndrome in pediatric patients with end-stage liver disease. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 13(3): E145-E149

Jonker, J.W.; Stedman, C.A.M.; Liddle, C.; Downes, M. 2009: Hepatobiliary ABC transporters: physiology, regulation and implications for disease. Frontiers in Bioscience 14(13): 4904-4920

Qhalib, H.A.; Zain, G.H. 2014: Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen. Sultan Qaboos University Medical Journal 14(4): E556-E560

Motosugi, U.; Bannas, P.; Sano, K.; Reeder, S.B. 2015: Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. Journal of Magnetic Resonance Imaging: Jmri 41(2): 251-265

Bhardwaj, S.; Canlas, K.; Kahi, C.; Temkit, M.'H.; Molleston, J.; Ober, M.; Howenstine, M.; Kwo, P.Y. 2009: Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood. Journal of Clinical Gastroenterology 43(9): 858-864

Almeida, R.P.; Ferreira, C.D.; Conceição, J.; Franca, R.; Lyra, I.; Silva, L.R. 2009: Hepatobiliary abnormalities in pediatric patients with sickle cell disease. Acta Gastroenterologica Latinoamericana 39(2): 112-117

Hope, T.A.; Fowler, K.J.; Sirlin, C.B.; Costa, E.A.C.; Yee, J.; Yeh, B.M.; Heiken, J.P. 2015: Hepatobiliary agents and their role in LI-RADS. Abdominal Imaging 40(3): 613-625

Kawakami, H.; Kuwatani, M.; Sakamoto, N. 2013: Hepatobiliary alveolar echinococcosis infiltration of the hepatic hilum diagnosed by endoscopic ultrasonography-guided fine-needle aspiration. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 25(3): 339-340

Heidenhain, C.; Rosch, R.; Neumann, U.P. 2011: Hepatobiliary anastomosis techniques. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 82(1): 7

Gaujoux, S.éb.; Salenave, S.; Ronot, M.; Rangheard, A.-S.; Cros, J.ér.ôm.; Belghiti, J.; Sauvanet, A.; Ruszniewski, P.; Chanson, P. 2014: Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism 99(1): E97-101

Stappaerts, J.; Fattah, S.; Annaert, P.; Augustijns, P. 2014: Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat model. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(6): 489-497

Bilgin, M.; Balci, N.C.; Erdogan, A.; Momtahen, A.J.; Alkaade, S.; Rau, W.S. 2008: Hepatobiliary and pancreatic MRi and MRCP findings in patients with HIV infection. AJR. American Journal of Roentgenology 191(1): 228-232

Rajagopalan, S. 2012: Hepatobiliary and pancreatic disorders. Medical Journal Armed Forces India 68(3): 209-210

Nievelstein, R.A.J.; Robben, S.G.F.; Blickman, J.G. 2011: Hepatobiliary and pancreatic imaging in children-techniques and an overview of non-neoplastic disease entities. Pediatric Radiology 41(1): 55-75

Saluja, S.S.; Ray, S.; Pal, S.; Kukeraja, M.; Srivastava, D.N.; Sahni, P.; Chattopadhyay, T.K. 2007: Hepatobiliary and pancreatic tuberculosis: a two decade experience. Bmc Surgery 7: 10

Kim, S.; Keum, B.; Kim, E.; Jeen, Y.; Chun, H. 2014: Hepatobiliary and pancreatic: Caput medusae. Journal of Gastroenterology and Hepatology 29(12): 1952

Albuquerque, A.; Sarmento, J.; Macedo, G. 2012: Hepatobiliary and pancreatic: Terry's nails and liver disease. Journal of Gastroenterology and Hepatology 27(9): 1539

Chopra, S.; Zeile, M.; Wildberger, J.; Schumacher, G.; Hünerbein, M. 2008: Hepatobiliary and pancreatic: biliary imaging with 3-dimensional ultrasound. Journal of Gastroenterology and Hepatology 23(12): 1941

Park, C.-H.; Bae, S.H.; Kim, H.Y.; Chun, H.J.; Kim, J.S.; Song, M.J.; Choi, J.Y.; Yoon, S.K.; Han, N.I.; Lee, Y.S. 2014: Hepatobiliary and pancreatic: bleeding duodenal ulcer associated with coil migration after transarterial chemoembolization and radiotherapy. Journal of Gastroenterology and Hepatology 29(5): 897

Hashash, J.; Chopra, K.; Behari, J. 2011: Hepatobiliary and pancreatic: bleeding duodenal varices. Journal of Gastroenterology and Hepatology 26(8): 1341

Malhotra, A.; Naniwadekar, A.; Sood, G. 2008: Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. Journal of Gastroenterology and Hepatology 23(12): 1942

Lu, J.; Xiong, X.-Z.; Cheng, N.-S. 2014: Hepatobiliary and pancreatic: coexisting cancers: Hepatic neuroendocrine carcinomas with gall bladder adenocarcinoma. Journal of Gastroenterology and Hepatology 29(7): 1343

Akgun, V.; Battal, B.; Hamcan, S.; Karaman, B. 2014: Hepatobiliary and pancreatic: cyst of the cystic duct. Journal of Gastroenterology and Hepatology 29(2): 232

Courcoutsakis, N.; Deftereos, S.; Daskalogiannakis, G.; Prassopoulos, P. 2008: Hepatobiliary and pancreatic: duplication of the gallbladder. Journal of Gastroenterology and Hepatology 23(8 Part 1): 1304

Choudhary, N.; Duseja, A.; Kalra, N.; Chawla, Y. 2011: Hepatobiliary and pancreatic: intrahepatic biloma after blunt abdominal trauma. Journal of Gastroenterology and Hepatology 26(8): 1342

Levi Sandri, G.B.; Sulpice, L.; Boudjema, K.; Meunier, B. 2014: Hepatobiliary and pancreatic: leiomyosarcoma of the inferior vena cava. Journal of Gastroenterology and Hepatology 29(5): 896

Lee, A.; Rajanayagam, J.; Sarikwal, A.; Davies, J.; Lewindon, P. 2014: Hepatobiliary and pancreatic: liver transplantation for massive hepatic lymphangiomatosis. Journal of Gastroenterology and Hepatology 29(2): 233

Limongelli, P.; Belli, A.; Cioffi, L.; Russo, G.; D'Agostino, A.; Fantini, C.; Maiello, F.; Belli, G. 2012: Hepatobiliary and pancreatic: nesidioblastosis. Journal of Gastroenterology and Hepatology 27(9): 1538

Duong, C.; Martin, I.; Kerlin, P.; Clouston, J.; Clouston, A. 2009: Hepatobiliary and pancreatic: papillary cholangiocarcinoma. Journal of Gastroenterology and Hepatology 24(12): 1893

Wai, C.-T.; Lin, M.; Tan, K.-C. 2008: Hepatobiliary and pancreatic: pulmonary embolism after injection therapy for gastric varices. Journal of Gastroenterology and Hepatology 23(8 Part 1): 1306

Itoyama, R.; Hashimoto, D.; Chikamoto, A.; Hayashi, H.; Beppu, T.; Baba, H. 2014: Hepatobiliary and pancreatic: sigmoidal mesenterial lymph node metastasis from pancreatic cancer. Journal of Gastroenterology and Hepatology 29(12): 1953

Tsauo, J.; Liu, L.; Li, X. 2013: Hepatobiliary and pancreatic: transient hepatic ischemia caused by acute portal vein thrombosis. Journal of Gastroenterology and Hepatology 28(9): 1433

Cheng, Y.; Jia, Q.; Xiong, X.; He, D.; Cheng, N.-S. 2014: Hepatobiliary and pancreatic: traumatic neuroma of the ampulla of Vater. Journal of Gastroenterology and Hepatology 29(7): 1342

Knight, C.; Murray, K.F. 2009: Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology 3(6): 681-691

Eichler, T.W.; Totland, C.; Haugen, M.; Vedeler, C.A. 2018: CCDC104 Antibodies and Mitosis of Cancer Cells. Scandinavian Journal of Immunology 87(2): 109-110

Benson, A.B. 2003: Hepatobiliary cancer. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN 1(1): 94-108

Benson, A.B.; D'Angelica, M.I.; Abrams, T.A.; Are, C.; Bloomston, P.M.; Chang, D.T.; Clary, B.M.; Covey, A.M.; Ensminger, W.D.; Iyer, R.; Kelley, R.K.; Linehan, D.; Malafa, M.P.; Meranze, S.G.; Park, J.O.; Pawlik, T.; Posey, J.A.; Scaife, C.; Schefter, T.; Sigurdson, E.R.; Tian, G.G.; Vauthey, J.-N.; Venook, A.P.; Yen, Y.; Zhu, A.X.; Hoffmann, K.G.; McMillian, N.R.; Sundar, H. 2014: Hepatobiliary cancers, version 2.2014. Journal of the National Comprehensive Cancer Network: Jnccn 12(8): 1152-1182

McDonald, G.B. 2010: Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 51(4): 1450-1460

Dai, Y-Hong.; Yeo, Y.Hui.; Li, Y-Feng.; Hsieh, C-Bao.; Shih, Y-Lueng. 2014: Hepatobiliary cystadenocarcinoma without mesenchymal stroma in a female patient: a case report. Bmc Gastroenterology 14: 109

Li, X.; Zhang, J.-L.; Wang, Y.-H.; Song, S.-W.; Wang, F.-S.; Shi, R.; Liu, Y.-F. 2013: Hepatobiliary cystadenoma and cystadenocarcinoma: a single center experience. Tumori 99(2): 261-265

Fukunaga, N.; Ishikawa, M.; Ishikura, H.; Ichimori, T.; Kimura, S.; Sakata, A.; Sato, K.; Nagata, J.; Fujii, Y. 2008: Hepatobiliary cystadenoma exhibiting morphologic changes from simple hepatic cyst shown by 11-year follow up imagings. World Journal of Surgical Oncology 6: 129

Geramizadeh, B.; Asadian, M.; Hourang, M.H. 2010: Hepatobiliary cystadenoma mimicking liver hydatid cyst. Archives of Iranian Medicine 13(6): 556-558

Abe, Y.; Kasuya, K.; Itoi, T.; Kikuchi, S.; Ikeuchi, N.; Ishii, K.; Serizawa, H.; Shimazu, M. 2012: Hepatobiliary cystadenoma of the liver prolapsing into the extrahepatic bile duct (with video). Gastrointestinal Endoscopy 75(5): 1099; Discussion: 1099-1100

Harmouch, T.; Vullierme, M-Pierre.; Sauvanet, A.; Paradis, Vérie.; Amarti, A. 2011: Hepatobiliary cystadenoma revealed by a jaundice: a case report. Case Reports in Gastrointestinal Medicine 2011: 895605

Cacciaguerra, S.; Lucenti, A.; Vasta, G.; Gangarossa, S.; Milone, P.; Rizzo, L.; Fraggetta, F.; Vasquez, E.; Di Benedetto, A. 1996: Hepatobiliary cystadenoma with hyaline stroma : a pediatric case associated with multiple hemangiomas. Pediatric Surgery International 11(5-6): 380-383

Yu, F.Chun.; Chen, J.Hao.; Yang, K.Ching.; Wu, C.Chu.; Chou, Y.Yu. 2008: Hepatobiliary cystadenoma: a report of two cases. Journal of Gastrointestinal and Liver Diseases: Jgld 17(2): 203-206

Barabino, M.; Leone, S.; Dapri, G.; Marsetti, M.; Ghislandi, R.; Opocher, E. 2004: Hepatobiliary cystadenoma: diagnostic uncertainty. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 6(1): 52-54

Maharaj, R.; Cawich, S.O.; Harnarayan, P.; Naraynsingh, V. 2014: Hepatobiliary cystadenomas. Annals of the Royal College of Surgeons of England 96(4): 326

Navarra, G.; Iusco, D.R.; Bonomi, S.; Grassi, A.; Ismail, I.; Vicari, S.; Virzì, S. 2010: Hepatobiliary cystoadenoma: a wolf in sheep's clothing. Updates in Surgery 62(3-4): 203-206

Morgan-Rowe, L.M.; Pericleous, M.; Luong, T.V.; Dooley, J.S.; Burroughs, A.K. 2011: Hepatobiliary disease associated with hypereosinophilia: a report of two patients and a review of the literature. Digestive Diseases and Sciences 56(12): 3689-3694

Moyer, K.; Balistreri, W. 2009: Hepatobiliary disease in patients with cystic fibrosis. Current Opinion in Gastroenterology 25(3): 272-278

Kahi, C.J.; Saxena, R.; Temkit, M.'H.; Canlas, K.; Roberts, S.; Knox, K.; Wilkes, D.; Kwo, P.Y. 2006: Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 23(2): 117-123

Méndez-Sánchez, N.; Chávez-Tapia, N.C.; Zamora-Valdés, D.; Medina-Santillán, R.; Uribe, M. 2007: Hepatobiliary diseases and insulin resistance. Current Medicinal Chemistry 14(18): 1988-1999

Lata, I. 2013: Hepatobiliary diseases during pregnancy and their management: An update. International Journal of Critical Illness and Injury Science 3(3): 175-182

Morsy, K.H.; Hasanain, A.F.A. 2012: Hepatobiliary disorders among naïve patients with ulcerative colitis in Upper Egypt. Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology 13(2): 71-76

Venkatesh, P.G.; Navaneethan, U.; Shen, B. 2011: Hepatobiliary disorders and complications of inflammatory bowel disease. Journal of Digestive Diseases 12(4): 245-256

Prasad, K.K.; Debi, U.; Sinha, S.K.; Nain, C.K.; Singh, K. 2011: Hepatobiliary disorders in celiac disease: an update. International Journal of Hepatology 2011: 438184

Sharma, S.; Ellis, E.C.S.; Gramignoli, R.; Dorko, K.; Tahan, V.; Hansel, M.; Mattison, D.R.; Caritis, S.N.; Hines, R.N.; Venkataramanan, R.; Strom, S.C. 2013: Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(2): 296-304

Megaraj, V.; Iida, T.; Jungsuwadee, P.; Hofmann, A.F.; Vore, M. 2010: Hepatobiliary disposition of 3alpha,6alpha,7alpha,12alpha-tetrahydroxy-cholanoyl taurine: a substrate for multiple canalicular transporters. Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(10): 1723-1730

Lee, J.K.; Marion, T.L.; Abe, K.; Lim, C.; Pollock, G.M.; Brouwer, K.L.R. 2010: Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation. Journal of Pharmacology and Experimental Therapeutics 332(1): 26-34

Nalesnik, M.A.; Federle, M.; Buck, D.; Fontes, P.; Carr, B.I. 2009: Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma. Human Pathology 40(1): 125-134

Siviero, I.; Ferrante, S.M.R.; Meio, I.B.; Madi, K.; Chagas, V.L. 2008: Hepatobiliary effects of cholic and lithocholic acids: experimental study in hamsters. Pediatric Surgery International 24(3): 325-331

Williams, W.H. 1990: Hepatobiliary excretion scintigraphy revisited. Western Journal of Medicine 152(6): 707

Blaise, J.; Raccurt, C.P. 2007: Hepatobiliary fascioliasis and echinococcosis/hydatidosis in domestic animals in Haiti. Revue Scientifique et Technique 26(3): 741-746

Goenka, M.K.; Majumder, S.; Sethy, P.K.; Kumar, S.; Goenka, U. 2010: Hepatobiliary fascioliasis treated at endoscopic retrograde cholangiopancreatography. Endoscopy 42(Suppl 2): E103

Yeşildağ, A.; Senol, A.ğ; Köroğlu, M.; Koçkar, C.; Oyar, O.; Işler, M. 2010: Hepatobiliary fascioliasis: a case with unusual radiological features. Diagnostic and Interventional Radiology 16(4): 299-301

Koç, Z.; Ulusan, S.; Tokmak, N. 2009: Hepatobiliary fascioliasis: imaging characteristics with a new finding. Diagnostic and Interventional Radiology 15(4): 247-251

Kula, M.; Karacavus, S.; Baskol, M.; Deniz, K.; Abdulrezzak, U.; Tutus, A. 2010: Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation. Nuclear Medicine Communications 31(4): 280-285

Marche, J. 1950: Hepatobiliary functions and vitamin metabolism. La Revue du Foie 9(1): 5-33

Girard, M.; Poujois, A.él.; Fabre, M.; Lacaille, F.; Debray, D.; Rio, M.èn.; Fenaille, F.ço.; Cholet, S.; Ruel, C.; Caussé, E.; Selves, J.; Bridoux-Henno, L.; Woimant, F.; Dupré, T.; Vuillaumier-Barrot, S.; Seta, N.; Alric, L.; de Lonlay, P.; Bruneel, A. 2018: CCDC115-CDG: a new rare and misleading inherited cause of liver disease. Molecular Genetics and Metabolism 124(3): 228-235

Enger, C.; Bennett, D.; Dawson, K.L.; Aivado, M.A.; Theodore, D.; McAfee, A.T. 2011: Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP). Annals of Hepatology 10(2): 188-195

Grigor'eva, G.A.; Meshalkina, N.Iu. 2013: Hepatobiliary lesions in Crohn's disease and conservative methods of treatment. Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 3-6

Kukuk, G.M.; Schaefer, S.G.; Fimmers, R.; Hadizadeh, D.R.; Ezziddin, S.; Spengler, U.; Schild, H.H.; Willinek, W.A. 2014: Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests. European Radiology 24(10): 2482-2490

Pfeiffenberger, J.; Mogler, C.; Gotthardt, D.N.; Schulze-Bergkamen, H.; Litwin, T.; Reuner, U.; Hefter, H.; Huster, D.; Schemmer, P.; Członkowska, A.; Schirmacher, P.; Stremmel, W.; Cassiman, D.; Weiss, K.H. 2015: Hepatobiliary malignancies in Wilson disease. Liver International: Official Journal of the International Association for the Study of the Liver 35(5): 1615-1622

Wong, T.C.L.; Poon, R.T.P. 2013: Hepatobiliary malignancies: lessons from Asia. Digestive Diseases 31(1): 130-137

Solís Herruzo, J.A.; Solís-Muñoz, P. 2007: Hepatobiliary manifestations in inflammatory bowel disease. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 99(9): 525-542

Rojas-Feria, M.ía.; Castro, M.; Suárez, E.; Ampuero, J.; Romero-Gómez, M. 2013: Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World Journal of Gastroenterology 19(42): 7327-7340

Nishihori, T.; Fernandez, H.F.; Coppola, D.; Ochoa-Bayona, J.L.; Lancet, J.E.; Komrokji, R.S.; Kharfan-Dabaja, M.A. 2011: Hepatobiliary manifestations of acute myeloid leukemia. Leukemia Research 35(6): E81-E83

Aronsohn, A.; Jensen, D. 2011: Hepatobiliary manifestations of critically ill and postoperative patients. Clinics in Liver Disease 15(1): 183-197

Samarasena, J.B.; Hu, K.-Q. 2011: Hepatobiliary manifestations of gastrointestinal and nutritional disorders. Clinics in Liver Disease 15(1): 89-110

Yarur, A.J.; Czul, F.; Levy, C. 2014: Hepatobiliary manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases 20(9): 1655-1667

Navaneethan, U. 2014: Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk. Gastroenterology Report 2(3): 193-200

Yu, J.; Wang, Y.; Yu, X.; Liang, P. 2010: Hepatobiliary mucinous cystadenoma and cystadenocarcinoma: report of six cases and review of the literature. Hepato-Gastroenterology 57(99-100): 451-455

Balkman, C. 2009: Hepatobiliary neoplasia in dogs and cats. Veterinary Clinics of North America. Small Animal Practice 39(3): 617-625

Manxhuka-Kerliu, S.; Petrusevska, G.; Maloku, H.; Sahatciu-Meka, V.; Loxha, S.; Loxha, N.; Shahini, L. 2010: Hepatobiliary neuroendocrine carcinoma: a case report. Journal of Medical Case Reports 4: 53

Shah, S.; Khandelwal, C.; Sharma, A.K. 2012: Hepatobiliary pancreatic surgery at the forefront. Indian Journal of Surgery 74(1): 1

Lefkowitch, J.H. 2007: Hepatobiliary pathology. Current Opinion in Gastroenterology 23(3): 221-231

Lefkowitch, J.H. 2008: Hepatobiliary pathology. Current Opinion in Gastroenterology 24(3): 269-277

Taylor, S.L.; Haque, S. 2011: Hepatobiliary pathology. Current Opinion in Gastroenterology 27(3): 248-255

Liu, Y.; Hou, W.; Li, L.; Cheng, W. 2014: Hepatobiliary physiological changes after Roux-en-Y cholecysto-colonic diversion. Journal of Pediatric Surgery 49(7): 1104-1108

Glockzin, G.; Renner, P.; Popp, F.C.; Dahlke, M.H.; von Breitenbuch, P.; Schlitt, H.J.; Piso, P. 2011: Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Annals of Surgical Oncology 18(4): 1052-1059

Hallay, J.; Olah, A.V.; Fulesdi, B.; Kocsor, M.; Vegh, T.; Kovacs, G.; Takacs, I.; Sapy, P.; Nagy, D.; Telessy, I.G. 2010: Hepatobiliary response in postoperative lipid therapy in gastrointestinal surgery. Hepato-Gastroenterology 57: 102-103

Elwahab, M.A.; Hamed, H.; Shehta, A.; Ali, M.; Zalata, K. 2014: Hepatobiliary rhabdomyosarcoma mimicking choledochal cyst: Lessons learned. International Journal of Surgery Case Reports 5(4): 196-199

Powell, D.K.; Goldfarb, R.C.; Ongseng, F. 2013: Hepatobiliary rim sign: new implications for acute and complicated cholecystitis. Nuclear Medicine Communications 34(5): 467-477

Yi, D.Y.; Kim, J.Y.; Choi, E.Y.; Choi, J.Y.; Yang, H.R. 2014: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children. Bmc Pediatrics 14: 51

Chamarthy, M.; Freeman, L.M. 2010: Hepatobiliary scan findings in chronic cholecystitis. Clinical Nuclear Medicine 35(4): 244-251

Cho, J.Y.; Han, H.-S.; Yoon, Y.-S.; Ahn, K.S.; Lee, S.H.; Hwang, J.-H. 2011: Hepatobiliary scan for assessing disease severity in patients with cholelithiasis. Archives of Surgery 146(2): 169-174

Zissimopoulos, A.; Cassimos, D.; Deftereos, S.; Prassopoulos, P.; Xinias, I.; Pavlidou, C.; Mavroudi, A.; Vrani, O.; Chatzimichael, A. 2009: Hepatobiliary scan in Alagille syndrome; arteriohepatic dysplasia. Hellenic Journal of Nuclear Medicine 12(2): 158-160

Castagnetti, M.; Davenport, M.; Tizzard, S.; Hadzic, N.; Mieli-Vergani, G.; Buxton-Thomas, M. 2007: Hepatobiliary scintigraphy after Kasai procedure for biliary atresia: clinical correlation and prognostic value. Journal of Pediatric Surgery 42(6): 1107-1113

Tarakji, A.M.; Morales, F.; Rovito, P. 2007: Hepatobiliary scintigraphy as a diagnostic modality for gastroparesis of the bypassed stomach after gastric bypass for morbid obesity. Obesity Surgery 17(3): 414-415

Arnell, H.; Fischler, B.ör.; Bergdahl, S.; Schnell, P.-O.; Jacobsson, H.; Nemeth, A. 2011: Hepatobiliary scintigraphy during cholestatic and noncholestatic periods in patients with progressive familial intrahepatic cholestasis after partial external biliary diversion. Journal of Pediatric Surgery 46(3): 467-472

Koç, Z.P.; Balci, T.A.; Kepenek, F. 2011: Hepatobiliary scintigraphy findings of a patient with polianomaly presenting with icterus. BMJ Case Reports

Kim, Y.J.; Lee, K.T.; Jo, Y.C.; Lee, K.H.; Lee, J.K.; Joh, J.-W.; Kwon, C.H.D. 2011: Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation. World Journal of Gastroenterology 17(21): 2626-2631

Fukuda, A.; Sakamoto, S.; Shigeta, T.; Kakiuchi, T.; Matsuno, N.; Tanaka, H.; Kitamura, M.; Nosaka, S.; Nakazawa, A.; Kasahara, M. 2011: Hepatobiliary scintigraphy for the assessment of biliary stricture after pediatric living donor liver transplantation for hepaticojejunostomy reconstruction: the value of the excretion rate at 60 min. Pediatric Transplantation 15(6): 594-600

Concannon, R.C.; Howman-Giles, R.; Shun, A.; Stormon, M.O. 2009: Hepatobiliary scintigraphy for the assessment of biliary strictures after pediatric liver transplantation. Pediatric Transplantation 13(8): 977-983

Ramírez-Ocaña, D.; Ruiz-Catena, M.J.; Doblado-Lopez, A.; Ruiz-García, J.; Puentes-Zarzuela, C. 2014: Hepatobiliary scintigraphy for the evaluation of hepatic cyst. Revista Espanola de Medicina Nuclear e Imagen Molecular 33(5): 322-323

Ziessman, H.A. 2014: Hepatobiliary scintigraphy in 2014. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 55(6): 967-975

Balakrishnan, V.B.; Kumar, R.; Dhanpathi, H.; Nadig, M.; Mohapatra, T.; Bal, C.S.; Malhotra, A. 2008: Hepatobiliary scintigraphy in detecting lesser sac bile leak in postcholecystectomy patients: the need to recognize as a separate entity. Clinical Nuclear Medicine 33(3): 161-167

Mittal, B.R.; Sunil, H.V.; Bhattacharya, A.; Singh, B. 2008: Hepatobiliary scintigraphy in management of bile leaks in patients with blunt abdominal trauma. ANZ Journal of Surgery 78(7): 597-600

El Desouki, M.; Mohamadiyeh, M.; Al Rabeaah, A.; Othman, S.; Al Jurayyan, N.; Asaad, A.; Skiff, Z.; Malabarey, T.; Al Samarrai, A. 1997: Hepatobiliary scintigraphy in the diagnosis of choledochal cysts in children. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 3(2): 78-83

El-Desouki, M.; Mohamadiyah, M.; Al Rabeeah, A.; Othman, S.; Al Jurayyan, N. 1998: Hepatobiliary scintigraphy in the distinction between biliary hypoplasia and biliary atresia. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 4(1): 8-12

Kitzing, B.; O'Toole, S.; Waugh, A.; Clayton, J.; McGill, N.; Allman, K.C. 2009: Hepatobiliary scintigraphy in vasculitis of the gallbladder as a manifestation of polyarteritis nodosa: a case report. Cases Journal 2: 9300

Kawaguchi, Y.; Ishizawa, T.; Masuda, K.; Sato, S.; Kaneko, J.; Aoki, T.; Beck, Y.; Sugawara, Y.; Hasegawa, K.; Kokudo, N. 2011: Hepatobiliary surgery guided by a novel fluorescent imaging technique for visualizing hepatic arteries, bile ducts, and liver cancers on color images. Journal of the American College of Surgeons 212(6): E33-E39

Tamura, S.; Sugawara, Y. 2014: Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth. Hepatobiliary surgery and nutrition 3(1): 55-56

Hamberger, C.; Kellert, M.; Schauer, U.M.; Dekant, W.; Mally, A. 2010: Hepatobiliary toxicity of furan: identification of furan metabolites in bile of male f344/n rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(10): 1698-1706

Ringe, K.I.; Husarik, D.B.; Gupta, R.T.; Boll, D.T.; Merkle, E.M. 2011: Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal?. European Journal of Radiology 79(2): 201-205

Chan, J.; Vandeberg, J.L. 2012: Hepatobiliary transport in health and disease. Clinical Lipidology 7(2): 189-202

Zhang, X.-y.; Yang, J.; Yin, X.-f.; Liu, X.-d.; Wang, G.-j. 2009: Hepatobiliary transport of glutathione and its role in cholestasis. Yao Xue Xue Bao 44(4): 327-332

Bernhardt, G.A.; Zollner, G.; Cerwenka, H.; Kornprat, P.; Fickert, P.; Bacher, H.; Werkgartner, G.; Müller, G.; Zatloukal, K.; Mischinger, H.-J.ör.; Trauner, M. 2012: Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy. Liver International: Official Journal of the International Association for the Study of the Liver 32(1): 119-127

De Lima Toccafondo Vieira, M.; Tagliati, C.A. 2014: Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opinion on Drug Metabolism and Toxicology 10(4): 581-597

Marin, J.J.G.; Briz, O.; Perez, M.J.; Romero, M.R.; Monte, M.J. 2009: Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs. Frontiers in Bioscience 14(11): 4257-4280

Amarapurkar, D.N.; Patel, N.D.; Amarapurkar, A.D. 2008: Hepatobiliary tuberculosis in western India. Indian Journal of Pathology and Microbiology 51(2): 175-181

Mercado, M.A.; Uribe, A.E. 2012: Hepatobiliary tumors. Revista de Gastroenterologia de Mexico 77(Suppl 1): 106-107

Seale, M.K.; Catalano, O.A.; Saini, S.; Hahn, P.F.; Sahani, D.V. 2009: Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics: a Review Publication of the Radiological Society of North America Inc 29(6): 1725-1748

Kudriashova, N.E.; Ermolov, A.S.; Ivanov, P.A.; Guliaev, A.A.; Samsonov, V.T.; Trofimova, E.I.; Pavlikova, E.I.; Kuprikov, S.V. 2007: Hepatobiliscintigraphy in the diagnosis of obstructive jaundice. Vestnik Rentgenologii i Radiologii 3: 39-45

Mansuroglu, T.üm.; Dudás, J.óz.; Elmaouhoub, A.; Joza, T.Z.; Ramadori, G. 2009: Hepatoblast and mesenchymal cell-specific gene-expression in fetal rat liver and in cultured fetal rat liver cells. Histochemistry and Cell Biology 132(1): 11-19

Li, F.; Liu, P.; Liu, C.; Xiang, D.; Deng, L.; Li, W.; Wangensteen, K.; Song, J.; Ma, Y.; Hui, L.; Wei, L.; Li, L.; Ding, X.; Hu, Y.; He, Z.; Wang, X. 2010: Hepatoblast-like progenitor cells derived from embryonic stem cells can repopulate livers of mice. Gastroenterology 139(6): 2158-2169.E8

Chan, R.; Mascarenhas, L.; Venkatramani, R. 2014: Hepatoblastoma and hypoplastic kidneys: a new association. Pediatric Blood and Cancer 61(8): 1476-1478

Becknell, B.; Pais, P.; Onimoe, G.; Rangarajan, H.; Schwaderer, A.L.; McHugh, K.; Ranalli, M.A.; Hains, D.S. 2011: Hepatoblastoma and prune belly syndrome: a potential association. Pediatric Nephrology 26(8): 1269-1273

Krawczuk-Rybak, M.; Jakubiuk-Tomaszuk, A.; Skiba, E.; Plawski, A. 2012: Hepatoblastoma as a result of APC gene mutation. Journal of Pediatric Gastroenterology and Nutrition 55(3): 334-336

Berger, M.; Neth, O.; Ilmer, M.; Garnier, A.ès.; Salinas-Martín, M.V.; de Agustín Asencio, J.C.; von Schweinitz, D.; Kappler, R.; Muñoz, M. 2014: Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Journal of Hepatology 60(5): 985-994

Bieze, M.; van Gulik, T.M.; Bennink, R.J. 2013: Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT. Clinical Nuclear Medicine 38(2): E80-E82

Meyers, A.B.; Towbin, A.J.; Geller, J.I.; Podberesky, D.J. 2012: Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation. Pediatric Radiology 42(7): 859-866

Shah, R.; Tran, H.C.; Randolph, L.; Mascarenhas, L.; Venkatramani, R. 2014: Hepatoblastoma in a 15-month-old female with trisomy 13. American Journal of Medical Genetics. Part a 164a (2): 472-475

Kopic, S.; Eirich, K.; Schuster, B.; Hanenberg, H.; Varon-Mateeva, R.; Rittinger, O.; Schimpl, G.ün.; Schindler, D.; Jones, N. 2011: Hepatoblastoma in a 4-year-old girl with Fanconi anaemia. Acta Paediatrica 100(5): 780-783

Calton, E.A.; Temple, I.K.; Mackay, D.J.G.; Lever, M.; Ellard, S.; Flanagan, S.E.; Davies, J.H.; Hussain, K.; Gray, J.C. 2013: Hepatoblastoma in a child with a paternally-inherited ABCC8 mutation and mosaic paternal uniparental disomy 11p causing focal congenital hyperinsulinism. European Journal of Medical Genetics 56(2): 114-117

Kaur, G.; Mutum, S.S. 2001: Hepatoblastoma in a low birth weight infant : a case report and review of the literature. Malaysian Journal of Medical Sciences: Mjms 8(1): 69-72

Pereira, E.M.; Marion, R.; Ramesh, K.H.; Kim, J.S.; Ewart, M.; Ricafort, R. 2012: Hepatoblastoma in a mosaic trisomy 18 patient. Journal of Pediatric Hematology/Oncology 34(4): E145-E148

Kato, M.; Takita, J.; Takahashi, K.; Mimaki, M.; Chen, Y.; Koh, K.; Ida, K.; Oka, A.; Mizuguchi, M.; Ogawa, S.; Igarashi, T. 2009: Hepatoblastoma in a patient with sotos syndrome. Journal of Pediatrics 155(6): 937-939

Zheng, M.Hua.; Zhang, L.; Gu, D.Na.; Shi, H.Qi.; Zeng, Q.Qiang.; Chen, Y.Ping. 2009: Hepatoblastoma in adult: review of the literature. Journal of Clinical Medicine Research 1(1): 13-16

Kummerfeld, M.; Klaunick, Götz.; Drückler, E.; Classen, C-Friedrich.; Hauenstein, C.; Stuhldreier, G. 2010: Hepatoblastoma in association with bilateral polycystic kidneys. Journal of pediatric surgery 45(11): e23-e25

Trobaugh-Lotrario, A.D.; Venkatramani, R.; Feusner, J.H. 2014: Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?. Journal of Pediatric Hematology/Oncology 36(5): 369-373

De Fine Licht, S.; Schmidt, L.S.; Rod, N.H.; Schmiegelow, K.; Lähteenmäki, P.M.; Kogner, P.; Träger, C.; Stokland, T.; Schüz, J. 2012: Hepatoblastoma in the Nordic countries. International Journal of Cancer 131(4): E555-E561

Chattopadhyay, S.; Mukherjee, S.; Boler, A.; Sharma, A.; Biswas, S.Kumar. 2012: Hepatoblastoma in the neonatal period: An unusual presentation. Journal of Cytology 29(4): 252-254

Izumi, Y.; Hoshino, K.; Shimojima, N.; Fuchimoto, Y.; Hayashi, Y.; Morikawa, Y.; Nomori, H. 2013: Hepatoblastoma metastasis confined to the pulmonary artery: report of a case. Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 19(3): 253-256

Kesik, V.; Yozgat, Y.; Sari, E.; Kocaoğlu, M.; Kismet, E.; Koseoglu, V. 2009: Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone. Pediatric Hematology and Oncology 26(8): 583-588

Marino, S.; Caruso, M.; Magro, G.; D'Amico, S.; La Spina, M.; Moscheo, C.; Russo, G.; Di Cataldo, A. 2015: Hepatoblastoma presenting as precocious puberty: a case report. Journal of Pediatric Endocrinology and Metabolism: Jpem 28(3-4): 429-432

Gutweiler, J.R.; Yu, D.C.; Kim, H.B.; Kozakewich, H.P.; Marcus, K.J.; Shamberger, R.C.; Weldon, C.B. 2008: Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. Journal of Pediatric Surgery 43(12): 2297-2300

Czauderna, P.; Lopez-Terrada, D.; Hiyama, E.; Häberle, B.; Malogolowkin, M.H.; Meyers, R.L. 2014: Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Current Opinion in Pediatrics 26(1): 19-28

Meyers, R.L.; Tiao, G.; de Ville de Goyet, J.; Superina, R.; Aronson, D.C. 2014: Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Current Opinion in Pediatrics 26(1): 29-36

Czauderna, P. 2012: Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt. Frontiers in Bioscience 4(1): 470-479

Huang, Y.-L.; Shih, S.-L.; Liu, H.-C.; Yeh, T.-C. 2010: Hepatoblastoma with tumor extension through the inferior vena cava into the right atrium. Journal of Pediatric Gastroenterology and Nutrition 50(6): 577

Sullivan, M.J. 2009: Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears. Cancer 115(24): 5623-5626

Devi, L.Purnima.; Kumar, R.; Handique, A.; Kumar, M. 2014: Hepatoblastoma--a rare liver tumor with review of literature. Journal of Gastrointestinal Cancer 45 Suppl. 1: 261-264

Leal-Leal, C.A.; Imaz-Olguín, V.; Robles-Castro, J.; Shalkow-Klincovstein, J.; Palacios-Acosta, Jé.M. 2010: Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system. Annals of Hepatology 9(1): 75-79

Moon, S.-B.; Shin, H.-B.; Seo, J.-M.; Lee, S.-K. 2011: Hepatoblastoma: 15-year experience and role of surgical treatment. Journal of the Korean Surgical Society 81(2): 134-140

Shukla, P.J.; Barreto, S.G.; Qureshi, S.S.; Hawaldar, R.; Shrikhande, S.V.; Ramadwar, M.R.; Banavali, S. 2008: Hepatoblastoma: a single institutional experience of 18 cases. Pediatric Surgery International 24(7): 799-802

Singh, T.; Satheesh, C.T.; Appaji, L.; Aruna Kumari, B.S.; Padma, M.; Kumar, M.V.; Mukherjee, G. 2010: Hepatoblastoma: experience from a single center. Indian Journal of Cancer 47(3): 314-316

Goh, C.Xian-yang.; Pua, U. 2014: Hepatobronchial fistula following multiple-session doxorubicin-eluting bead chemoembolization in a large hepatocellular carcinoma. Journal of Vascular and Interventional Radiology: Jvir 25(1): 150-152

Morales, A.; Mari, M.; Garcia-Ruiz, C.; Colell, A.; Fernandez-Checa, J.C. 2012: Hepatocarcinogenesis and ceramide/cholesterol metabolism. Anti-Cancer Agents in Medicinal Chemistry 12(4): 364-375

Nishina, S.; Hino, K. 2012: Hepatocarcinogenesis and iron metabolic disorder. Nihon Shokakibyo Gakkai Zasshi 109(4): 563-570

Honda, M.; Yamashita, T.; Kaneko, S. 2011: Hepatocarcinogenesis by HBV. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 356-362

Tang, C-Hui.; Wei, W.; Hanes, M.A.; Liu, L. 2013: Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition. Cancer Research 73(9): 2897-2904

Hirakawa, M.; Ikeda, K.; Arase, Y.; Kawamura, Y.; Yatsuji, H.; Hosaka, T.; Sezaki, H.; Akuta, N.; Kobayashi, M.; Saitoh, S.; Suzuki, F.; Suzuki, Y.; Kumada, H. 2008: Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients. Internal Medicine 47(19): 1637-1643

Calvisi, D.Francesco.; Evert, M.; Dombrowski, F. 2009: Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats. Archives of Physiology and Biochemistry 115(2): 97-104

Liu, N.; Meng, Z.; Lou, G.; Zhou, W.; Wang, X.; Zhang, Y.; Zhang, L.; Liu, X.; Yen, Y.; Lai, L.; Forman, B.M.; Xu, Z.; Xu, R.; Huang, W. 2012: Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Molecular Endocrinology 26(5): 775-785

Nakade, Y.; Sato, K.; Nakao, H.; Yoneda, M. 2012: Hepatocarcinogenesis in NASH. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 693-697

Yamashita, N.; Ohho, A.; Yamasaki, A.; Kurokawa, M.; Kotoh, K.; Kajiwara, E. 2014: Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes. Journal of Gastroenterology 49(11): 1504-1513

Fujinaga, H.; Tsutsumi, T.; Yotsuyanagi, H.; Moriya, K.; Koike, K. 2011: Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology 81(Suppl 1): 11-17

Marx-Stoelting, P.; Borowiak, M.; Knorpp, T.; Birchmeier, C.; Buchmann, A.; Schwarz, M. 2009: Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met. International Journal of Cancer 124(8): 1767-1772

Tokushige, K.; Hashimoto, E.; Kodama, K. 2013: Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan. Journal of Gastroenterology and Hepatology 28(Suppl 4): 88-92